Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2010

OspC in the pathogenesis of Borrelia burgdorferi
Sunita V. Seemanapalli
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Veterinary Pathology and Pathobiology Commons

Recommended Citation
Seemanapalli, Sunita V., "OspC in the pathogenesis of Borrelia burgdorferi" (2010). LSU Doctoral
Dissertations. 447.
https://digitalcommons.lsu.edu/gradschool_dissertations/447

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

OSPC IN THE PATHOGENESIS OF BORRELIA BURGDORFERI

A Dissertation

Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical College
In partial fulfillment of the
Requirements for the degree of
Doctor of Philosophy

in
The Interdepartmental Program in
Veterinary Medical Sciences
Through the Department of Pathobiological Sciences

by
Sunita V. Seemanapalli
M.B.B.S., Federal University of Paraiba, 1994
M.S., Southern University, 1998
May 2010

DEDICATION
“Worthy is the Lamb, who was slain, to receive power and wealth and wisdom and strength and
honor and glory and praise.”
Revelation 5:12

To my Father and Mother
Dr. Sarma V.K. Seemanapalli, Ph.D.
and Mrs. Santa K. Seemanapalli, M.P.A.

ii

ACKNOWLEDGEMENTS
My first acknowledgement goes to my Lord and Savior Jesus. Without Him and His
Word, I could not have seen my way through to the completion of this Ph.D. program. Next, I
would like to thank my parents, Dr. Sarma V.K. Seemanapalli and Mrs. Santa K. Seemanapalli
who have always been there to encourage me and to strengthen me. They also provided a safe
haven in their home to rest and relax. Thank you, Mother, for the many “extra” meals that you
cooked for me! Thanks also to my sister Sujata and my brother Sastry for supporting me in this
endeavor.
I am immensely grateful to my major Professor, Dr. Fang-ting Liang, for all the guidance
and support he has given me both in the lab and in life and for the patience he had with me. I will
always admire his keenness, innovative thinking and scientific writing skills. I also want to thank
Dr. Qilong Xu for all the guidance he gave me concerning molecular biology and other
techniques. I will miss the informal discussions we used to have about science and research in
general. Special thanks to Kristy McShan for the many times we needed to do mouse isolations. I
will miss you! I also want to thank Cecilia Koon and the staff in the Department of Laboratory
Animal Medicine.
I am also grateful to the rest of my Graduate Committee Members Dr. Elzer, Dr.
Kousoulas, Dr. Macaluso and Dr. Schowalter. They have each uniquely contributed to my
development as a researcher and to this research work with their questions, comments, guidance,
support and constructive criticism. Thanks also to every member that came along Dr. Liang’s
lab, including: Amanda P.D. Polito, Katie Reif, Yanlin Shi, Rajiv Gaur, Rebecca Christofferson,
and more recently added members of the lab, Yihe Ge, Xiaomei He, Poonam Dhadwal, and Rui
Wang for their friendship and support. Thanks also to all the Professors in the Department of
Pathobiological Sciences and the Main Campus who had taught me all the different courses, and
iii

conducted journal clubs and labs. I am also thankful to Thaya Guedry in BioMMed for her help
with the gel imager and DNA sequences. I would also like to acknowledge the staff in the
Pathology section, Cheryl Crowder, Hal Holloway and Kendra Schultz, for their help with the
histopathogy slides and the staff in the PBS Office, especially Tracy Rook, for her help with
paperwork and course registrations. Finally, I would like to thank my friends from Bethany
World Prayer Center and from The Chapel who have been there for me, cheering me up. I
enjoyed their fellowship and am thankful for their prayers.

iv

TABLE OF CONTENTS
DEDICATION ................................................................................................................................ ii
ACKNOWLEDGMENTS ............................................................................................................. iii
LIST OF TABLES ......................................................................................................................... ix
LIST OF FIGURES ....................................................................................................................... xi
ABSTRACT ................................................................................................................................. xiii
CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW ................................................1
INTRODUCTION ....................................................................................................................1
LITERATURE REVIEW .........................................................................................................2
Discovery of Lyme Disease .................................................................................................2
Clinical Manifestations of Lyme Disease ............................................................................3
Diagnosis and Treatment of Lyme Disease .........................................................................6
Vaccine Development against Lyme Disease ......................................................................8
EPIDEMIOLOGY AND TICK VECTOR LIFE CYCLE ......................................................10
MOUSE MODEL OF LYME DISEASE ...............................................................................16
BORRELIA BURGDORFERI .................................................................................................17
Taxonomy .........................................................................................................................17
Biology of B. burgdorferi .................................................................................................18
Genome .............................................................................................................................19
Lipoproteins ......................................................................................................................20
Coordinated Expression of OspA and OspC ....................................................................22
OspC Groups and Invasiveness ........................................................................................24
Regulation of ospC Gene Expression ...............................................................................24
Characteristics of OspC ....................................................................................................26
Crystal Structure of OspC .................................................................................................27
Functions of OspC ............................................................................................................28
STATEMENT OF THE PROBLEM ......................................................................................32
GOAL, SPECIFIC OBJECTIVES AND HYPOTHESIS .......................................................33
REFERENCES .......................................................................................................................36
CHAPTER 2. SELECTIVE STRUCTURAL DELETIONS OF OSPC ABOLISH THE ROLE
OF OSPC IN EVASION OF BORRELIA BURGDORFERI FROM HOST INNATE
DEFENCES ............................................................................................................................54
INTRODUCTION ..................................................................................................................54
MATERIALS AND METHODS ............................................................................................55
Strains Generated Previously and Used in This Study ...................................................55
Construction of Plasmids pBBE22-ospCβs1, pBBE22-ospCβs2, pBBE22-ospCαH4
and pBBE22-ospCNt10...................................................................................................55
Additional Plasmids Generated Previously and Used in This Study ..............................61
Generation of ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4, ∆ospC/∆Nt10 and
∆ospC/∆ct13 Transformants ...........................................................................................61
v

Immunoblot Analysis ......................................................................................................62
SCID Mice Infection Study ............................................................................................63
Examination of Plasmid Content by PCR .......................................................................63
RESULTS ...............................................................................................................................64
The Plasmid Contents of the Various Transformants Generated.....................................64
Various Truncated OspC Mutants Are Unable to Aid Borrelia Evade Quick Clearance 65
DISCUSSION .........................................................................................................................65
REFERENCES .......................................................................................................................69
CHAPTER 3. OUTER SURFACE PROTEIN C IS A DISSEMINATION-FACILITATING
FACTOR OF BORRELIA BURGDORFERI DURING MAMMALIAN INFECTION .........73
INTRODUCTION ..................................................................................................................73
MATERIALS AND METHODS ............................................................................................76
Previously Generated Strains and Constructs Used in The Current Study ....................76
Creation of The Constructs pBBE22-ospCnt5 and pBBE22-ospCnt10 .........................76
Transformation of B. burgdorferi and Selection of Transformants ................................78
Indirect Immunofluorescence Assay ..............................................................................78
SCID Mice Infectivity Studies ........................................................................................80
Determination of ID50 Values .........................................................................................81
Dissemination Studies in SCID and Wild Type Mice ...................................................81
Quantitation of Tissue Spirochetal Load .......................................................................82
Preparation of flaB-actin Fusion Standard .....................................................................82
DNA Preparation ...........................................................................................................83
Quantitative PCR (qPCR) ...............................................................................................83
Statistical Analysis .........................................................................................................84
RESULTS ...............................................................................................................................84
Generation of B. burgdorferi Producing OspC with Either 5 or 10 Amino
Acid Deletion .................................................................................................................84
Neither The 5- nor The 10-AA Deletion Affects The Surface Location of OspC ........84
The 10- but not the 5-AA Deletion Abolishes Infectivity .............................................84
The 5-AA Deletion Does Not Affect The ID50 Value in SCID Mice ............................86
The 5-AA Deletion Does Not Reduce Spirochete Burdens in Joint or Skin of
SCID Mice .....................................................................................................................86
The 5-AA Deletion Leads to Slowed Dissemination During Infection of
SCID Mice ....................................................................................................................87
The 5-AA Deletion Causes Severely Impaired Dissemination During Infection of
Immunocompetent Mice ...............................................................................................89
DISCUSSION .........................................................................................................................90
REFERENCES .......................................................................................................................95
CHAPTER 4. OUTER SURFACE PROTEIN C IS INVOLVED IN SELF-REGULATION
IN BORRELIA BURGDORFERI DURING MURINE INFECTION ....................................99
INTRODUCTION ..................................................................................................................99
MATERIALS AND METHODS ..........................................................................................102
Strains and Constructs Generated Previously and Used in This Study ....................102
Generation of B. burgdorferi Producing OspC with N-terminus 5-AA Deletion......102
Indirect Immunofluorescene Assay (I-IFA)...............................................................103
vi

Quantitation of ospC Gene Expression .....................................................................105
RNA Preparation .......................................................................................................105
cDNA Preparation .....................................................................................................106
Quantitative RT-PCR (qRT-PCR) ............................................................................106
Passive Immunization of SCID Mice with Anti-OspC Monoclonal Antibody .........107
Evaluation of Anti-Borrelia Specific Immune Response in Wild Type Mice...........107
Statistical Analysis .....................................................................................................107
RESULTS .............................................................................................................................107
Generation of B. burgdorferi Producing OspC with OspC N-terminal
5-AA Deletion ............................................................................................................107
The N-terminal Truncation Does Not Affect The Surface Location of OspC ..........108
Deletion of The N-terminal 5-AA Sequence Severely Affects The Ability of
B. burgdorferi to Downregulate ospC During Infection of SCID Mice ....................108
OspC Monoclonal Antibodies Clear Borrelia Expressing N-terminus 5-AA
Deleted OspC ............................................................................................................109
Anti-Borrelia Specific Immune Responses Clear ∆ospC/∆Nt5 Spirochetes in
Immunocompetent Mice ............................................................................................112
DISCUSSION .......................................................................................................................113
REFERENCES .....................................................................................................................118
CHAPTER 5. THE C-TERMINAL 9-AA STRETCH OF OspC IS NOT IMPORTANT
FOR VIRULENCE OF BORRELIA BURGDORFERI BUT FOR BALANCING
ospC EXPRESSION DURING MURINE INFECTION ....................................................123
INTRODUCTION ................................................................................................................123
MATERIALS AND METHODS ..........................................................................................126
Generation of B. burgdorferi Expressing OspC with Different C-terminal
Deletions .....................................................................................................................126
Infection Study in SCID Mice ....................................................................................127
Determination of ID50 Values .....................................................................................127
Quantification of Tissue Spirochetal Load and ospC Gene Expression Level ...........129
Statistical Analysis ......................................................................................................129
RESULTS .............................................................................................................................129
Generation of B. burgdorferi Expressing OspC with Different
C-terminal Deletions………………………………………………………………. .129
Deletion of The C-terminal 6- but Not 9-AA Sequence Abrogates
Arthritis Virulence in SCID Mice ...............................................................................130
Deletion of The C-terminal 6- or 9-AA Sequence Does Not Lead to an Increase in
ID50 Values in SCID or Immunocompetent Mice ......................................................131
Deletion of the C-terminal 9-AA Sequence Does Not Affect Tissue Colonization in
Heart or Joint Tissue but Increases Colonization in The Skin of SCID Mice ...........133
Deletion of The C-terminal 9-AA Sequence Leads to Significant Changes in
ospC mRNA Accumulation in All Tissues of SCID Mice .........................................136
DISCUSSION .......................................................................................................................137
REFERENCES .....................................................................................................................142
CHAPTER 6. GENERAL CONCLUSIONS ..............................................................................147
REFERENCES .....................................................................................................................154
vii

APPENDIX A. CALCULATION OF ID50 VALUE BASED ON REED AND MUENCH
MATHEMATICAL TECHNIQUE ......................................................................................157
APPENDIX B. COMPARISION OF ARTHRITIS VIRULENCE BETWEEN MICE
INOCULATED WITH CONTROL SPIROCHETES AND MICE INOCULATED
WITH SPIROCHETES EXPRESSING THE N-TERMINUS 5-AA DELETED OSPC ....158
VITA ...........................................................................................................................................159

viii

LIST OF TABLES
Table 2.1. Primers used to make the pBBE22-ospCβs1, pBBE22-ospCβs2, pBBE22-ospCαH4
and pBBE22-ospCNt10................................................................................................60
Table 2.2. PCR primers for examination of plasmid content in B. burgdorferi............................64
Table 2.3. Various types of truncated OspC mutants are unable to aid Borrelia evade
quick clearance from murine skin ................................................................................66
Table 3.1. Constructs and clones used in the study. ......................................................................77
Table 3.2. Primers used in the study ............................................................................................78
Table 3.3. The 10-AA deletion abolishes infectivity of B. burgdorferi ........................................87
Table 3.4. Deletion of the N-terminus 5-AA sequence of OspC does not significantly
affect the ID50 value in immunodeficient mice ..........................................................88
Table 3.5. N-terminal 5-AA deletion of OspC impairs the ability of
B. burgdorferi to disseminate to remote tissues in immunodeficient mice .................92
Table 3.6. N-terminal 5-AA deletion of OspC severely impairs the ability of
B. burgdorferi to disseminate to remote tissues in immunocompetent mice ...............93
Table 4.1. Constructs and clones used in this study ....................................................................102
Table 4.2. Primers used in this study ..........................................................................................105
Table 4.3. Monoclonal antibodies clear spirochetes expressing N-terminus 5-AA deleted
OspC ...........................................................................................................................112
Table 4.4. Spirochetes expressing the N-terminus 5-AA deleted OspC are unable to evade
specific immune response in wild type mice .............................................................114
Table 5.1. Primers used in the study . .........................................................................................127
Table 5.2. Deletion of the C-terminal 13- but not 6- or 9-AA sequence abrogates
infectivity in SCID mice .............................................................................................133
Table 5.3. Deletion of neither C-terminal 6- nor 9-AA sequence significantly
affects the ID50 value in SCID mice ..........................................................................134
Table 5.4. Deletion of neither C-terminal 6- nor 9-AA sequence significantly
affects the ID50 value in immunocompetent mice.......................................................135

ix

Table 6.1. Functions of OspC within the tick vector and the mammalian host ..........................148
Table 6.2. The effect of OspC amino-acid sequence deletions on OspC function, regulation
of ospC transcript, and other parameters ...................................................................152

x

LIST OF FIGURES
Figure 1.1. Erythema chronicum migrans ......................................................................................5
Figure 1.2. Lyme arthritis ..............................................................................................................6
Figure 1.3. Reported cases of Lyme disease by year, United States, 1994-2008 .........................11
Figure 1.4. Average rate of Lyme disease by County of Residence, United States, 1992-2006 ..12
Figure 1.5. The 2 year enzootic life cycle of the Lyme disease vector .........................................15
Figure 1.6. Phylogeny of spirochetes ............................................................................................17
Figure 1.7. Schematic representation of a spirochete ...................................................................19
Figure 1.8. Membrane structure of spirochetes compared to that of Gram-negative
and Gram-positive bacteria .........................................................................................20
Figure 1.9. The segmented genome of B.burgdorferi ...................................................................21
Figure 1.10. Biosynthesis of lipoproteins ....................................................................................23
Figure 1.11. Coordinated expression of OspA and OspC as Borrelia cycles
between the tick vector and the mammalian host ....................................................25
Figure 1.12. Crystal structure of OspC .........................................................................................30
Figure 1.13. Topology diagram of OspC-HB19 monomer ..........................................................31
Figure 2.1. Generation of B. burgdorferi producing OspC with βs1 deletion ...............................56
Figure 2.2. Generation of B. burgdorferi producing OspC with βs2 deletion ...............................57
Figure 2.3. Generation of B. burgdorferi producing OspC with αH4 deletion ..............................58
Figure 2.4. Generation of B. burgdorferi producing OspC with Nt10 deletion............................59
Figure 3.1. Generation of B. burgdorferi producing OspC with N-terminal
5-AA deletion.............................................................................................................79
Figure 3.2. Deletion of the N-terminal 5-AA or 10-AA does not affect the surface exposure of
OspC ...........................................................................................................................85
Figure 3.3. The N-terminal 5-AA deletion does not reduce the ability of B. burgdorferi
to colonize joint or skin tissues of SCID mice ...........................................................89
xi

Figure 4.1. Generation of B. burgdorferi producing OspC with N-terminal
5-AA deletion...........................................................................................................104
Figure 4.2. The N-terminal 5-AA deletion does not affect the surface exposure of OspC.........110
Figure 4.3. Deletion of N-terminus 5-AA residues leads to significant changes in
ospC mRNA accumulation in the joint tissues .........................................................111
Figure 5.1. The tertiary structure and possible cellular location of OspC ..................................125
Figure 5.2. Generation of B. burgdorferi expressing OspC with C-terminal deletions ..............128
Figure 5.3. Deletion of the C-terminal 6- but not 9-AA sequence diminishes arthritis
virulence in SCID mice ............................................................................................132
Figure 5.4. Influence of deletion of the C-terminal 6- and 9-AA sequences on the
tissue bacterial burden and ospC expression ............................................................138

xii

ABSTRACT
Lyme disease is a multisystem disorder caused by the tick vector Borrelia burgdorferi.
During its life cycle between the tick vector and the mammalian host, Borrelia up- and downregulates the expression of its surface lipoproteins. Of its many surface lipoproteins, the Outer
surface protein C (OspC) is crucial for initial mammalian infection. OspC has a common role
shared with other lipoproteins of protection against host innate defences and a unique function in
facilitating the dissemination of B. burgdorferi in the murine host.
The structure of OspC was solved in 2001 and the lipoprotein was found to be
predominantly alpha-helical with 5 alpha helices and 2 beta sheets interconnected by 6 loops,
and an N- and C-terminus. Not much is known as to how the OspC structure relates to the
function of the lipoprotein and/or possible regulation. The up-and down-regulation of OspC is
achieved by the rpoS alternative sigma factor and by an unidentified repressor, respectively.
Several truncated versions of OspC were tested in an OspC-deficient background to
better understand the role of the amino acid sequences deleted. Structural deletions of 5 to 8-AA
made within the OspC core, resulted in loss of infectivity. Longer deletions of 10- and 13 AA
towards the N- and C-terminus of OspC, respectively, also resulted in loss of infectivity.
Interestingly, a deletion of only 5-AA of the N-terminus of OspC did not affect the role of OspC
in evasion but caused inefficient dissemination of B. burgdorferi in SCID mice.
Interestingly, whereas the deletion of N-terminus 5-AA of OspC resulted in upregulation,
a deletion of 6- and 9-AA of the C-terminus of OspC resulted in downregulation of ospC mRNA
in joints, indicating that OspC may be involved in self-regulation. This hypothesis was
confirmed by the use of monoclonal antibody treatment. Deletion of 6-AA of the C-terminus of
OspC resulted in lower spirochete burdens in heart and joint, whereas deletion of 9-AA resulted
in higher spirochete burden in skin, indicating the tissue-dependent effects resulting from the
xiii

deletion of the C-terminal sequence. Taken together, these results indicate that OspC is involved
in the pathogenesis of B. burgdorferi.
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CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW
INTRODUCTION
Borrelia burgdorferi, the agent of Lyme disease, differentially expresses several
lipoproteins during its transmission cycle between a tick vector and a mammalian host
(Burgdorfer et al., 1982). Timely expression of the outer surface protein C (OspC) is crucial for
the pathogenic strategy of B. burgdorferi. The pathogen expresses OspC abundantly during early
infection of a mammal, when the antigen is required (Liang et al., 2002a, Liang et al., 2002b).
However, OspC being a protective antigen, its continued presence poses a threat to the pathogen,
once anti-OspC humoral response has developed. If the pathogen does not down-regulate OspC
or undergo escape mutations on the ospC gene, infection would be cleared (Xu et al., 2006).
When the crystal structure of OspC was resolved, OspC was shown to be predominantly
alpha-helical in structure (Eicken et al., 2001, Kumaran et al., 2001). The molecule forms dimers
in solution. Each subunit is made up of five alpha helices, two beta strands, six loops that
connect the alpha helices and the beta strands and an amino (N-) and a carboxy (C-) terminus.
Although the solution of the crystal structure did not shed much light to the function of OspC,
through genetic and molecular methodologies, recent studies have shown that OspC has dual
roles in early protection and in facilitation of dissemination of B. burgdorferi (Tilly et al., 2007,
Xu et al., 2008).
In terms of regulation, the ospC gene is under the control of the sigma factor RpoS.
Several virulent genes have an RpoS-dependent promoter (Yang et al., 2000, Yang et al., 2003a).
In mice, RpoS appears to be constitutively expressed. The down-regulation of OspC when under
immune pressure is thus dependent on an as-yet unidentified repressor that negatively regulates
the gene via a specific interaction with the ospC operator (Xu et al., 2007).
1

In this research project, we explored the crystal structure of OspC and made several types
of strategic deletion mutants and analyzed the same for their effects on the functions of OspC
and the regulation of the lipoprotein. The results show that deletion of the beta strands 1, 2 and
alpha helix 4, 13-AA of the C-terminus and 10-AA of the N-terminus of OspC (βs1, βs2, αH4,
Ct13-AA and Nt10-AA) leads to non-infectious spirochete phenotypes, thus abrogating the role
of OspC in early evasion of B. burgdorferi from host innate defences; that 5-AA sequence of the
N-terminus of OspC is able to dissect the role of OspC in early immune evasion from that of
dissemination, because the mutant is infectious but unable to disseminate efficiently in SCID
mice; that the same 5-AA N-terminus sequence and along with the C-terminus of OspC are
involved in self-regulation of ospC. Collectively, this study showed a correlation between the
structure of OspC and its function in innate immune evasion, dissemination and self-regulation.
LITERATURE REVIEW
Discovery of Lyme Disease. Lyme disease was first recognized in 1975 as a distinct
clinical disorder by Dr. Allen Steere. The disease derives its name from the small town of Lyme,
Connecticut, USA (Steere et al., 1977b). Awareness of the disease began when a cluster of
children with an initial diagnosis of “juvenile rheumatoid arthritis” on one small street in Old
Lyme, CT was reported by their parents to the State Health Department. Investigation of this
unexplained arthritis in three contiguous Connecticut communities led to the description of Lyme
arthritis. The geographical clustering of the patients in heavily wooded areas along with the peak
occurrences in summer months suggested an infectious etiology and transmission of the
infectious agent by an arthropod vector (Steere et al., 1977a, Steere et al., 1977b). However, the
serendipitous discovery of the spirochetal etiology of Lyme disease was closely linked with
studies on the natural history of spotted fever rickettsiae on Long Island, New York, where
during 1971-1975, a total of 124 cases of spotted fever with eight deaths occurred. A scientist by
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the name Dr. Willy Burgdorfer along with another scientist, Dr. Jorge Benach from the New
York State Health Department were primarily interested in obtaining a virulent strain of
Rickettsia rickettsii from Dermacentor variabilis ticks collected near the homes of spotted fever
patients on Long Island, New York. Instead, they found R. montana, a rickettsia non-pathogenic
for humans. This then led them to speculate that possibly other tick species, such as the blacklegged deer tick Ixodes dammini (now, I. scapularis), might play a role in the ecology of spotted
fever group. In the fall of 1981, Dr. Benach supplied Dr. Burgdorfer with additional ticks from
Shelter Island, NY. None of the ticks examined contained Rickettsia but Dr. Burgdorfer found
several microfilarias in the hemolymph of two female ticks, and to determine if this nematode
was present in other tissues, he dissected and prepared smears of all other tissues, including the
midgut. Surprisingly, instead of additional microfilaria, he found poorly shaped, long, irregularly
coiled spirochetes. Dark-field microscopy confirmed the nature of the organism. Thus, the
previously unidentified spirochete was named Borrelia burgdorferi, after the scientist Willy
Burgdorfer (Burgdorfer et al., 1982, Glaser, 2006). The antigenic relationship between the I.
scapularis spirochete and Lyme disease was established by indirect immunofluorescence and by
Western Blot of sera from patients recovered from Lyme disease (Burgdorfer et al., 1982). The
discovery of this spirochete as the long-sought etiologic agent of Lyme disease was hailed as an
important breakthrough that led to an exploration of research on other spirochetal diseases.
Clinical Manifestations of Lyme Disease. Lyme disease generally occurs in stages,
with different clinical manifestations at each stage. Although the initial classification of Lyme
disease was as simple as erythema migrans (stage 1), meningitis or Bell’s palsy (stage 2) and
arthritis (stage 3) (Steere et al., 1983), due to the overlap of the clinical manifestations at the
different stages, the disease was re-classified in a system similar to that used to classify Syphilis
(Asbrink and Hovmark, 1988). Thus, Lyme disease was essentially divided into early and late
3

infection. Early infection consists of stage 1 (early localized), followed within days or weeks by
stage 2 (early disseminated) and within weeks or months by intermittent symptoms. Late or
persistent infection (stage 3) usually begins a year or more after the onset of the disease
(Nadelman and Wormser, 1998, Steere, 1989, Yoshinari et al., 1989).
The initial most common and clinical hallmark of the early localized stage of Lyme
disease is a skin rash known as erythema chronicum migrans (Figure 1.1). The rash is recognized
in about 90% of patients with objective evidence of B. burgdorferi infection (Gerber et al.,
1996). Erythema chronicum migrans typically develops at the site of the bite, within 7 to 10 days
after the bite, as a small red annular macule or papule. As the redness around the center grows
larger, the lesion tends to have red outer borders with partial central clearing that may expand to
a diameter of up to 50 cm (Behera et al., 2005, Steere et al., 1978), for which reason the rash is
also known as a “bull’s eye rash”. The lesion is usually asymptomatic but may be pruritic or
painful and it may be accompanied by constitutional symptoms such as low-grade fever, fatigue,
malaise, arthralgias, headaches, cough, stiff neck and regional lymphadenopathy (Steere et al.,
1983).
The most common manifestation of the early disseminated stage is multiple erythema
migrans. These secondary skin lesions appear 3 to 5 weeks after the tick bite and consist of
multiple annular erythematous lesions similar to, but usually smaller than the primary lesion.
Other manifestations of this stage include cranial nerve palsy, especially facial nerve palsy
(Bell’s palsy), and meningitis. Unilateral or bilateral facial palsy is the most common cranial
neuropathy, and it may be the only neurologic abnormality (Clark et al., 1985). Rarely, carditis,
manifested by various degrees of atrio-ventricular (A-V) block, may also occur at this stage
(Steere et al., 1980).

4

Figure 1.1. Erythema chronicum migrans. (Courtesy of Dori F Zaleznik, MD). The rash is
often seen in the early stage of Lyme disease. It is not an allergic reaction to the tick bite but an
actual skin infection by Borrelia burgdorferi. Because of its reddish outer borders and central
clearing, it is commonly referred to as “Bull’s eye rash”.
In the United States, the most common manifestation of late Lyme disease is arthritis.
Arthritis occurs weeks to months after the initial infection; it is usually monoarticular or
oligoarticular (Steere et al., 1977b) and affects the large joints, particularly the knee (Figure 1.2).
Although the joint is swollen and tender, the intense pain associated with a septic arthritis is
usually not present. At this stage, about 10% of adults and 5% of children are refractory to
antimicrobial treatment.
Other manifestations highly indicative of Lyme disease are lymphocytoma,
meningoradiculoneuritis (Garin-Bujadoux-Bannwarth syndrome), and acrodermatitis chronic
atrophicans. Borrelial lymphocytoma, is a solitary bluish-red swelling with a diameter of up to
few centimeters that appears most commonly on the ear lobe or nipple of the breast (Asbrink and
Hovmark, 1988, Maraspin et al., 2002, Strle et al., 1992). Patients with meningoradiculoneuritis
tend to have severe pain, usually in the thoracic or abdominal region, often belt-like and most
pronounced during night (Kristoferitsch, 1991, Pachner and Steere, 1985, Steere, 1989).
Acrodermatitis chronica atrophicans is a skin lesion that begins insidiously with bluish-red
discoloration and swollen skin on an extremity. The lesion’s inflammatory phase may persist for
5

Figure 1.2. Lyme arthritis. (Rahn and Evans, 1998). Lyme arthritis occurs during the late stage
of Lyme disease. It tends to be mono or oligoarticular, usually affecting the large joints,
particularly the knee joint. Although the area is typically swollen, the intensity of joint pain is not
comparable to that of a septic arthritis.
many years and it gradually leads to atrophy of the skin (Asbrink and Hovmark, 1988). It is
most often located in the extensor sites of the hands and feet. It is frequent in patients older than
40 years and is more frequent in women than in men (Asbrink and Hovmark, 1988, Asbrink et
al., 1986, Steere, 1989).
Lyme disease is caused by Borrelia burgdorferi sensu lato strains. The human infection
is caused primarily by three pathogenic genospecies, Borrelia burgdorferi sensu strictu, B.
garinii, and B. afzelii (Johnson et al., 1984). Whereas B. burgdorferi is the sole cause of
infection in the United States, B. garinii and B. afzelii are the main causes of the disease in
Europe and Asia (Baranton et al., 1992, Canica et al., 1993). The various clinical manifestations
of chronic Lyme disease have been associated with different tissue tropisms of the three
genospecies of Borrelia. Cutaneous and neurological manifestations such as acrodermatitis
chronica atroficans and neuroborreliosis are often associated with B.afzelii and B.garinii
infections, respectively, whereas Lyme arthritis is mainly a complication of B. burgdorferi sensu
strictu infections (Balmelli and Piffaretti, 1995, van Dam et al., 1993).
Diagnosis and Treatment of Lyme Disease. According to the Center for Disease
Control and Prevention (CDC, 2009), the diagnosis of Lyme disease is based on symptoms,
objective physical signs (such as the typical erythema migrans, facial palsy, or arthritis), and a
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history of possible exposure to infected ticks. Validated laboratory tests can be very helpful, but
are generally not recommended when a patient has erythema migrans. The most recommended
laboratory tests are serodiagnostic.
CDC recommends a two-step process when testing blood for evidence of Lyme disease.
The first step uses an enzyme immunoassay such as Enzyme-Linked Immunosorbant Assay
(ELISA) or Immunofluoresence Assay (IFA) tests. These tests are designed for screening and are
very sensitive. The ELISA provides a quantitative estimate of the concentration of antibodies
against B. burgdorferi. If the ELISA or IFA is positive or indeterminate (equivocal), a second
step should be performed to confirm the results. The second step uses a Western blot test, for its
high specificity. The immunoblot provides antibodies against specific protein antigens of
Borrelia burgdorferi. Most authorities require the presence of antibodies against at least 2 (for
IgM) or 5 (for IgG) specific protein antigens of B. burgdorferi for the immunoblot to be
considered positive (CDC, 1995). CDC does not recommend testing blood by Western blot
without first testing it by ELISA or IFA. Dressler et al., (Dressler et al., 1993) and Johnson, et
al., (Johnson et al., 1996) showed that the use of Western blot is important in determining
whether “intermediate” results by ELISA are true positive.
Treatment of Lyme disease involves primarily antibiotic therapy. The recommended
treatment for early localized or disseminated Lyme disease, in the absence of specific neurologic
manifestations, involves oral administration of doxycycline, amoxicillin, or cefuroxime axetil for
14 days. The intravenous use of ceftriaxone for 14 days in early Lyme disease is recommended
for adult patients with acute neurologic disease manifested by meningitis or radiculopathy
(Wormser et al., 2006).
Lyme arthritis can usually be treated successfully with antimicrobials administered
orally. Doxycycline, amoxicillin, or cefuroxime axetil for 28 days is recommended for adult
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patients without clinical evidence of neurologic disease. Adult patients with arthritis and
objective evidence of neurologic disease should receive ceftriaxone IV (intravenous) (Wormser
et al., 2006). For persons who have persistent or recurrent joint swelling after a recommended
course of oral antibiotic therapy, the panel formed by Wormser, GP and colleagues recommend
re-treatment with another 4-week course of oral antibiotics or with 2-4- week course of
ceftriaxone IV (Wormser et al., 2006).
The severity and the duration of Lyme arthritis are increased in patients with IgG
antibodies against OspA (Kalish et al., 1993, Steere et al., 1994). Particular class II major
histocompatibility molecule (MHC) genes can determine a host immune response to B.
burgdorferi that results in chronic arthritis and lack of response to antibiotic therapy (Steere et
al., 1990, Steere et al., 1994). Due to the increased frequency of certain MHC molecules such as
HLA-DR3 and HLA-DR4 alleles (Nocton, 1994, Steere et al., 1988, Steere et al., 2006) and the
identification of human leukocyte function-associated antigen-1 (hLFA-1) as a candidate
autoantigen (Gross et al., 1998) in these patients, an autoimmune mechanism has been proposed.
However, LFA-1 is unlikely a relevant autoantigen, instead, an OspA epitope may be critical in
triggering an antibiotic treatment-resistant Lyme arthritis (Steere et al., 2003). Although the
pathogenesis of this refractory arthritis is not well understood, future technologies may allow the
identification of spirochetal components or a relevant autoantigen, or both in the joint synovia of
these patients. Since most patients with treatment-resistant Lyme arthritis yield consistently
negative PCR results after antibiotic treatment, it is possible that chronic synovitis is maintained
in the absence of B. burgdorferi.
Vaccine Development against Lyme Disease. Considerable morbidity is associated
with Lyme disease and there are areas in the United States and Europe where up to 3% of the
population is infected annually (Fahrer et al., 1991). Based on pharmaco-economic studies, there
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is a clear need for a Lyme disease vaccine, particularly in populations where the annual risk
exceeds 1% (Meltzer et al., 1999, Shadick et al., 2001). However, at the present time a human
vaccine is not commercially available. The first human Lyme disease vaccine was an Outer
surface protein A or OspA-based formulation named as LYMErix (GlaxoSmithKline); however,
its tenure was short, and citing a drop in sales, it was voluntarily pulled from the market in 2002.
The decline in sales could be traced to concerns, real or perceived, of possible adverse effects
including a chronic inflammatory arthritis that could theoretically develop in HLA-DR4 positive
patients suggesting a vaccine associated auto-immune arthritis (Kalish et al., 1993). While new
OspA based vaccinogens are being developed to mitigate this potential complication (Koide et
al., 2005, Willett et al., 2004), questions remain about the viability of an OspA-based vaccine.
One concern is the frequency of boosts required to maintain long term protection. OspA is
expressed in the tick midgut, is rapidly down-regulated upon tick feeding, and is not expressed in
mammals. The inherent problems associated with OspA-based vaccines can be avoided by use of
antigens that are expressed at high levels during early mammalian infection and that elicit
bactericidal antibody, such as the outer surface protein C or OspC.
OspC has received considerable attention in Lyme disease vaccine development. Its
expression is induced during tick feeding and maintained during early mammalian infection
(Schwan, 2003). Anti-OspC antibodies have been demonstrated to protect against infection, but
only against strains that are closely related in sequence to the vaccinogen (Bockenstedt et al.,
1997, Gilmore et al., 1996, Scheiblhofer et al., 2003). Analysis of OspC sequences has
delineated 21 phyletic ospC clusters or types that are differentiated by letter designation (A-U)
(Seinost et al., 1999, Wang et al., 1999). Although OspC exhibits diversity, it is genetically
stable during infection (Hodzic et al., 2000, Stevenson et al., 1994). Identification of protective
epitopes of each OspC type will allow for construction of, recombinant, polyvalent, chimeric
9

vaccines that will elicit broad protection. Thus, a tetravalent (Earnhart et al., 2007) and an
octavalent (Earnhart and Marconi, 2007) vaccine based on OspC types have been developed and
resulted in induction of complement-dependent bactericidal activity. Interestingly, a DNAvaccine encoding ospC gene was also shown to be suitable for inducing protection against Lyme
borreliosis (Scheiblhofer et al., 2003).
EPIDEMIOLOGY AND TICK VECTOR LIFE CYCLE
According to the Center for Disease Control and Prevention, since 1985, Lyme disease
has been the most prevalent vector-borne illness in the United States (CDC, 2000). In 2007, more
than 27,000 new cases of Lyme disease were reported in the United States, yielding a national
average of 9.1 cases per 100,000 persons (CDC, 2007). In 2008, State health departments
reported 28,921 confirmed cases and 6,277 probable cases of Lyme disease to CDC (Figure 1.3).
The 2008 Case Definition for Lyme disease, for the purpose of surveillance, states a
confirmed case as:
a) a case of EM with a known exposure. Exposure is defined as having been (less than or equal
to 30 days before onset of EM) in wooded, brushy, or grassy areas (i.e., potential tick habitats) in
a county in which Lyme disease is endemic. A history of tick bite is not required;
b) a case of EM with laboratory evidence of infection and without a known exposure; or
c) a case with at least one late manifestation that has laboratory evidence of infection;
and a probable case as: any other case of physician-diagnosed Lyme disease that has laboratory
evidence of infection. For the purposes of surveillance, the definition of a qualified laboratory
assay is
(1) a positive culture for B. burgdorferi,
(2) two-tier testing interpreted using established criteria (CDC, 1995), or
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Figure 1.3. Reported cases of Lyme disease by year, United States, 1994-2008. (CDCDivision of Vector-borne Infectious Diseases-last reviewed August 2009).
http://www.cdc.gov/ncidod/dvbid/lyme/ld_UpClimbLymeDis.htm. State health departments
reported 28,921 confirmed cases and 6,277 probable cases of Lyme disease to CDC in 2008.
This represents a 5% increase in confirmed cases compared to 2007. The definition and reporting
of probable cases was initiated in 2008 based on revisions to the national surveillance case
definition.

(3) single-tier IgG immunoblot seropositivity interpreted using established criteria (CDC, 2005,
CDC, 1995, Dressler et al., 1993, Engstrom et al., 1995).
Lyme disease is endemic in several regions of the United States, particularly areas of the
Northeast, upper Midwest, and northern California (CDC, 2004, CDC, 2000) (Figure 1.4). The
ten states of the United States with the highest incidence rates are Connecticut, Delaware, New
Hampshire, Massachusetts, Maryland, Maine, New Jersey, Pennsylvania, Minnesota, and
Wisconsin.
Lyme disease is considered a zoonosis because Borrelia burgdorferi, the causative agent
is maintained in a natural infectious cycle that does not include humans, who only inadvertently
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become infected. Transmission of B. burgdorferi to humans occurs by the bite of an infected tick
vector of the genus Ixodes, which is a hard-tick (Steere et al., 1978, Wallis et al., 1978). The tick
vectors vary depending on the region of the United States. The main species involved are I.
scapularis in northeastern and upper midwestern United States, I. pacificus in the far-western

Figure 1.4. Average rate* of Lyme disease by County of Residence† –United States,
1992-2006. (CDC 2008). During the 15-year study period, the number of cases reported
increased 101%. The highest incidence rates were found in Northeastern and North-Central
States.
United States, I. ricinus and I. persulcatus in Eurasia (Lane et al., 1991). In the southeastern and
western United States, immature stages of the vector ticks feed primarily on lizards (Apperson et
al., 1993, Durden et al., 2002, Wright et al., 1998). Lizards, however, rarely serve as competent
reservoir hosts for the pathogenic Lyme disease spirochetes in the USA, probably because
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proteins comprising the alternative complement pathway are responsible for the borreliacidal
activity observed in the blood of certain species of lizards (Kuo et al., 2000).
Ixodes scapularis, also known as the blacklegged tick, was first described by Spielman et
al., (Spielman et al., 1979) as a vector of Babesia microti infecting man in New England. This
tick vector can also transmit Anaplasma the agent of human granulocytic anaplasmosis (HGA)
(Dumler et al., 2001). Ixodes scapularis Say is the same species as I. dammini (Cooley and
Kohls, 1945) and thus has retained the older name (Oliver et al., 1993). I. scapularis, particularly
the immature stages, has a broad host range (mainly small mammals and birds) (Anderson,
1989a, Anderson, 1989b, Anderson, 1988) and the adult ticks feed on large mammals. However,
two hosts stand-out as central to the survival of the tick I. scapularis and of the spirochete B.
burgdorferi: the white-footed mouse, P. leucopus (Anderson and Magnarelli, 1980), which
serves as the host for larval and nymphal ticks, and the white-tailed deer, Odocoileus virginianus
(Bosler et al., 1984, Carey et al., 1980, Piesman et al., 1979, Wilson et al., 1990), which serves
as the host for adult ticks.
The tick has a 2-year life cycle and has four life stages: the egg, and 3 developmental
stages: larva, nymph and adult stages (Figure 1.5). Ixodes ticks feed once at each of the three
developmental stages. The cycle begins with eggs being laid during the spring. The larvae hatch
in the summer and are usually uninfected with B. burgdorferi. The uninfected larval tick feeds on
an infectious vertebrate (during August, September), primarily the white footed mouse,
Peromyscus leucopus which is the natural reservoir for B. burgdorferi. After feeding slowly for 3
to 5 days, engorged larvae drop from the host to the ground where they overwinter. The
following spring, the larvae molt into nymphs. In a similar manner, nymphs also feed for 3-5
days on mammals (during May, June), detach and drop to the forest floor, where they molt into
the adult stage during the fall. After mating, the females lay eggs on the ground the following
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spring before they die and the 2-year life cycle begins again. (Burgdorfer et al., 1988b, Lane and
Loye, 1991, Magnarelli and Anderson, 1988).
Transovarial transmission of B. burgdorferi does occur in ticks (Burgdorfer et al., 1983,
Magnarelli et al., 1986, Piesman et al., 1986). However, it is rare and inadequate to maintain
infected populations of either the tick vector or vertebrate hosts (Schulze et al., 1985). Adult
ticks are infected through transtadial transmission of the spirochetes from immature stage ticks
which had fed earlier in their life history on infected animals (Bosler et al., 1984). It is critical
that the tick feeds on the same host species (particularly rodents and chipmunks) in both of its
immature stages (larval and nymphal), because the life cycle of the spirochete depends on
horizontal transmission (Steere et al., 2004). Studies using animals have shown that the infected
nymphal ticks must remain attached for 36 to 48 hours or longer and infected adult ticks must
remain attached for 48 to 72 hours or longer before the risk of transmission of B. burgdorferi
becomes substantial (Falco et al., 1996, Piesman, 1993, Piesman et al., 1987, Piesman et al.,
1991).
Although all stages have been observed to feed on humans (Main et al., 1981), the
nymphal stage tick is the most likely to transmit the infection to humans. Presumably, because
(1) the nymphs are smaller than the adult ticks, and thus are difficult to be identified and
removed soon; (2) they become engorged quicker than the adults and engorgement is necessary
before the bacteria can be transmitted; and (3) they are prevalent during spring and summer,
when humans enter the habitats where ticks thrive. Interestingly, the seasonal questing (hostseeking pattern) of nymphal I. scapularis precedes the peak of human disease cases (Lane et al.,
1991).
Thus, uninfected larval ticks generally acquire B. burgdorferi by feeding on infectious
mammals and uninfected mammals acquire B. burgdorferi by feeding on infected nymphal ticks.
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Figure 1.5. The 2 year enzootic life cycle of the Lyme disease vector. (CDC-Division of
Vector-borne Infectious Diseases-last modified November 2007).
http://www.cdc.gov/ncidod/dvbid/lyme/ld_transmission.htm. Ixodes scapularis ticks feed once at
each of the three stages of their usual life cycle. Eggs are laid on the ground during the spring,
larvae hatch from the eggs in the summer and take one blood meal on a small mammal or bird,
molt to nymphs the following spring and feed once during late spring or early summer when the
risk of human infection is greatest, and molt into adult stage during fall. After mating, the adult
females feed once, usually on large mammals, and lay their eggs the following spring before they
die.
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Larval feeding follows nymphal feeding and thus it increases the efficiency of the enzootic cycle
of B. burgdorferi because it ensures that juvenile rodents become infected with spirochetes
(May, June) before serving as hosts to larvae (August, September), thus perpetuating the
infection from year to year (Spielman et al., 1985, Wilson and Spielman, 1985).
MOUSE MODEL OF LYME DISEASE
In 1988, Schaible, et al., found that experimental inoculation of several inbred mouse
strains with high-passage isolate of B. burgdorferi led to pathomorphological changes in several
organs, comparable with those found in patients with Lyme disease (Schaible et al., 1988). The
following year, Schaible, et al. reported that severe combined immunodeficiency (SCID) mice
with severely impaired T and B cell functions develop multisystemic disease with a
preponderance for polyarthritis and carditis after inoculation with tick isolate of B. burgdorferi
(Schaible et al., 1989). Although natural rodent hosts and most laboratory mice can have
persistent B. burgdorferi infections without signs of disease, some inbred mice develop joint and
heart pathologies that resemble human infection of Lyme disease (Barthold et al., 1990). Thus,
the mouse serves as a useful model for Lyme disease.
In a mouse model of infection, B. burgdorferi initially establishes a localized infection at
the site of the tick bite, transiently disseminates via the bloodstream to various tissues, including
skin, joints, heart and bladder (Barthold et al., 1991). In addition to mice, other experimentally
infected animals include rats, hamsters, gerbils, rabbits, dogs, and monkeys (Kornblatt et al.,
1984, Kornblatt et al., 1985, Mursic et al., 1990, Piesman et al., 1987). Significantly, infected
primates can develop infection of the central nervous system (CNS) and neurological
manifestations that are not common in infected rodents (Philipp and Johnson, 1994). In 2000, a
study showed for the first time, evidence of induced infection in ponies by exposure to adult
ticks infected with B. burgdorferi (Chang et al., 2000).
16

BORRELIA BURGDORFERI
Taxonomy. Spirochetes are a phylogenetically ancient group of eubacteria (Paster et al.,
1984). The phylum Spirochetes is composed of a single class (Spirochetes) and order
(Spirochetales). The order is divided into three families: Brachyspiraceae, Leptospiraceae,
Spirochaetaceae (Paster and Dewhirst, 2000). Within the family Spirochaetaceae is the genus
Borrelia. Of the 37 known Borrelia species, 12 can cause Lyme disease (LD) transmitted by
ticks (Hengge et al., 2003) (Figure 1.6).

Figure 1.6. Phylogeny of Spirochetes. (Rosa et al., 2005). Members of the phylum Spirochaetes
are easily identified by their unique spiral morphology and periplasmic flagella. The phylum is
composed of a single class and order, divided into three families. Spirochetes include the genera
Leptospira, Treponema and Borrelia, which all contain species pathogenic for the human host.
Borrelia is the only known member of the phylum that contains linear DNA molecules.
Since Borrelia burgdorferi was first isolated in 1982 and identified as a new species of
the genus Borrelia in 1984, hundreds of B. burgdorferi isolates have been cultured worldwide.
Molecular analysis has indicated that these isolates are genetically and phenotypically divergent.
A closely related cluster containing at least 10 tick-borne Borrelia species associated with Lyme
Borreliosis has been defined (Baranton et al., 1992, Canica et al., 1993, Fukunaga et al., 1996,
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Kawabata et al., 1993, Marconi et al., 1995, Postic et al., 1998, Wang et al., 1997). The term
“Borrelia burgdorferi sensu lato” is now collectively used for all Borrelia isolates within this
cluster and to distinguish it from the species “Borrelia burgdorferi sensu strictu” (strict sense of
Borrelia burgdorferi) (Baranton et al., 1992). Hence, the Borrelia burgdorferi sensu lato
complex includes species such as B. burgdorferi sensu strictu, B. afzelii, B. garinii, and B.
japonica.
Biology of B. burgdorferi. Borreliae belong to the spirochete Family and as such have in
common with other spirochetes the following structural characteristics: 1) helical shape and
motile; 2) a double-membrane: an outer membrane, which surrounds the protoplasmic cylinder
complex, consisting of the cytoplasm, the peptidoglycan complex, and the inner membrane; 3)
flagella, located in the periplasmic space between the outer membrane and the protoplasmic
cylinder (Barbour and Hayes, 1986, Holt, 1978, Johnson, 1977) (Figure 1.7).
In terms of size, borreliae are 10-30 μm long and 0.2-.3μm wide; the 7 to 11 periplasmic
flagella give the bacteria its spiral shape (Burgdorfer et al., 1982, Hovind-Hougen et al., 1986).
Borreliae are extracellular, fastidious bacteria requiring a rich growth medium. Dr. Alan Barbour
first grew B. burgdorferi (strain B31) in BSK (Barbour-Stoenner-Kelly) medium (Burgdorfer et
al., 1982). The spirochete is grown at temperatures between 30 and 37 °C in the laboratory in
microaerophilic conditions (Kelly, 1971), hence, it is usually grown in capped tubes with limited
air space. The generation time for Borrelia is 8 to 24 h and culture adapted strains achieve cell
densities of about 108 /ml (Barbour, 1984).
Although B. burgdorferi contains a double-membrane similar to enteric Gram-negative
bacteria, it has several distinct features (Figure 1.8).These features include: an extraordinary
abundance of membrane proteins covalently linked with lipids also known as lipoproteins
(Bergstrom et al., 1989, Brandt et al., 1990); the absence of lipopolysaccharide (LPS)
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Figure 1.7. Schematic representation of a spirochete. (Canale-Parola, 1977). The broken line
indicates the outer membrane. The area delimited by the thick solid line represents the
protoplasmic cylinder. The circles near the ends of the protoplasmic cylinder indicate the
insertion points of the periplasmic flagella. The thin solid lines denote periplasmic flagella.
(Takayama et al., 1987) and phosphatidylethanolamine (Belisle et al., 1994); the presence of
glycolipids other than LPS (Belisle et al., 1994, Eiffert et al., 1991) and an outer membrane
which contains a relatively low density of transmembrane proteins (Radolf et al., 1994).
Genome. The genome of B. burgdorferi sensu strictu strain B31 was completed in 1997
(Fraser et al., 1997). The genome size is relatively small, about 1.5 MB. One of the most striking
features of B. burgdorferi is its unusual genome, which includes a linear chromosome of
approximately 910 kilobases (kb) (Baril et al., 1989, Davidson et al., 1992), and 12 linear and 9
circular plasmids that total 610kb (Figure 1.9). The linear plasmids (lp) and circular plasmids
(cp) are numbered according to their sizes in kilo base pairs. The isolate B31 contains the
following linear plasmids: lp5, lp17, lp21, lp25, four different homologous plasmids of 28 kbp
(lp28-1, lp28-2, lp28-3, and lp28-4), lp36, lp38, lp54, and lp56; and the following circular
plasmids: cp9, cp26 and six or seven homologous plasmids of 32 kbp (cp32-1, cp32-3, cp32-4,
cp32-6, cp32-7, cp32-8 and cp32-9) (Fraser et al., 1997). Comparisons with other B31 cultures
suggest that this isolate may have lost one linear plasmid (lp21) and one or two 32 kbp circular
plasmids during growth in culture since its original isolation (Barbour, 1988, Barbour and Garon,
1987, Norris et al., 1995). Eight plasmids: lp5, lp21, lp28-1, lp28-2, lp28-4, lp56, cp9 and cp32-
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Figure 1.8. Membrane structure of spirochetes compared to that of Gram-negative and
Gram-positive bacteria. (Courtesy of Dr. Fang-ting Liang). All three types of bacteria contain
an inner membrane. Whereas Gram-positive bacteria do not contain an outer membrane and
instead contain an abundance of peptidoglycans, both Gram-negative bacteria and spirochetes
contain an inner and an outer membrane. The difference between the last two is the presence of
lipopolysaccharides on the outer surface of Gram-negative bacteria and the absence thereof in
spirochetes. Instead, spirochetes have an abundance of lipoproteins.
3, tend to be spontaneously lost during in vitro propagation (Purser and Norris, 2000). The
overall G+C contents of the B31 plasmids vary from 20.7% to 31.6% (Casjens, 2000).
Some of the most unusual aspects of the Borrelia genome are the presence of (1) linear
replicons; (2) more than 20 replicons in a single bacterium; and (3) large tracts of directly
repeated short DNA sequences. Approximately 5% of B. burgdorferi chromosomal genes and
5% of plasmid genes are de voted to encoding more than 130 lipoproteins (Casjens, 2000).
These percentages are larger than any for lipoproteins encoded in a sequenced bacterial genome
(Templeton, 2004).
Lipoproteins. Most of the outer surface proteins (osps) that have been characterized in
Borrelia are lipoproteins (Rosa, 1997). Orthologues of the genes encoding the essential
components of the bacterial secretory machinery and homologues of the three enzymes required
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Figure 1.9. The segmented genome of B.burgdorferi. Borrelia is a unique bacterium that
contains one linear chromosome and up to 21 extrachromosomal elements. (Stewart et al.,
2005). Linear plasmids are abbreviated lp and circular plasmids cp, the number represents the
approximate size of the plasmid in kilobases. Evidence supports that plasmids shown in red are
required for infectivity or persistence in the tick or vertebrate host.

for biosynthesis of lipoproteins were found when sequencing the B. burgdorferi genome (Fraser
et al., 1997, Haake, 2000).
Lipoproteins are synthesized as precursors in the cytoplasm and then translocated across
the inner membrane by a preprotein translocase complex, in an energy-dependent cycle.
Subsequent modifications take place sequentially leading to the formation of mature lipoproteins
having a lipid-modified cystein at the N-terminus (Hayashi and Wu, 1990, Pugsley, 1993). Thus,
the characteristic feature of all lipoproteins is a signal sequence in the N-terminal end, followed
by a cystein (Hayashi and Wu, 1990). Lipoprotein processing is similar to that in E.coli. The first
of the three enzymes in the pathway is phosphadidyl-glycerol: prolipoprotein diacylglyceryl
transferase (Lgt). This enzyme transfers a diacylglyceryl group (containing two fatty acids) from
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phosphatidylglycerol to the sulfur atom of cystein. The second enzyme in the pathway is
prolipoprotein signal peptidase (Lsp), which proteolytically removes the signal peptide, making
cystein the new N-terminal amino acid. The third enzyme is phospholipid:apolipoprotein
transacylase (Lnt) which transfers a third fatty acid from a membrane phospholipid to the
nitrogen atom of cystein. After processing, lipoproteins will have three fatty acids attached to the
cystein residue (Wu, 1996). Figure 1.10 summarizes the biosynthesis of lipoproteins.
Among the various lipoproteins of B. burgdorferi described are the outer surface proteins
OspA, which was the first Osp identified in culture (Barbour et al., 1983, Bergstrom et al.,
1989), OspB (Bergstrom et al., 1989, Howe et al., 1985), OspC (Fuchs et al., 1992, Wilske et al.,
1993), OspD (Norris et al., 1992), OspE (Lam et al., 1994), and OspF (Lam et al., 1994).
Coordinated Expression of OspA and OspC. The spirochetes are transmitted to small
mammals, mainly rodents, through the bite of Ixodes ticks (Burgdorfer et al., 1982). In unfed
ticks, the spirochetes remain in the tick midgut. During tick feeding, which lasts several days,
bacteria migrate from the tick midgut to the salivary glands, from which they are transmitted
through the saliva to the dermis of the mammalian host (Ribeiro, 1987). Studies have shown that
spirochetes in unfed ticks have OspA, but no OspC; yet, immediately after a blood meal, a
significant number of spirochetes are stained positive for OspC and negative for OspA (Schwan
et al., 1995). This switch from OspA to OspC accompanies a change in location of the
spirochetes within the tick, from the tick midgut to the salivary glands (de Silva et al., 1997,
Schwan et al., 1995). Figure 1.11 summarizes the changes in the expression of the surface
lipoproteins, especially OspA and OspC as Borrelia transits between the tick vector and the
mammalian host. Aspects of the midgut environment that change during tick feeding, such as
temperature, pH, and nutrients, influence the expression of many genes, including ospA and
ospC (Carroll et al., 1999, Ojaimi et al., 2003, Revel et al., 2002, Schwan et al., 1995).
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Figure 1.10. Biosynthesis of lipoproteins. (Juncker et al., 2003). Shown here are the transfer of
a diacylglyceride to the cystein sulphydryl group of the unmodified prolipoprotein; cleavage of
the signal peptide by signal peptidase II, forming an apolipoprotein; and finally, acylation of the
α-amino group of the N-terminal cystein of the apolipoprotein. Lipids are attached to cystein.
Peptides are shown to the left and to the right of the cystein residue. Catalytic enzymes are
written beside reaction arrows.
According to some findings, a tick midgut receptor for OspA which has been identified and has
an acronym as TROSPA was shown to be required for spirochetal colonization of I. scapularis
(Pal et al., 2004a). On the other hand, Salp 15 a tick salivary gland ligand was shown to be a
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ligand for both OspC and the CD4 molecule of CD4+ T cells (Garg et al., 2006, Ramamoorthi et
al., 2005).
OspC Groups and Invasiveness. The ospC gene has a high degree of sequence
variability (Jauris-Heipke et al., 1995, Theisen et al., 1993, Wilske et al., 1995). On the basis of
ospC sequence analysis of ospC alleles collected from a single site on Shelter Island, NY, Wang
et al., (Wang et al., 1999) defined 19 major ospC groups or types (from A to S, with divergence
of < 2% within a group and > 8% between groups) for B. burgdorferi sensu strictu strain. Two
new groups (groups T and U) were described by Seinost, et al., 1999 (Seinost et al., 1999). Of
the 21 major groups, only four (A, B, I and K) contain invasive clones and therefore cause
infections of the skin (or primary site) and extra-cutaneous sites, also known as secondary sites
(such as heart, joint, and nervous system), while the others are non-human pathogens, or infect
the skin only (Seinost et al., 1999). The ospC gene could, therefore, be one of the determinants
involved in the invasiveness of Borrelia strains leading to disseminated forms of the disease. The
B. burgdorferi sensu strictu strain B31 belongs to the ospC invasive group A.
Regulation of ospC Gene Expression. Borrelia burgdorferi has an enzootic life cycle
alternating between Ixodes ticks and mammalian hosts (mice or deer) (Lane et al., 1991).
Therefore, the spirochete must transition between, adapt to and survive in the tick and
mammalian host, which are two vastly different environments. Similar to many other pathogenic
bacteria, B. burgdorferi senses and responds to environmental cues by regulating the synthesis of
various proteins. These cues include changes in temperature, pH, cell density, oxygen and/or
exposure to host factors (Carroll et al., 1999, Indest and Philipp, 2000, Indest et al., 1997, Ojaimi
et al., 2002, Ramamoorthy and Philipp, 1998, Schwan and Piesman, 2000, Schwan et al., 1995,
Seshu et al., 2004, Stevenson et al., 1995).
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Figure 1.11. Coordinated expression of OspA and OspC as Borrelia cycles between the tick
vector and the mammalian host. (Mulay et al., 2007). In the flat tick, Borrelia expresses high
levels of OspA and does not express OspC (shown in red). A fresh blood meal changes the
microenvironment in the tick midgut inducing the downregulation of OspA and the upregulation
of OspC, preparing the bacteria to infect a mammalian host. This switch of OspA to OspC
coincides with the migration of the bacteria from the tick midgut to the salivary glands. Within
the host, Borrelia abundantly produces OspC. However, in order to avoid clearance by specific
antibody response, Borrelia downregulates OspC. Once Borrelia enters a naïve tick, it
upregulates OspA which remains upregulated in the flat tick. Figure was modified from its
original version.
For example, B. burgdorferi alters its Osps with changes in temperature. During in vitro
growth, a temperature shift from 24 °C to 37 °C stimulates the spirochetes to synthesize OspC,
whereas decreasing the temperature back to 24 °C caused OspC to be decreased to below
detectable levels (Schwan et al., 1995). Also, high spirochete density at least in vitro influences
the upregulation of OspC (Indest et al., 1997, Ramamoorthy and Philipp, 1998). In vitro, the
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expression of OspC is thus phase-dependent. Finally, although B. burgdorferi produces OspC at
pH 6.0 and 7.0, it does not at pH 8.0 (Carroll et al., 1999).
Recent advances in genetic manipulation of B. burgdorferi have culminated in the
discovery of the first genetic regulatory network, the RpoN-RpoS pathway (Caimano et al.,
2004, Yang et al., 2003b). In this pathway, the response regulator, Rrp2, functions as an
enhancer binding protein (EBP), along with the alternative sigma factor RpoN (σN), to control
the expression of another alternative sigma factor, RpoS (σS). RpoS, in turn regulates the
expression of OspC, and other lipoproteins, such as DbpA and Mlp family of lipoproteins (Yang
et al., 2000, Yang et al., 2003b). In B. burgdorferi, interestingly, the regulation of the ospC gene
expression involves not only the RpoN-RpoS signaling pathway but also DNA supercoiling
(Alverson et al., 2003). The discovery of the RpoN-RpoS regulatory network prompts an
important question concerning how σS induces the expression of ospC.
Mechanisms governing in vitro OspC regulation may be controlled solely by an RpoSdependent promoter (Eggers et al., 2004, Yang et al., 2005). In the mammalian host, it would be
unfeasible for B. burgdorferi to turn off rpoS to achieve selective OspC downregulation. Two
sets of conserved inverted repeats (IRs) of 20 bp have been proposed to be candidate binding
sites for a potential transactivator (Fraser et al., 1997). Xu et al., (Xu et al., 2007) have
identified the operator region of OspC immediately upstream of the promoter region. To
negatively regulate its controlled gene, the operator must interact with an as yet unidentified
regulatory protein(s) called a repressor.
Characteristics of OspC. The ospC gene (named as BBB19 on the genome) is located
on the circular plasmid cp26 which is ubiquitously present in B. burgdorferi isolates (Casjens et
al., 2000, Tilly et al., 1997). B. burgdorferi exhibits tissue-specific ospC gene expression during
mammalian infection (Narasimhan et al., 2003). The ospC gene is more abundantly expressed in
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both heart and skin than in the joints in the absence of immune pressure (Liang et al., 2004b).
The expression of ospC gene is also dependent on the present or absence of adaptive immune
pressure. The spirochete persistently expresses OspC during infection of severe combined
immunodeficient (SCID) mice (Liang et al., 2002a, Liang et al., 2002b). The development of
OspC antibody, however, preferentially selects for spirochetes that do not abundantly express
OspC in wild type mice. It is likely that antibodies against OspC antigens exert an immune
pressure on spirochetes that express OspC (Liang et al., 2004a).
Of all the Outer surface proteins, OspC is one of the well-characterized lipoproteins in B.
burgdorferi. OspC is a basic protein (with an isoelectric point of ~ 9.0) and has a subunit
molecular weight of 22 kDa (Fuchs et al., 1992). The full length lipoprotein is 220 amino acids
long. The signal peptide is 18-AA long, the N-terminal linker is 23-AA long, and the C terminal
stretch (CTS) is 13-AA long. Compared to the N-terminal linker, the C-terminal stretch is
conserved among borrelial isolates and highly immunogenic (Mathiesen et al., 1998). The lipid
moiety of OspC is highly immunogenic; the lipoprotein is a strong innate agonist which interacts
with toll-like receptor TLR2 (Aliprantis et al., 1999, Brightbill et al., 1999, Hirschfeld et al.,
1999).
Crystal Structure of OspC. The crystal structure of OspC was resolved in 2001 by two
different scientific groups (Eicken et al., 2001, Kumaran et al., 2001) (Figure 1.12). Whereas
Kumaran et al., used the B. burgdorferi strains HB19 (ospC group I) and B31 (ospC group A),
Eicken et al., used strain N40 (ospC group E) to study OspC structure (Seinost et al., 1999). The
OspC monomer is predominantly an up and down alpha helical bundle. It is composed of five
parallel α-helices and two short β-strands. The α-helices consist of α1 (residues 43-74), α2
(residues 94-112), α3 (residues 119-144), α4 (residues 151-154), and α5 (residues 169-196). The
two β-strands, β1 (residues 78-82) and β2 (residues 85-89) connect helices α1 and α2. The long
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helices α1 and α5 are closely packed together such that the N and C termini, which define the
membrane proximal end of both subunits, are in close proximity to each other. It is suggested
that the biologically functional OspC molecule may be a dimer with a characteristic central fourhelical bundle formed by the association of the two longest helices of each subunit, namely α
helix 1 and α helix 5 (Eicken et al., 2001, Kumaran et al., 2001). Both the N- and the C-terminal
regions of the protein are quite flexible and unable to produce crystals. Neither the N terminal
linker nor the C terminal stretch contributes to the core structure of OspC. The N- and C-termini
are on the same side of the molecule and are close to each other, suggesting that the C-terminus
is also close to the membrane surface on which the lipidated N-terminus is anchored (Kumaran
et al., 2001). The topology diagram of the OspC monomer is shown in Figure 1.13.
All helices, except for α4 and α5, are anti-parallel. The dimeric interaction is mostly
between helices α1 and α1' (of each monomer), which are parallel. The interaction in the dimeric
interface is almost completely hydrophobic (Kumaran et al., 2001). The surface that projects
away from the membrane has a strong negative electrostatic potential. It also has two 50 Å
cavities ~8 Å below the exposed surface. Thus the pocket formed by these cavities may bind an
as yet unknown ligand of OspC. A Dali server (network service for comparing protein structures
in 3D) search (Holm and Sander, 1996) indicates that OspC has similarity to the periplasmic
domain of the Salmonella aspartate receptor (AR), which is also a dimer (Yeh et al., 1996).
Functions of OspC. The structural similarity between the aspartate receptor (AR) of
Salmonella and OspC HB19 suggests that OspC may possibly be a binding protein. If OspC is a
binding-protein, the region that projects away from the membrane may be involved in the
binding (Kumaran et al., 2001). As an extracellular bacterium, Borrelia has a predilection for
extracellular matrix (ECM) and connective tissue. Although some lipoproteins are known to bind
ECM components such as the Decorin binding protein (DbpA) which binds to the proteoglycan
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decorin (Guo et al., 1995), no such role has been attributed to OspC yet. A better understanding
of the function of OspC began with a better understanding of the requirements for OspC by
Borrelia.
In 2003, Schwan T.G., stated that B. burgdorferi probably requires OspC for initial
infection of mammals but that no definitive proof of this hypothesis existed (Schwan, 2003).
The analysis of OspC knock-out mutants has demonstrated that the OspC protein is required for
the spirochete to establish infection in a mammal, following either a tick bite or needle
inoculation (Grimm et al., 2004, Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006).
Concerning the role of OspC in tick colonization, while Grimm et al., March 2004
(PNAS) of Patricia Rosa group, concluded that OspC is not required for migration in the tick
(from the I. scapularis tick midgut to the salivary glands), Utpal Pal et al., January 2004 (JCI) of
Erol Fikrig group, concluded that OspC is required for migration of B. burgdorferi in the tick
(Pal et al., 2004b). The discrepancy between the two studies may be due to the fact that the two
groups used different types of OspC knock-out mutants. As proof of principle, the Patricia Rosa
group (Tilly et al., 2006) constructed a complete deletion of OspC, and was able to confirm that
OspC is not required for migration of spirochetes from tick midguts to salivary glands. It was
however, shown to be required for mammalian infection. Furthermore, the study concluded that
OspC is required only during an early period (first 28 days post-inoculation) in mammalian
infection.
OspC is the only surface lipoprotein to be essential for mammalian infection (Grimm et
al., 2004, Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006). Rosa and colleagues had
hypothesized that OspC is required for evasion of innate immunity during initial mammalian
infection. One pertinent study by Tilly, et al., showed that OspC-knockout mutants were cleared
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Figure 1.12. Crystal Structure of OspC. (Kumaran et al., 2001). A ribbon representation of the
OspC dimer is shown. The core structure of OspC is predominantly α-helical. It contains five
parallel α helices and two short β sheets. The α helices pack closely together such that the N and
C termini are in close proximity to each other. These termini are quite flexible and unable to
produce crystals. The membrane distal end is towards the β sheets whereas the membrane
proximal end is defined by the N and C termini. The lipoprotein is anchored to the outer surface
of the outer membrane of B. burgdorferi by the N-terminus.
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Figure 1.13. Topology diagram of OspC-HB19 monomer. (Kumaran et al., 2001). Red
cylinders represent α-helices and green arrows β-sheets. The N terminus amino acids were
added to represent the peptide sequence from the lipidated cystein. The C-terminus aminoacids
were added to represent the complete peptide sequence (Figure was modified from its original
version).

within 48h from C3H wild type mice (Tilly et al., 2007). However, Xu., et al, 2008 (Xu et al.,
2008) using OspC-deficient B. burgdorferi, which were modified to increase expression of other
well-defined surface lipoproteins (such as OspA, OspE, VlsE and DbpA), were able to show that
the essential protective role of OspC against early elimination can be overridden by increasing
the expression of any of the four lipoproteins. Thus, although during natural infection OspC is
exclusively required for initial infection of a mammalian host, on a laboratory experimental
basis, it is not so. Heterologous lipoproteins can substitute for the function of OspC when
overexpressed, suggesting that an abundance of lipoprotein(s) is needed to stabilize the borrelial
outer membrane against innate defences. Furthermore, the study showed that OspC is required
for efficient dissemination and this function can be substituted to varying extents by other outer
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surface lipoproteins; OspC was also shown not to be required for the efficient colonization of the
joint or skin, but for the heart tissues of SCID mice. Hence, the following functions for OspC
have been identified so far: evasion of innate immunity and facilitating dissemination in the
vertebrate host.
Recently, a study by the P. Rosa group (Tilly et al., 2009), has shown that mammalian
host-adapted spirochetes can infect and disseminate in mice in the absence of OspC. They
proposed a model in which OspC is one of a succession of functionally equivalent, essential
proteins that are synthesized at different stages of mammalian infection.
STATEMENT OF THE PROBLEM
More than three decades have elapsed since the discovery of the tick-borne illness named
Lyme disease in 1975. Since then, much has been learnt about the life cycle of the tick vector, I.
scapularis, and the molecular changes that Borrelia, the agent of Lyme disease, undergoes in
order to survive in two very disparate environments, the tick vector and the mammalian host
(Burgdorfer et al., 1988a, de Silva and Fikrig, 1997, Lane and Loye, 1991, Schwan et al., 1995).
Of the molecular changes that Borrelia undergoes, the up- and down-regulation of its many
lipoproteins, both during its transmission between the tick vector and the mammalian host and
within the mammalian host itself, are obviously crucial for its survival and maximal virulence
(de Silva et al., 1997, Schwan et al., 1995). OspC is a known virulence factor of B. burgdorferi.
Since the upregulation of OspC within the tick vector is required for initial mammalian infection
(Schwan et al., 1995, Tilly et al., 2006, Yang et al., 2000) whereas its downregulation is required
for avoidance of spirochetal clearance (Liang et al., 2002a, Xu et al., 2007, Xu et al., 2006),
many researchers are focused on the function and regulation of OspC in order to better
understand the role of OspC in the pathogenesis of B. burgdorferi.
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Recent studies have shown that a common role of all surface lipoproteins, including
OspC, is that of evasion from host innate immune defences (Tilly et al., 2007, Xu et al., 2008)
and that the unique role of OspC is that of a dissemination-facilitating factor of B. burgdorferi
(Xu et al., 2008). Since the solution of the three-dimensional structure of OspC (Eicken et al.,
2001, Kumaran et al., 2001), not much is known as to how the various secondary structures that
make up OspC as a whole lipoprotein relate to its function(s) and/or possible ospC mRNA
regulation.
GOAL, SPECIFIC OBJECTIVES AND HYPOTHESES
The overall goal of this dissertation research was to make strategic structural deletions of
OspC and study their phenotypic effects on infectivity, dissemination, pathogenicity and
colonization of B. burgdorferi and on the regulation of ospC mRNA expression in the murine
model. The specific objectives were:
1. To create beta sheets 1 and 2 (βs1 and βs2) and alpha helix 4 (αH4) deletions of OspC and
study the effects of such deletions on the infectivity of B. burgdorferi.
2. To create an N-terminus 5-AA and 10-AA deletion of OspC in order to dissect the role of
OspC in evasion from innate immunity and in dissemination of B. burgdorferi to distal tissues
during mammalian infection.
3. To study the role of the N-terminus 5-AA sequence in regulation of ospC mRNA expression.
4. To create C-terminus 6-,9-, and 13-AA deletions of OspC and study their contributions to the
overall function(s) of OspC and to the regulation of ospC mRNA expression.
The hypotheses of the proposed work for the above objectives were the following: 1) that
there is a correlation between the OspC secondary structure and function of the lipoprotein that
can be well delineated; and 2) that OspC is involved in self-regulation.
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Chapter 2 describes the selective, relatively small, deletions that were made within the
core of OspC structure of beta sheets 1and 2 and alpha helix 4 (βs1 and βs2 and αH4). Included in
this work were longer deletions of the N- and C-terminus of OspC (Nt10 and Ct13). All these
deletions resulted in complete abolishment of the immune evasion role of OspC, indicating that
these regions of OspC are critical for the survival of the spirochetes during the initial infection of
the mammalian host.
Chapter 3 describes a deletion of 5-AA of the N-terminus of OspC. This deletion did not
affect the innate immune evasive role of OspC as measured by a 50% infectious dose (ID50)
study. The tissue spirochetal load measured by qPCR was used as another criterion of the
evasion of the spirochete from elimination. There was no significant difference in the tissue
spirochetal burden in the joint and skin; however, there was a significant decrease in the heart
tissues as compared to controls. Deletion of N-terminus 5-AA of OspC resulted in inefficient
dissemination of B. burgdorferi to remote tissues in the SCID mice. This dissemination defect
was even more pronounced in wild type mice. This particular deletion, therefore, led to a
dissection of the role of OspC in evasion from that of facilitating dissemination of B.
burgdorferi.
Chapter 4 describes the influence of the 5-AA N-terminus deletion of OspC on ospC
mRNA levels as measured by RT-qPCR in the heart, joints and skin tissues of SCID mice. The
results show an upregulation in ospC expression in the joint of mutant spirochetes as compared
to control spirochetes containing a full length OspC copy, indicating that OspC is involved in
self-regulation. There was no significant difference in ospC mRNA levels the heart and skin
tissues between the mutant and control spirochetes. The role of OspC in self-regulation was
further confirmed by OspC monoclonal antibody treatment of SCID mice inoculated with
Borrelia expressing the truncated OspC. The treatment resulted in clearance of spirochetes from
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all sites tested, except the joints, indicating that the joint tissue may serve as an immune
privileged site.
Chapter 5 describes the phenotypic effects of sequential deletion of 6-, 9-, and 13-AA of
the C-terminus of OspC on infectivity and pathogenicity of B. burgdorferi and on ospC
expression. While spirochetes containing a deletion of 13-AA resulted in a non-infectious
phenotype, as described earlier, spirochetes containing deletions of 6- and 9-AA retained their
innate immune evasive roles as measured by ID50 values in both SCID and wild type mice,
which were similar to those of control spirochetes. However, interestingly, whereas spirochetes
with 6-AA deletion had lost their arthritis virulence, spirochetes with 9-AA C-terminus deletion
retained their arthritis virulence. In terms of tissue spirochete burden, the study highlighted the
tissue-dependent effects of the C-terminus deletion. Finally, deletion of C-terminus 9-AA
sequence of OspC led to significant changes in ospC mRNA accumulation in all tissues, whereas
deletion of C-terminus 6-AA sequence of OspC led to significant changes in ospC expression in
the joint tissue only. Interestingly, in the joints, the deletion of 6-AA and 9-AA sequence of the
C-terminus of OspC resulted in a down-regulation of ospC transcripts, indicating that OspC is
involved in self-regulation.
Chapter 6, the last chapter, describes the general conclusions of this study. It summarizes
the major findings of this dissertation research in a table format. It also provides an overview of
our current accumulated knowledge in regards to the function(s) of OspC and how this
dissertation research has contributed to a better understanding of those functions and of the
regulation of OspC. Ultimately, this work contributes to an appreciation of the role that OspC
plays in the pathogenesis of B. burgdorferi.
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CHAPTER 2
SELECTIVE STRUCTURAL DELETIONS OF OSPC ABOLISH THE
ROLE OF OSPC IN EVASION OF BORRELIA BURGDORFERI FROM
HOST INNATE DEFENCES
INTRODUCTION
Borrelia burgdorferi, the agent of Lyme disease, requires OspC upon initial infection of a
mammalian host. OspC-knock out mutants were shown to be cleared from skin after
intradermal/subcutaneous inoculation of Borrelia burgdorferi (Tilly et al., 2007). The
requirement for OspC may be exclusive in nature; however, under laboratory setting, this role of
OspC in evasion from host innate defences can be overridden by other heterologous lipoproteins
(Xu et al., 2008). OspC has been shown to have dual roles: in protection against (or evasion
from) host innate immune response and in dissemination during infection of murine hosts (Xu et
al., 2008). To understand the function of a lipoprotein at a molecular level, it is often necessary
to determine the three-dimensional structure of that lipoprotein. Based on this premise, the
crystal structure of OspC was explored for its possible role in infectivity of B. burgdorferi. OspC
is a predominantly α-helical in structure. A single unit of OspC is composed of five parallel αhelices and two short β-strands inter-connected by six loops, apart from an amino (N) - and
carboxy (C)-terminus. The N-terminus linker is 23 AA long, whereas the C-terminal stretch is
13-AA long (Eicken et al., 2001, Kumaran et al., 2001). Of these, the nucleotides encoding for
the two β strands (βs1 and βs2), alpha helix 4 (αH4), C-terminus 13-AA (Ct13) and N-terminus
10-AA (Nt10) sequence of OspC were deleted, and the resulting truncated OspC for each clone
was tested for infectivity potential in the SCID mouse. All five (βs1, βs2, αH4, Ct13 and Nt10)
OspC mutations produced non-infectious phenotypes. There was, however, recovery of OspCdeficient spirochetes containing a mutation in DbpA lipoprotein. The truncated OspC mutants
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revealed that these corresponding regions of the ospC gene are required for the function of the
lipoprotein in protection against host innate defences.
MATERIALS AND METHODS
Strains Generated Previously and Used in This Study. The B. burgdorferi strain B31
clone 13A was generated previously (Xu et al., 2007). Serially diluting the B. burgdorferi B31
5A13 culture led to the identification of a single clone designated 13A, which lost lp25 and lp56
but contained the remaining 19 plasmids. This clone is highly transformable because lp25 and
lp56 may carry restriction enzymes to negatively affect transformation efficiency of B.
burgdorferi (Kawabata et al., 2004, Lawrenz et al., 2002). The ospC mutant clone was also
generated previously by insertion of the aacC1 cassette within the ospC locus and was confirmed
by PCR (Xu et al., 2007). This clone contained lp28-1 but lost cp9, lp5 and lp21, in addition to
lp25 and lp56.
Construction of Plasmids pBBE22-ospCβs1, pBBE22-ospCβs2, pBBE22-ospCαH4 and
pBBE22-ospCNt10. As illustrated in Fig. 2.1 through Fig. 2.4, to efficiently generate constructs
encoding the two beta strands, alpha helix 4 and N-terminus 10 amino acid deletions, a 1057-bp
fragment covering the ospC-coding region and up- and down-stream sequences was amplified by
PCR using primers P1F and P1R (Table 2.1) and cloned into TA cloning vector pNCO1T
(Downie et al., 2004), creating an intermediate vector designated pNCO1T-ospC. Four large
amplicons, βs1, βs2, αH4 and Nt10 were generated by PCR using pNCO1T-ospC as a template
and each of four forward primers P2F, P3F, P4F, P5F and each of four reverse primers, P2R,
P3R, P4R and P5R, respectively (Table 2.1).
Primers P4F and P4R for αH4 were designed for blunt end ligation; these primers were
phosphorylated using T4 polynucleotide kinase, ATP and appropriate buffer (New England
55

Figure 2.1. Generation of B. burgdorferi producing OspC with βs1 deletion. A. Construction
of pBBE22-ospCβs1 coding for OspC with beta sheet 1 deletion. The five codons coding for
the five amino acid residues (residues 78—82) and their adjacent codons are presented. The
amplification starting sites and directions of four primers, P1F, P1R, P2F and P2R, used for
plasmid construction are also marked. The long bar represents the 1057-bp fragment, covering
the entire ospC-coding region and down- (extending to +801 from the transcriptional start site)
and up-stream sequences (extending to -256). The detailed construction of the vector was
described in Materials and Methods section. B. Restoration of OspC production. The parental
clone 13A and the clones ΔospC/βs1/1 through ΔospC/βs1/3 (of the total of 7 transformants) were
verified for OspC expression by immunoblot probed with a mixture of FlaB and OspC anti-sera.
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Figure 2.2. Generation of B. burgdorferi producing OspC with βs2 deletion. A. Construction
of pBBE22-ospCβs2 coding for OspC with beta sheet 2 deletion. The five codons coding for
the five amino acid residues (residues 85—89) and their adjacent codons are presented. The
amplification starting sites and directions of four primers, P1F, P1R, P3F and P3R, used for
plasmid construction are also marked. The long bar represents the 1057-bp fragment, covering
the entire ospC-coding region and down- (extending to +801 from the transcriptional start site)
and up-stream sequences (extending to -256). The detailed construction of the vector was
described in Materials and Methods section. B. Restoration of OspC production. The parental
clone 13A and the clones ΔospC/βs2/1 through ΔospC/βs2/7 were verified for OspC expression by
immunoblot probed with a mixture of FlaB and OspC anti-sera.
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Figure 2.3 Generation of B. burgdorferi producing OspC with αH4 deletion. A.
Construction of pBBE22-ospCαH4 coding for OspC with alpha helix 4 deletion. The eight
codons coding for the eight amino acid residues (residues 152—159) and their adjacent codons
are presented. The amplification starting sites and directions of four primers, P1F, P1R, P4F and
P4R, used for plasmid construction are also marked. The long bar represents the 1057-bp
fragment, covering the entire ospC-coding region and down- (extending to +801 from the
transcriptional start site) and up-stream sequences (extending to -256). The detailed construction
of the vector was described in Materials and Methods section. B. Restoration of OspC
production. The parental clone 13A and the clones ΔospC/αH4/1 through ΔospC/αH4/4 were
verified for OspC expression by immunoblot probed with a mixture of FlaB and OspC anti-sera.
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Figure 2.4. Generation of B. burgdorferi producing OspC with Nt10 deletion. A.
Construction of pBBE22-ospCNt10 coding for OspC with N-terminus 10 amino acid
deletion. The ten codons coding for the ten amino acid residues (residues 26—35) and their
adjacent codons are presented. The amplification starting sites and directions of four primers,
P1F, P1R, P5F and P5R, used for plasmid construction are also marked. Downstream of the
deletion, the S was changed to a D as marked by an asterisk. The long bar represents the 1057-bp
fragment, covering the entire ospC-coding region and down- (extending to +801 from the
transcriptional start site) and up-stream sequences (extending to -256). The detailed construction
of the vector was described in Materials and Methods section. B. Restoration of OspC
production. The parental clone 13A and the clones ΔospC/Nt10/1 through ΔospC/Nt10/6 were
verified for OspC expression by immunoblot probed with a mixture of FlaB and OspC MAbs.
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Table 2.1. Primers used to make the pBBE22-ospCβs1, pBBE22-ospCβs2, pBBE22-ospCαH4
and pBBE22-ospCNt10.
Construct

Primer name

Primer sequence (5’-3’)a

FL

P1F
P1R

5’-TAGTTGGCTATATTGGGATCCAA-3’
5’-TTCCTCTAGAGAAGAGCTTAAAGTTAA-3’

βs1

P2F
P2R

5’-ACGCTCTTCTTCAAAATAATGGTTTGGATACC-3’
5’-ATGCTCTTCTTGAATAGCTTTAGCAGCAATTTC-3’

βs2

P3F
P3R

5’-ACGCTCTTCTTGAAAATAATCACAATGGATCATTG-3’
5’-ACGCTCTTCTTCATTTTGGTGTATTTTTTTACC-3’

αH4

P4F
P4R

5’-AGTAACACCTTCTTTACCAAG-3’
5’-TTAAAAACAAATGGTACTAAAAC-3’

Nt10

P5F
P5R

5'-ATGACGTCAAAGGGCCTA-3'
5'-CTGACGTCTTCCCCTGAATT-3'

a

The underlined sequences are restriction enzyme sites. P1F contains a BamHI site; P1R has an XbaI site;
P2F, P2R, P3F and P3R have SapI sites; P4F and P4R are blunt end primers, with no restriction sites; P5F
and P5R contain AatII sites.

Biolabs, Ipswich, MA). After PCR, the termini of the PCR product was polished using T4 DNA
polymerase (New England Biolabs, Ipswich, MA); digested with DpnI (to cut methylated
Adenine), purified, and underwent T4 DNA ligation with the vector pNCO1T.
To construct the N terminus 10-AA deletion, an AatII restriction enzyme site was chosen
as the appropriate site to be added to primers P5F and P5R. In order to introduce the site, the S
(serine) residue was changed to a D (aspartic acid) residue at position 36 from start codon.
After digestion with SapI for βs1 and βs2 and digestion with AatII for Nt10 and
subsequent purification, the four amplicons were circularized via ligation (blunt-end ligation in
the case of αH4) and then digested with BamHI and XbaI to release, βs1, βs2, αH4 and Nt10.
These four fragments, encoding an OspC variant with βs1, βs2 αH4, and Nt10 deletions, were
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cloned into the recombinant plasmid pBBE22 (a gift from S. Norris) after the vector was
digested with BamH1 and XbaI. Resulting constructs were designated, pBBE22-ospCβs1,
pBBE22-ospCβs2, pBBE22-ospCαH4 and pBBE22-ospCNt10 respectively. The inserts and their
flanking regions within pBBE22 were sequenced to ensure the constructs were as designed.
Additional Plasmids Generated Previously and Used in This Study. Construct
pBBE22-ospCct13 was generated and described further in Chapter 5. OspCct13 is a truncated
ospC in which the nucleotides corresponding to 13-AA of the carboxy-terminus of OspC were
deleted. Mouse infectivity studies (included in Chapter 5) had shown that clone ∆ospC/ospCct13
was non-infectious at one month post-inoculation in SCID mice. Therefore, to test if infectivity
was lost at an earlier time point, clone ∆ospC/ospCct13 now named as ∆ospC/∆ct13 was
included in this study. Construct pBBE22-dbpAmt82 was also generated in a previous study
(unpublished data). The dbpAmt82 has a point mutation at the nucleotide coding for one of the
three critical lysine residues for the binding of decorin-binding protein A (DbpA) to decorin.
This was the lysine at amino acid position 82 from the methionine start codon (Brown et al.,
1999, Pikas et al., 2003). The construct pBBE22-ospC’ which has a flaB-promoter to
constitutively express a full length copy of OspC was used as a positive control (Xu et al., 2006).
All three plasmids were electroporated into an OspC mutant. The resulting clones were
designated ∆ospC/ospCct13, ∆ospC/dbpAmt82 and ∆ospC/ospC’ and were used in the SCID mice
infection study.
Generation of ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4, ∆ospC/∆Nt10 and ∆ospC/∆ct13
Transformants. Complementation plasmids were electroporated into an ospC mutant, namely,
∆ospC, which was generated in our previous study (Xu et al., 2007). Briefly, ∆ospC spirochetes
were grown in 10 ml of BSK-H medium at densities of 5x107 to 1x108 cells/ml (mid to late
exponential phase), harvested, washed, and transformed with 1.5 µg of plasmid pBBE2261

ospCαH4, pBBE22-ospCβs , pBBE22-ospCβs2, and pBBE22-ospCNt10 under standard
electroporation conditions (Lawrenz et al., 2002, Stewart et al., 2001). The plasmid pBBE22 was
derived from shuttle vector pBSV2 by inserting the gene BBE22 (Purser et al., 2003, Stewart et
al., 2001). The cells were allowed to recover in 20 ml of BSK-H medium at 33 °C for 18h. After
adding kanamycin at a concentration of 200 µg/ml and gentamycin at 50 µg/ml, the suspension
was transferred into 96 PCR tubes (200 µl/tube). The limited dilution assay has been widely used
in the screening of transformants (Blevins et al., 2004, Caimano et al., 2004, Revel et al., 2005,
Yang et al., 2004). Aliquots were incubated at 33 °C for 10 days and live spirochetes were
examined under a dark-field microscope. Viable spirochetes were found in 7, 7, 4, 6 and 5 of the
96 tubes for ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4, ∆ospC/∆Nt10 and ∆ospC/∆ct13 clones,
respectively. Approximately 30 µl of the kanamycin/gentamycin resistant culture was transferred
to 1.3 ml of BSK-H medium in a 1.5 ml microcentrifuge tube and grown to stationary phase at
33 °C. Spirochetes were harvested from 200 µl of culture by centrifugation at 11,000xg for 5 min
at room temperature and washed twice with excess volumes of phosphate-buffered saline (pH
7.3) to remove residual plasmid DNA and resuspended in 200 µl and resuspended in 200 µl of
deionized H20. One microliter of suspension was used as a DNA template source for
examination of recombinant plasmid pBBE22 by examining the kanamycin-resistant cassette by
PCR. The specific kanamycin primers (forward: 5’-ATGAGCCATATTCAACGGGAAACGT3’; reverse: 5’-TCAGCGTAATGCTCTGCCAGTGT-3’) were used. The PCR conditions
included: 94 °C for 1 min; 94 °C for 30 seconds, 54 °C for 30 seconds, 72 °C for 1 min, 35
cycles; 72 °C for 10 min. PCR products were separated on an ethidium bromide-agarose gel.
Immunoblot Analysis. Transformants were grown in BSK-H complete medium to late
log phase at 33 °C and harvested by centrifugation. Spirochetes were dissolved in sodium
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dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer, separated by electrophoresis
(Biorad, Hercules, CA), and electrotransferred onto nitrocellulose membranes (Thermo
Scientific, Rockford, IL). Restoration of OspC expression was verified using immunoblots
probed with a mixture of FlaB and OspC monoclonal antibodies (MAbs) for clone ∆ospC/∆Nt10,
or with the FlaB MAb and mouse anti-OspC sera raised against a recombinant OspC antigen for
clones ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4 and ∆ospC/∆ct13. The flaB and OspC MAbs were
developed by Barbour et al., (Barbour et al., 1986) and Mbow et al., (Mbow et al., 1999) and
used at 1:100 and 1:10,000 final dilutions, respectively. The secondary antibody used was goat
anti-mouse IgG conjugated with horseradish peroxidase (hrp) at a 1:5,000 final dilution (Thermo
Scientific, Waltham, MA). To develop the nitrocellulose membrane, a colorimetric blotting
substrate solution (4CN) was used (Kirkegaard and Perry Laboratories, Gaithesburg, MD). The
clone ∆ospC/FL/1, which was generated in our previous study (Xu et al., 2007) and expressed
wild-type OspC, was included as a control.
SCID Mice Infection Study. BALB/c SCID mice (ages 4-8 weeks, provided by the
Division of LSU Laboratory Animal Medicine) were given two intradermal/subcutaneous
injections of 105 spirochetes. The two inoculation sites were at least 2 cm apart. Animals were
sacrificed at 24 and 48h later; inoculation skin site tissues were harvested for spirochete isolation
as previously described (Xu et al., 2005).
Examination of Plasmid Content by PCR. The presence of lp28-1, lp28-2, lp28-4 and
cp32-3, that tend to be spontaneously lost, was surveyed by PCR with primer pairs specific for
each of the four plasmids (Table 2.2). Approximately 1 µl of spirochete culture was used as a
DNA template source in a PCR volume of 25 µl. Taq polymerase was purchased from Takara
Mirus Bio Inc (Madison, WI). The PCR conditions included: 94 °C for 1 min; 94 °C for 30
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seconds, 54 °C for 30 seconds, 72 °C for 1 min, 35 cycles; 72 °C for 10 min. PCR products were
separated on an ethidium bromide-agarose gel.
Table 2.2. PCR primers for examination of plasmid content in B. burgdorferi
Sequence
Plasmid
Forward

Reverse

lp28-1

5’-TTTCATTATAAGGAGACGATGA-3’ 5’-CGTCGTACTACTTATATCGC-3’

lp28-2

5’-TTCTAGTATCTACTAGACCG-3’

lp28-4

5’-GTGTCGCTTAATTTTAGAGTTA-3’ 5’-ATAGAGATCCTCTATTAGAGA-3’

cp32-3

5’-CTGTTTAATCCACCACCAGTA-3’

5’-AGCCAAGTATTTCTTCTGCA-3’

5’-ACTTTCTCAGTACTTTCTCC-3’

RESULTS
The Plasmid Contents of The Various Transformants Generated. All of the identified
transformants had the kanamycin-resistant cassette as tested by PCR, indicating the presence of
pBBE22. Then, the transformants were surveyed for the presence of lp28-1, a plasmid essential
for infection of immunocompetent hosts (Labandeira-Rey et al., 2003, Purser and Norris, 2000),
but not required for infectivity in SCID mice (Labandeira-Rey et al., 2003). Only clones
containing lp28-1 were further analyzed for the content of those plasmids that tend to be
spontaneously lost during in vitro propagation, described in the Materials and Methods section,
with the exception of αH4 construct for which only one of the four transformants contained lp281. For the majority of clones, two transformants from each clone that had identical plasmid
contents were chosen for inoculation into SCID mice, except for ∆ospC/∆Nt10 and ∆ospC/∆αH4.
For ∆ospC/∆Nt10, the plasmid content was identical for lp28-2 but not lp28-4. For ∆ospC/∆αH4,
the two transformants had lp28-2 and lp28-4, although one clone had lp28-1 and the other did
not.
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Various Truncated OspC Mutants Are Unable to Aid Borrelia Evade Quick
Clearance. Groups of four SCID mice each received two intradermal/subcutaneous inoculations
of the clones ∆ospC/ospC’/1, ∆ospC/ospC’/2, ∆ospC/∆βs1/1, ∆ospC/∆βs1/2, ∆ospC/∆βs2/1,
∆ospC/∆βs2/2, ∆ospC/∆αH4/1, ∆ospC/∆αH4/2, ∆ospC/∆Nt10/1, ∆ospC/∆Nt10/2, ∆ospC/∆Ct13/1,
∆ospC/∆Ct13/2, ∆ospC/dbpAmt82/1, or ∆ospC/dbpAmt82/2. The control spirochetes
∆ospC/ospC’/1 and ∆ospC/ospC’/2 were consistently grown from each of the 16 inoculation
sites from all the eight inoculated mice (Table 2.3). In contrast, none of the ∆ospC/∆βs1/1,
∆ospC/∆βs1/2, ∆ospC/∆βs2/1, ∆ospC/∆βs2/2, ∆ospC/∆αH4/1, ∆ospC/∆αH4/2, ∆ospC/∆Nt10/1,
∆ospC/∆Nt10/2, ∆ospC/∆Ct13/1, or ∆ospC/∆Ct13/2 were grown from either the 8 inoculation
sites at 24h time point or the 48h time point. Like the positive control, the clone
∆ospC/dbpAmt82/1 and ∆ospC/dbpAmt82/2 were also recovered from all inoculation sites at both
time points. These results indicate that strategic deletions of OspC of small number of amino
acids within the core region or of large number of amino acids in the termini of OspC abolish the
ability of the lipoprotein to aid B. burgdorferi evade from quick clearance. In contrast, the DbpA
mutant is able to compensate for the role of OspC in evasion of host innate defenses, although
one of its decorin binding sites was mutated.
DISCUSSION
B. burgdorferi depends on the expression of OspC for its survival during early
mammalian infection. The essential role of OspC was demonstrated when OspC knock-out
spirochetes were cleared from skin inoculation site by 48h (Tilly et al., 2007). In spite of a
myriad of host innate immune responses devised by neutrophils, macrophages, or by toll-like
receptors (TLRs), particularly TLR-2 against borrelial lipoproteins (Hartiala et al., 2008,
Hirschfeld et al., 1999, Linder et al., 2001, Peterson et al., 1984), one of the mechanisms by
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which Borrelia are able to evade these responses is through the abundance of expression of
OspC and other lipoproteins on the outer surface of the outer membrane of the spirochete.
Table 2.3. Various types of truncated OspC mutants are unable to aid Borrelia evade quick
clearance from murine skin a

Clone

No. of sites positive/total
no. of sites examined at
post-inoculation hours
24
48
∆ospC/ospC’/1
4/4
4/4
∆ospC/ospC’/2
4/4
4/4

Clone

No. of sites positive/total
no. of sites examined at
post-inoculation hours
24
48
0/4
0/4
0/4
0/4

∆ospC/∆βs1/1
∆ospC/∆βs1/2

∆ospC/∆βs2/1
∆ospC/∆βs2/2

0/4
0/4

0/4
0/4

∆ospC/∆αH4/1
∆ospC/∆αH4/2

0/4
0/4

0/4
0/4

∆ospC/∆Nt10/1
∆ospC/∆Nt10/2

0/4
0/4

0/4
0/4

∆ospC/∆Ct13/1
∆ospC/∆Ct13/2

0/4
0/4

0/4
0/4

∆ospC/dbpAmt82/1
4/4
4/4
∆ospC/dbpAmt82/2
4/4
4/4
a
Groups of four BALB/c SCID mice each received two intradermal/subcutaneous injections of the clone
∆ospC/ospC’/1, ∆ospC/ospC’/2, ∆ospC/∆βs1/1, ∆ospC/∆βs1/2, ∆ospC/∆βs2/1, ∆ospC/∆βs2/2,
∆ospC/∆αH4/1, ∆ospC/∆αH4/2, ∆ospC/∆Nt10/1, ∆ospC/∆Nt10/2, ∆ospC/∆Ct13/1, ∆ospC/∆Ct13/2,
∆ospC/dbpAmt82/1 or ∆ospC/dbpAmt82/2. Approximately 105 organisms were administered in each
inoculation; two inoculations sites were at least 2 cm apart. Two animals from each group were
euthanized at 24 and 48 h post-inoculation; skin specimen s were harvested from inoculations sites and
cultured for spirochetes in BSK-H complete medium.

OspC has been found to have a dual function: that of protection against host innate
immune responses, which is common to that of other surface lipoproteins and thus can be
overridden by the same, such as DbpA and OspA; and that of dissemination, which is one of the
unique roles of OspC, discovered so far, in the pathogenesis of B. burgdorferi (Xu et al., 2008).
Since the crystal structure of OspC has been resolved, many labs have focused on
exploring the structure of OspC for finding epitopes for adaptive immune responses (Earnhart et
al., 2005, Jobe et al., 2003). To our knowledge, this is the first study that explored the crystal
structure of OspC for finding its function in protection against innate immune response. Since
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deleting several regions of OspC within the core structure (the 2 beta sheets and alpha helix 4)
resulted in non-infectious phenotypes, we decided to test clones with larger deletions of the
OspC termini. The results showed that larger segments in the flexible, non-crystalizable portion
of OspC (the N- and C-terminus) are also involved in protection against host innate immune
responses. Both ∆ospC/∆Nt10 and ∆ospC/∆Ct13 clones were included because studies
(described in Chapter 3 and 5, respectively) have shown that these clones were non-infectious at
least at a one month post-inoculation time point and therefore tested in this study to verify that
the loss of infectivity occurred at an earlier time point.
Although numerous studies have attempted to associate infectivity of B. burgdorferi with
plasmid content (Caimano et al., 2000, Casjens et al., 2000, Labandeira-Rey and Skare, 2001,
Marconi et al., 1996, Purser and Norris, 2000, Simpson et al., 1990), two of them proved that
lp25 and lp28-1 may be necessary for full virulence (Labandeira-Rey and Skare, 2001, Purser
and Norris, 2000). In this study, because the B. burgdorferi strain B31 clone 13A, an ospC
mutant, had lost lp25, the plasmid that carries the gene bbe22 coding for a nicotinamidase
essential for survival of B. burgdorferi in the mammalian environment, the recombinant plasmid
pBBE22, which harbors a copy of bbe22, was used as the shuttle vector (Purser et al., 2003). The
clone 13A had also lost lp56 but contained the remaining 19 plasmids (Xu et al., 2007).
However, plasmid lp56 is not associated with loss of infectivity (Purser and Norris, 2000). B.
burgdorferi B31 clones that lacked lp28-1 were shown to be of either low or intermediate
infectivity (Purser and Norris, 2000). However, B. burgdorferi strains that have lost lp28-1 are
still infectious and persist in immunodeficient mice (Labandeira-Rey et al., 2003). The plasmid
lp28-1 contains the vlsE locus that is required for evasion of humoral immune response
(Labandeira-Rey et al., 2003, Labandeira-Rey and Skare, 2001, Purser and Norris, 2000, Zhang
et al., 1997). For that reason, an effort was made in this study to select clones that contained
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lp28-1 and to verify the content of those plasmids that can be spontaneously lost. Since one of
the ∆ospC/∆αH4 clones had the plasmid lp28-1 while the other had lost the plasmid, and yet both
clones were non-infectious, it can be implied that the resulting phenotypes are due to the lack of
the alpha helix rather than the lack of the plasmid lp28-1.
The small beta strands may be involved in the stabilization of the OspC dimers (Eicken et
al., 2001). Hence, deletion of their beta strands led to complete loss of infectivity, suggesting that
the dimer formation may be important in the function of OspC. Interestingly, when the two beta
sheets βs1 and βs2 of OspC were deleted, the truncated protein expression levels were
significantly lower than that of the full length OspC controls. The biological significance of this
observation is not yet known. It could be that the beta sheets are involved in the degradation of
the lipoprotein.
A previous study showed that OspC-deficient spirochetes showing increased DbpA
expression were able to be recovered from skin inoculation site of SCID mice within 24h (Xu et
al., 2008). In order to test if mutation of one of the active sites of decorin-binding may
compromise the protective role of this lipoprotein, a DbpAmt82 was included in the study. The
results of this study indicate that in spite of the mutation, spirochetes were still able to be
recovered for at least up to 48h. It also indicates that spirochetes lacking OspC but expressing
DbpA, although in a mutant form, could protect B. burgdorferi against host innate defenses.
This study has shown that a broad range of deletions in the OspC structure can lead to the
abolishment of OspC function in protection against host innate responses. Since βs1 and βs2 and
αH4 are part of the core structure of OspC, their deletions might have led to a collapse in the
structure of the lipoprotein. Deletion of 10-AA of the N-terminus of OspC, on the other hand,
might have compromised the anchoring of the lipoprotein to the outer surface of the outer
membrane of the spirochete. Finally, deletion of the C-terminus of OspC might have hindered
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the interaction of the lipoprotein with the outer environment, since the terminus is not linked to
the borrelial membrane. A further analysis by circular dichroism, which examines protein
structures in solution (Kelly et al., 2005), could demonstrate whether these truncated OspC
proteins cause a collapse of the core structure of OspC. Nevertheless, this study shows that there
is a correlation between the certain regions of OspC and the role of this surface lipoprotein in
evasion of B. burgdorferi from host innate defences.
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CHAPTER 3
OUTER SURFACE PROTEIN C IS A DISSEMINATION-FACILITATING
FACTOR OF BORRELIA BURGDORFERI DURING MAMMALIAN
INFECTION
INTRODUCTION
Coordinated production of outer surface proteins (Osp) is crucial for the pathogenic
strategy of the Lyme disease spirochete, Borrelia burgdorferi (Burgdorfer et al., 1982). In
engorged and unfed ticks, B. burgdorferi abundantly produces OspA and OspB, but no OspC
(Ohnishi et al., 2001, Schwan et al., 1995), but dramatically upregulates OspC in response to a
fresh blood meal and prepares itself for infection of mammals (Grimm et al., 2004b, Pal et al.,
2004, Stewart et al., 2006). B. burgdorferi maintains high OspC synthesis during early
mammalian infection (Liang et al., 2002a, Liang et al., 2002b, Liang et al., 2004b). However,
OspC is not only a strong immunogen, but also an effective target of protective immunity; its
production ultimately induces a robust humoral response that imposes tremendous pressure on
the pathogen (Fung et al., 1994, Liang et al., 2004b) To effectively evade the adaptive immune
response and establish persistent infection, B. burgdorferi must downregulate ospC after the
specific humoral response has developed (Xu et al., 2006) , suggesting an early role for OspC in
mammalian infection.
Inactivation of the ospC gene completely abolishes infectivity of B. burgdorferi (Grimm
et al., 2004a); however, the resulting mutant is able to persist in mammalian tissues, once the
initial requirement for OspC is overcome, via introduction of an unstable ospC copy, which is
readily lost under the immune selection pressure during infection of immunocompetent mice,
leading to a conclusion that OspC is required exclusively for initial mammalian infection
(Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006). In fact, however, this initial
requirement for OspC can be overridden by either increasing expression of another Osp (Xu et
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al., 2008), or simply adapting ospC mutants in mammalian hosts (Tilly et al., 2009). The nature
of adaptation is to alter gene expression, and it has been known for years that B. burgdorferi
undergoes dramatic changes in its surface lipoprotein expression during mammalian infection
(Liang et al., 2002a, Liang et al., 2002b). Most notably, the downregulation of OspC in response
to the development of the anti-OspC humoral response is always coordinated with an
upregulation of both VlsE and BBF01 (Liang et al., 2004b). Although remaining to be
investigated, the host adaptation process most likely provides OspC-deficient spirochetes with
both time and environment that enable the upregulation of other Osps, such as VlsE and BBF01,
to occur during the course of the disappearance of unstable ospC copies. The ability of an Osp to
replace the function of OspC in initial mammalian infection highlights a redundant function of
the Osps, which is to assist B. burgdorferi evade innate immune defenses (Xu et al., 2008).
However, increasing expression of an Osp fails to fully restore ospC mutants with expected
dissemination ability, leading us to hypothesize that the unique function of OspC is to promote
dissemination (Xu et al., 2008).
As described by some investigators, the protective and dissemination-promoting
functions of OspC are like two sides of the same coin (Radolf and Caimano, 2008), highlighting
the challenge to dissect the functions of OspC. Fortunately, the event of borrelial infection can
be divided into several steps. After inoculated into the dermis of a mammal, B. burgdorferi must
first be able to evade innate immune clearance, and then replicate, disseminate and colonize
distal tissues. The 50% infectious dose (ID50) should be the best indication for the ability of B.
burgdorferi to evade this initial innate immune elimination. After initial replication, B.
burgdorferi disseminates and colonizes distal tissues. Examining the presence of spirochetes in
distal tissues would reveal its dissemination ability. Again, information about tissue bacterial
loads would be another indication of B. burgdorferi to evade innate immune clearance. If an
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ospC mutant showing the similar ID50 value and tissue bacterial load as a wild-type control can
be generated, dissecting the protective from dissemination-facilitating functions would become
possible.
The goal of the study was to dissect the dissemination-facilitating from protective
function of OspC. Our strategy was to generate OspC mutants that can evade innate immunity
but are unable to efficiently disseminate via mutagenizing the ospC gene. Based on X-ray
analyses, OspC is a largely α-helical protein and may be a dimer with a characteristic central
four-helical bundle formed by the association of the two longest helices, helices 1 and 5, from
each subunit (Eicken et al., 2001, Kumaran et al., 2001). Each subunit consists of five α-helices,
two β-sheets and six loops, in addition to the amino (N-) terminal 23-AA linker and the carboxyl
(C-) terminal 14-AA stretch. Neither the N-terminal linker nor the C-terminal stretch contributes
to the core three-dimensional structure of OspC; instead, the α-helices 1 and 5 bring the two
terminal regions in close proximity, where the lipoprotein is anchored to the bacterial outer
membrane through lipidation of the first cysteine residue of the N-terminal linker. Within the
core, several small secondary structures are present, including α-helix 4 (consisting of 8 amino
acids) β-sheet 1 (5 amino acids) and 2 (5 amino acids). We first generated B. burgdorferi
expressing OspC with each of these small units being deleted. Unfortunately, none of the
resulting mutants were infectious, suggesting that these sequences are critical for the functions of
OspC (data shown in Chapter 2).
Next, we focused on the N-terminal sequence. One role of this sequence is to carry the
sorting signal, which determines the surface location of OspC. In E. coli the so-called “+2” rule
determines the cellular location of a lipoprotein. However, the sorting signal of B. burgdorferi
can extend to the +4 position (Schulze and Zuckert, 2006). To create N-terminal deletions, which
can be successfully sorted to the outer surface, we intended to generate mutations starting at the
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+7 position, and tested the mutants for OspC surface exposure, and then analyzed the mutants for
the protective and dissemination-facilitating roles of OspC.
In this study, mutants producing OspC with a 5-AA and a 10-AA N-terminus deletion
were generated. Although the N-terminus 10-AA deletion did not affect its surface exposure of
the truncated OspC, the deletion mutant was non-infectious and thus could not be used in a
dissemination study (data shown in Chapter 2 and here). However, a mutant producing OspC
with only 5-AA N-terminal deletion was infectious. This mutant registered a similar ID50 value
and tissue bacterial load as a control but disseminated to remote tissues at a noticeably slower
pace. The study allowed us to confirm that OspC is a dissemination-facilitating factor of B.
burgdorferi.
MATERIALS AND METHODS
Previously Generated Strains and Constructs Used in The Current Study. The B.
burgdorferi B31 clone 13A and the ospC mutant were generated previously (Xu et al., 2007).
The TA cloning vector pNCO1T was constructed in a previous study (Downie et al., 2004). The
shuttle vector pBBE22 was a gift from S. Norris (Purser et al., 2003). The features of these
constructs and clones are summarized in Table 3.1.
Creation of The Constructs pBBE22-ospCnt5 and pBBE22-ospCnt10. As illustrated
in Figure 3.1, to efficiently generate a 5-AA N-terminus deletion, a 1057-bp fragment covering
the ospC region and the up- and down-stream sequences was amplified from genomic DNA by
PCR using primers P1F and P1R (Table 3.2) and cloned into the TA cloning vector pNCO1T
(Downie et al., 2004), creating an intermediate vector designated pNCO1T-ospC. One large
amplicon was generated by inverse PCR using pNCO1T-ospC as a template and primers P2F and
P2R (Table 3.2). After digestion with SapI and subsequent purification, the amplicon was
circularized via ligation and then digested with BamHI and XbaI to release ospCnt5. This
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Table 3.1. Constructs and clones used in the study.
Construct or clone

Description

Source

pNCO1T
homemade T/A cloning vector
(Downie, et al., 2004)
pNCO1T-ospC
pNCO1T carrying ospC gene driven by its native promoter
This study
pNCO1T-ospCnt5 pNCO1T carrying ospC gene expressing N-terminus 5-AA deletion
This study
pNCO1T-ospCnt10 pNOC1T carrying ospC gene expressing N-terminus 10-AA deletion
This study
pBBE22
pBSV2 carrying a bbe22 copy
(Purser, et al., 2003)
pBBE22-ospCnt5
pBBE22 carrying ospC gene expressing N-terminus 5-AA deletion
This study
pBBE22-ospCnt10 pBBE22 carrying ospC gene expressing N-terminus 10-AA deletion
This study
13A
B. burgdorferi B31 clone lacking plasmids lp25 and lp56
(Xu, et al., 2007)
ΔospC
ospC mutant
(Xu, et al., 2007)
ΔospC/FL/1
ospC mutant expressing ospC controlled by ospC regulatory elements a (Xu, et al., 2007)
ΔospC/FL/2
ospC mutant expressing ospC controlled by ospC regulatory elements (Xu, et al., 2007)
ΔospC/Nt5/1
ospC mutant expressing N-terminus 5-AA deletion
This study
ΔospC/Nt5/2
ospC mutant expression N-terminus 5-AA deletion
This study
ΔospC/Nt10/1 ospC mutant expression N-terminus 10-AA deletion
This study
ΔospC/Nt10/2 ospC mutant expression N-terminus 10-AA deletion
This study
a.

The ospC regulatory elements include both operator and promoter.

fragment, encoding an OspC variant with N-terminal 5-AA deletion, was cloned into the
recombinant plasmid pBBE22 after the vector was digested with BamHI and XbaI. The resulting
construct was designated pBBE22-ospCnt5. The insert and its flanking regions within pBBE22
were sequenced to ensure the construct was as designed. Sequencing was performed on an ABI
3130 Genetic Analyzer (Applied Biosystems, Foster city, CA) using a BigDye Terminator kit
protocol version 3.1, at the Division of Biotechnology and Molecular Medicine (BioMMed),
LSU-School of Veterinary Medicine (LSU-SVM), Baton Rouge, LA. The same strategy was
used to generate construct pBBE22-ospCnt10. The details of this construct are found in Chapter
2.
Two constructs, pBBE22-ospCnt5 (shown in Figure 3.1A) and pBBE22-ospCnt10
(shown in Chapter 2), with a 5 and 10 amino acid sequence deletion, respectively, were
generated. The two constructs were electroporated into the ospC mutant, ΔospC, which was
generated and characterized in our previous study (Xu et al., 2007). Because ΔospC lacks lp25,
the plasmid that carries the gene bbe22 coding for a nicotinamidase essential for survival of B.
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burgdorferi in the mammalian environment, the recombinant plasmid pBBE22, which harbors a
copy of bbe22, was used as the shuttle vector (Purser et al., 2003). Expression of truncated
OspC resulting from the introduced construct was confirmed by immunoblot analysis (Figure
3.1B).
Table 3.2. Primers used in the study.

Sequences (5’ to 3’) a

Clone

Primer

FL

P1F
P1R

5’-TAGTTGGCTATATTGGGATCCAA-3’
5’-TTCCTCTAGAGAAGAGCTTAAAGTTAA-3’

Nt5

P2F
P2R

5'-GACTGCTCTTCAGACAATTCTGCTGATGAGTCT-3'
5'-CGTACGCTCTTCAGTCTTTCCCAGAATTATTACAAGA-3'

a

P1F and P1R contain restriction enzyme sites (underlined) BamHI, and XbaI, respectively.
P2F and P2R contain SapI restriction sites (underlined).

Transformation of B. burgdorferi and Selection of Transformants. Constructs were
electroporated into ∆ospC; resulting transformants were screened and analyzed for plasmid
content as described previously (Xu et al., 2005). Restoration of OspC production was verified
using immunoblots probed with a mixture of FlaB and OspC MAbs (Figure 3.1B), as described
in an earlier study (Xu et al., 2007).
Indirect Immunofluorescence Assay. Spirochetes were grown to stationary phase in
BSK-H complete medium. Indirect immunofluorescence was performed on unfixed spirochetes
only. Briefly, B. burgdorferi was grown to stationary phase (108cells/ml) in BSK-H complete
medium at 33 °C. To count the cell, cells were diluted and counted by averaging eight fields
under the microscope. It was assumed that one hundred spirochetes/field was equivalent to 3x107
spirochetes/ml. For fluorescent labeling, 6x107cells were harvested from 0.6 ml of ∆ospC/FL
control, ∆ospC/nt5 or ∆ospC/nt10 mutant spirochetes by centrifugation at 8,000xg for 10 min,
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Fig. 3.1A

Fig. 3.1B

Figure 3.1. Generation of B. burgdorferi producing OspC with N-terminal 5-AA deletion.
A. Construction of pBBE22-ospCnt5 coding for OspC with N-terminal 5-AA deletion. The
five codons coding for the five amino acid residues (residues 26—30) and their adjacent codons
are presented. The amplification starting sites and directions of four primers, P1F, P1R, P2F and
P2R, used for plasmid construction are also marked. The long bar represents the 1057-bp
fragment, covering the entire ospC-coding region and down- (extending to +801 from the
transcriptional start site) and up-stream sequences (extending to -256). The detailed construction
of the vector was described in Materials and Methods section. B. Restoration of OspC
production. The parental clone 13A, ΔospC, and the clones ΔospC/FL, ΔospC/Cnt5/1 and
ΔospC/Cnt5/2 were verified for OspC expression by immunoblot probed with a mixture of FlaB
and OspC MAbs.
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gently suspended in 100 μl PBS supplemented with 3.6 μl of mouse OspC MAb preparation B5
(Gilmore and Mbow, 1999), and incubated for 1 hour at 33 °C. After one wash with excess
volume of PBS by centrifugation at 10,000xg for 10 min, spirochetes were resuspended in 100 μl
of PBS containing 1 μg of fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG
(Thermo Fisher Scientific, Rockford, IL), incubated for 1 hour, washed once with PBS by
centrifugation, resuspended in 30μl PBS, applied to microscopic slides, and analyzed using Axio
Imager (Carl Zeiss Microimaging, Inc., Thornwood, NY). Differential interference contrast
(DIC) images were also taken for the same field to identify all the spirochetes present.
SCID Mice Infectivity Studies. To test for infectivity, groups of three C3H SCID mice
were inoculated with 104 spirochetes of the clone ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, ΔospC/ΔNt10/1,
or ΔospC/ΔNt10/2. As a control, mice were also inoculated with the clone ΔospC/FL/1 or
ΔospC/FL/2. The clones ΔospC/FL/1 and ΔospC/FL/2 were generated via introduction of a fulllength ospC gene including both the operator and promoter carried by the shuttle vector pBBE22
into the ospC mutant in our previous study (Xu et al., 2007). All mice were sacrificed 1 month
post-inoculation; heart, tibiotarsal joint and skin specimens were harvested for spirochete culture
in BSK-H complete medium.
Because ΔospC/ΔNt10/1 and ΔospC/ΔNt10/2 spirochetes could remain at inoculation sites
and not disseminate to other tissues, groups of four SCID mice each received two
intradermal/subcutaneous inoculations of 105 spirochetes of the clone ΔospC/ΔNt10/1 or
ΔospC/ΔNt10/2. As a control, an additional eight animals were inoculated with the clone
ΔospC/FL/1 or ΔospC/FL/2. The two inoculation sites were at least 2 cm apart. Two animals
from each group were euthanized at 24 or 48 h later; inoculation site skin specimens were
harvested for spirochete culture.
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Determination of ID50 Values. Spirochetes were grown to late-log phase (108 cells/ml)
in BSK-H complete medium at 33 °C and 10-fold serially diluted with fresh medium. C3H SCID
mice (ages 4-6 week; provided by the Division of Laboratory Animal Medicine at Louisiana
State University, Baton Rouge, LA) each received one single intradermal/subcutaneous injection
of 100 µl of spirochetal suspension (containing 101 to 104 organisms). Mice were euthanized one
month post-inoculation; heart, tibiotarsal joint, and skin (not from inoculation site) specimens
were harvested for bacterial isolation. The ID50 value was calculated as described by Reed and
Muench (Reed and Muench, 1938). Briefly, mice were inoculated with sequential 10-fold
dilutions of spirochetes ranging from 104 to 101. The ID50 value was based on the calculation of
an index. The index and a table related to the calculation are shown in Appendix A, along with
an example. The values were input into an ID50 value calculation tool from
www.biorubyrails.com website.
Dissemination Studies in SCID and Wild Type Mice. C3H SCID mice (ages 4-6
weeks; provided by the Division of LSU Laboratory Animal Medicine) each were given a single
intradermal/subcutaneous injection of 103 spirochetes in the chest and were euthanized at 1, 2, 3
and 4 weeks post-inoculation. Tiobiotarsal joint, inoculation site and remote site skin, ear and
heart specimens were harvested for spirochete isolation as described previously (Xu et al., 2005).
Because spirochetes were injected into the dermis of the chest, the skin from the back was
harvested as a remote site. In a second experiment, BALB/c mice (ages 4-8 weeks; provided by
the Division of LSU Laboratory Animal Medicine) each received a single
intradermal/subcutaneous injection of 105 spirochetes and were euthanized at 1, 2, 3 and 4 weeks
post inoculation. The reminder of the experiment was done as previously described for C3H
SCID mice.
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Quantitation of Tissue Spirochetal Load. C3H SCID mice (4-6 weeks; provided by the
Division of LSU Laboratory Animal Medicine) each were intradermally/subcutaneously
inoculated with 104 spirochetes. Animals were sacrificed one month post-inoculation; heart,
joint, and skin specimens were harvested for DNA isolation. DNA was quantified for the copy
numbers of flaB and murine actin genes by quantitative PCR (qPCR) as described previously
(Xu et al., 2005). The tissue spirochete burden was expressed as flaB DNA copies per 106 host
cells (2×106 actin DNA copies).
Preparation of flaB-actin Fusion Standard. To better normalize the flaB and actin
concentration for quantitative PCR (qPCR), an internal sequence from both actin and flaB genes
were cloned into TA vector pNCO1T (Downie et al., 2004). A primer pair (forward: 5’-AAGG
ATCCATGAGACCACTTTCAACT-3’; reverse: 5’-GGACAGTGAGGCCAGAATG GA-3’)
was designed to amplify a 231-bp internal fragment of the actin gene using murine DNA as a
template. A second primer pair (forward: 5’-CAGCTGAAGAGCTTGGAATGCA-3’; reverse:
5’-AAGGATCCGCCTTGAGAAGGTGCT-3’) was used to generate a 260-bp internal fragment
of flaB with spirochete DNA as a template. The underlined sequences were BamH1 sites.
After digestion with restriction enzyme and purification, the two amplicons were ligated
and then amplified by nested PCR with use of a third primer pair (forward: 5’CCTCTAGAGTTCATGTTGGAGCAAAC-3’; reverse: 5’-ATTCTAGAATGGAGCCACCGA
TCCA-3’). The PCR product was cloned into TA vector pNCO1T as described previously
(Downie et al., 2004). The flaB-actin insert was confirmed by DNA sequencing using the ABI
3130 Genetic analyzer (Applied Biosystems, Foster City, CA) performed at BioMMed, LSUSVM, Baton Rouge, LA. DNA concentrations were determined by measuring optical density at
650 nm wavelength and converted to copy numbers.
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DNA Preparation. Frozen heart, joint, and skin samples were transferred into liquid
nitrogen and ground thoroughly with a mortar and pestle. An appropriate amount of tissue
powder was transferred into a 1.5 ml microcentrifuge tube for DNA preparation with the use of
DNeasy Mini kit according to the manufacturer’s instructions (Qiagen, Valencia, CA).
Quantitative PCR (qPCR). qPCR analyses were performed using the ABI 7900HT
Sequence Detection System (Applied Biosystems, Foster City, CA), at BioMMed, LSU-SVM,
Baton Rouge, LA. The Platinum Taq DNA polymerase High fidelity kit was purchased from
Invitrogen Life Technologies (Carlsbad, CA). The sequences of primers and internal probes
were: for flaB (forward: 5’-GCAGCTAATGTTGCAAATCTTTTC-3’; reverse: 5’GCAGGTGCTGGC TGTTGA-3’; probe: 5’-AAACTGCTCAGGCTCCACCGGTTC-3’) and
actin (forward: 5’-CCATGTACCCAG GCATTGC-3’; reverse: 5’-CCAGAC
TGAGTACTTGCGTTC-3’; probe: 5’- GCAGAAGGA GATCACAGCCCTAGCACC-3’).
Taqman 6-carboxytetramethylrhodamine (TAMRA) probes were ordered from Applied
Biosystems (Foster City, CA). Amplification was performed in a final volume of 10 µl in the
ABI PRISM 384-well clear optical reaction plate (Applied Biosystems, Foster City, CA). Two
sets of 12 wells were assigned as DNA standards for actin or flaB. The standard concentrations
ranged from 102 to 107 copies/well for actin DNA Quantitation, and from 100 to 105 copies for
flaB. Both standards and samples were amplified in duplicate wells. A PCR program with the
following parameters was used: 50 °C for 30 seconds; 95 °C for 5 min; 50 cycles of 95 °C for 20
seconds; and 60 °C for 1 min. The mean DNA copy numbers of flaB and actin of each DNA
sample were calculated from duplicate wells. Tissue spirochete burdens were converted to flaB
DNA copy number per 2x106 actin DNA copies (spirochete burden per 106 host cells).
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Statistical Analysis. A one-way analysis of variance (ANOVA) was used to analyze
data, followed by a two-tailed Student t test to calculate a P value for each two groups. A P value
≤ 0.05 was considered to be significant.
RESULTS
Generation of B. burgdorferi Producing OspC with Either 5 or 10 Amino Acid
Deletion. B. burgdorferi B31 ∆ospC mutants were transformed with recombinant plasmid
pBBE22-ospCnt5 (shown in Figure 3.1A) and pBBE22-ospCnt10 (shown in Chapter 2, Figure
2.4). Seven and six transformants, respectively, were obtained receiving each construct; plasmid
analyses by PCR led to the selection of four clones, ΔospC/ΔNt5/1, ΔospC/ΔNt5/2,
ΔospC/ΔNt10/1 and ΔospC/ΔNt10/1. These clones shared the same plasmid content as ΔospC,
which had lost lp25, lp5, lp21, lp56 and cp9 (Xu et al., 2007). Expression of the truncated OspC
proteins was verified by immunoblot analyses (Figure 3.1B). The in vitro growth rate of both
clones, ΔospC/ΔNt5 and ΔospC/ΔNt10, was similar to that of ∆ospC/FL controls.
Neither The 5- nor The 10-AA Deletion Affects The Surface Location of OspC.
Because the deletion was generated close to the N-terminus, which may harbor the sorting signal,
it is important to show that truncated OspC can be successfully sorted to the outer surface of B.
burgdorferi. To this end, we used indirect immunofluorescence to locate truncated OspC. As
shown in Figure 3.2, both truncated proteins showed similar fluorescence patterns as the wildtype control protein, indicating that neither deletion influenced the cellular location of OspC.
The 10- but Not 5-AA Deletion Abolishes Infectivity.

As shown in Table 3.3, like the

two control clones, the ΔospC/ΔNt5/1 and ΔospC/ΔNt5/2 spirochetes were grown from each
sample of all inoculated mice. In contrast, neither ΔospC/ΔNt10/1 nor ΔospC/ΔNt10/2 bacteria
were recovered from any specimens, suggesting that the 10-AA deletion may completely abolish
the functions of OspC.
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Figure 3.2. Deletion of N-terminus 5-AA or 10-AA does not affect surface exposure of
OspC. ∆ospC/FL, ∆ospC/Nt5 or ∆ospC/Nt10 spirochetes were grown to late log phase (108/ml)
in BSK-H medium at 33°C. Spirochetes were incubated with mouse mOspC antibodies, washed
in PBS, probed with FITC-conjugated goat anti-mouse antibody, washed again before being
placed onto slides. Differential interference contrast (left panel) and immunofluorescence images
(right panel) were taken from the same field. Magnification: x400.
The ΔospC/ΔNt10/1 and ΔospC/ΔNt10/2 bacteria might have remained at the inoculation
sites without dissemination. To rule out this possibility, C3HS mice were given
intradermal/subcutaneous inoculations of ΔospC/ΔNt10/1, ΔospC/ΔNt10/2, ΔospC/FL/1 or
ΔospC/FL/2 at a total of four sites for each clone and the inoculation sites were harvested at 24h
and 48h post-inoculation. Control bacteria were consistently grown from each of the 16
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inoculation sites from all eight inoculated mice. In contrast, neither ΔospC/ΔNt10/1 nor
ΔospC/ΔNt10/2 spirochetes were recovered from any of the 8 sites harvested at each time point,
confirming that the 10-AA deletion completely destroys the functions of OspC and leads to quick
clearance of spirochetes (results shown in Chapter 2, Table 2.3).
The 5-AA Deletion Does Not Affect The ID50 Value in SCID Mice. Because the ID50
value reflects the smallest number of organisms to sufficiently initiate an infection in 50%
inoculated individuals, it is the best measurable criterion to assess how a pathogen can evade
innate immune elimination, especially when this is measured in SCID mice. To examine
whether the 5-AA deletion reduced the ability of OspC to assist B. burgdorferi avoid innate
immunity, groups of three C3H SCID mice each received one single inoculation of 101 to 104
spirochetes of the clone ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, ΔospC/FL/1, or ΔospC/FL/2. All animals
were euthanized 1 mo post-inoculation; heart, joint and skin specimens were cultured for
spirochetes. The ID50 values of the clones ΔospC/Nt5/1 and ΔospC/Nt5/2 were 18 and 32
organisms, compared to 18 and 32 organisms determined for the clones ΔospC/FL/1 and
ΔospC/FL/2, respectively (Table 3.4), indicating that the truncated OspC retains the innate
immunity evasive function.
The 5-AA Deletion Does Not Reduce Spirochete Burdens in Joint or Skin of SCID
Mice. The tissue bacterial load reflects the balance between the replication and death rates so
that it is another measurable criterion to assess how well a pathogen is protected from
elimination by innate immunity (Figure 3.3). To examine the influence of the 5-AA deletion on
the tissue bacterial load, subgroups of five SCID mice each received a single
intradermal/subcutaneous inoculation of 104 spirochetes of the clone ΔospC/Nt5/1, ΔospC/Nt5/2,
ΔospC/FL/1, or ΔospC/FL/2. In 10 mice that were inoculated with the ΔospC/FL/1 or
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ΔospC/FL/2, joint swelling evolved around 10 d post-inoculation and developed into severe
month post-inoculation; DNA was extracted from heart, joint and skin specimens and quantified
Table 3.3. The 10-AA deletion abolishes infectivity of B. burgdorferi a
No. of cultures positive/total
specimen examined
Heart Joint Skin All sites

Clone

No. of mice infected/total
mice inoculated

ΔospC/FL/1
ΔospC/FL/2

3/3
3/3

3/3
3/3

3/3
3/3

9/9
9/9

3/3
3/3

ΔospC/ΔNt5/1
ΔospC/ΔNt5/2

3/3
3/3

3/3
3/3

3/3
3/3

9/9
9/9

3/3
3/3

ΔospC/ΔNt10/1
ΔospC/ΔNt10/2

0/3
0/3

0/3
0/3

0/3
0/3

0/9
0/9

0/3
0/3

a

Groups of three C3H SCID mice were inoculated with 104 spirochetes of the clone
ΔospC/FL/1, ΔospC/FL/2, ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, ΔospC/ΔNt10/1, or ΔospC/ΔNt10/2.
Mice were sacrificed 1 mo post-inoculation; heart, tibiotarsal joint and skin specimens were
harvested for spirochete culture in BSK-H complete medium.
for bacterial burden. Although the ΔospC/Nt5 spirochete burden was 6.7-fold lower than that of
the ΔospC/FL (P = 2.83 × 10‾10) in the heart tissue, there was no significant difference detected
either in joint (P = 0.52) or skin tissue (P =0.13). The study indicated that the 5-AA deletion
does not reduce the ability of OspC to protect B. burgdorferi against innate immunity.
The 5-AA Deletion Leads to Slowed Dissemination During Infection of SCID Mice.
Groups of 20 SCID mice each received a single intradermal/subcutaneous inoculation of 104
spirochetes of the clone ΔospC/FL/1 or ΔospC/ΔNt5/1. Five animals from each group were
euthanized at 1-wk intervals; inoculation site and remote site skin, ear, heart, and joint specimens
were harvested for spirochete isolation. Bacteria were injected into the dermis of the chest so the
skin from the back was harvested as remote sites. As a positive control, the ΔospC/FL/1 bacteria
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were grown from all of the skin, joint and heart specimens but from none of the ear samples at
first week; all sites became culture positive at 2 wk after initial inoculation (Table 3.5).
Table 3.4. Deletion of the N terminus 5-AA sequence of OspC does not significantly affect
the ID50 value in immunodeficient mice a
Clone
and dose
(no. of organisms)

No. of cultures positive/total
no. of specimens examined
Heart Joint Skin All sites

No. of mice infected/total
no. of mice inoculated

ΔospC/FL/1
104
103
102
101

3/3
3/3
3/3
1/3

3/3
3/3
3/3
1/3

3/3
3/3
3/3
1/3

9/9
9/9
9/9
3/9

3/3
3/3
3/3
1/3

ΔospC/FL/2
104
103
102
101

3/3
3/3
3/3
0/3

3/3
3/3
3/3
0/3

3/3
3/3
3/3
0/3

9/9
9/9
9/9
0/9

3/3
3/3
3/3
0/3

ΔospC/ΔNt5/1
104
103
102
101

3/3
3/3
3/3
1/3

3/3
3/3
3/3
1/3

3/3
3/3
3/3
1/3

9/9
9/9
9/9
3/9

3/3
3/3
3/3
1/3

ΔospC/ΔNt5/2
104
103
102
101

ID50
(No. of
organisms)
18

32

18

32
3/3
3/3
2/3
1/3

3/3
3/3
2/3
1/3

3/3
3/3
2/3
1/3

9/9
9/9
6/9
3/9

3/3
3/3
2/3
1/3

a

The ΔospC/FL/1, ΔospC/FL/2, ΔospC/ΔNt5/1and ΔospC/ΔNt5/2 spirochetes were grown to
late-log phase (108 cells/ml) and 10-fold serially diluted with BSK-H medium. Approximately
100 µl of bacterial suspension was intradermally/subcutaneously inoculated into each C3HS
mouse. Animals were sacrificed 1 month later; heart, tibiotarsal joint and skin specimens were
harvested for bacterial isolation. The ID50 values were calculated by the method of Reed and
Muench (Reed and Muench, 1938).
In contrast, the ΔospC/ΔNt5/1 spirochetes were grown only from inoculation sites at a week
post-inoculation. Although the mutant disseminated to most of the joint, remote skin and heart
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specimens at 2 wk, the majority of ear tissues were not colonized until 3 wk. These data
indicated that OspC is important for efficient dissemination.

Figure 3.3. The N-terminal 5-AA deletion does not reduce the ability of B. burgdorferi to
colonize joint or skin but heart tissues of SCID mice. Subgroups of five SCID mice were
inoculated with 105 spirochetes of the clone ΔospC/FL/1, ΔospC/FL2, ΔospC/ΔNt5/1, or
ΔospC/ΔNt5/2, and euthanized a month later. DNA was prepared from heart, joint and skin
specimens and analyzed for spirochete flaB and murine actin DNA copies by qPCR. Data are
expressed as spirochete numbers per 106 host cells and presented in four groups by combining
the subgroups ΔospC/FL/1 and ΔospC/FL/2, ΔospC/ΔNt5/1 and ΔospC/ΔNt5/2 and named as FL
and Cnt5 respectively.*, P < 0.05 between FL and Cnt5.
The 5-AA Deletion Causes Severely Impaired Dissemination During Infection of
Immunocompetent Mice. More severely impaired dissemination was noted during infection of
immunocompetent mice. Groups of 24 BALB/c mice each received a single
intradermal/subcutaneous inoculation of 105 spirochetes of the clone ΔospC/FL/1 or
ΔospC/ΔNt5/1. Six animals from each group were euthanized at 1-wk intervals; inoculation site
and remote site skin, ear, heart, and joint specimens were harvested for spirochete isolation.
Bacteria were injected into the dermis of the chest so the skin from the back was harvested as
remote sites. As a positive control, the ΔospC/FL/1 bacteria were grown from all of the remote
tissues but the ear at first week; all sites became culture positive at 2 wk after initial inoculation
(Table 3.6). In contrast, the ΔospC/ΔNt5/1 spirochetes were not grown from joint tissues until 4
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weeks after inoculation, and no heart, remote skin or ear tissues became culture positive during
the period. These data further highlights that OspC is required for efficient dissemination.
DISCUSSION
Like typical Gram-negative bacteria, B. burgdorferi possesses inner and outer
membranes, between which is a periplasmic space (Cullen et al., 2004, Steere, 2001). Gramnegative pathogens typically make a thick lipopolysaccharide (LPS) coat to provide a broad
array of crucial protection (Raetz and Whitfield, 2002). However, B. burgdorferi does not
produce any LPS but instead abundantly expresses lipoproteins and anchors them to the outer
membranous surface through lipidation (Cullen et al., 2004, Radolf et al., 1994, Takayama et al.,
1987). This unique surface antigenic architecture makes the host-pathogen interactions more
complicated and may contribute to the pathogenic strategy of B. burgdorferi. As protein is a
direct product of gene expression, regulation of surface antigen expression can quickly result in
modification of the surface antigenic architecture. B. burgdorferi indeed takes this advantage and
vigorously modifies its surface lipoprotein expression to constantly reformulate its overall
surface antigenic architecture during the enzootic life cycle traveling between the tick vector and
a mammal, and during the course of mammalian infection (Yang et al., 2004). The pathogen
abundantly expresses outer surface proteins (Osps) A and B in the unfed tick (Schwan and
Piesman, 2000, Schwan et al., 1995), suggesting a critical role for these surface antigens while
residing in the tick vector, which has been confirmed by series of subsequent studies (Fikrig et
al., 2004, Neelakanta et al., 2007, Ohnishi et al., 2001, Yang et al., 2004). A fresh blood meal
induces the down-regulation of OspA/B and the up-regulation of OspC and other lipoproteins, a
process that prepares B. burgdorferi for infection of mammals (Fingerle et al., 2007, Grimm et
al., 2004b, Pal et al., 2004, Stewart et al., 2006). Abundant OspC expression ultimately induces a
robust early humoral response that imposes tremendous pressure on the pathogen (Fung et al.,
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1994, Xu et al., 2006). To evade the specific humoral response and cause persistent infection, B.
burgdorferi down-regulates OspC and dramatically upregulates other surface lipoproteins,
including VlsE and BBF01 (Crother et al., 2004, Liang et al., 2004a, Liang et al., 2002a, Liang
et al., 2002b). This demonstrated ospC expression pattern strongly suggested its early role in
mammalian infection. This initial requirement has been confirmed as genetic manipulation of B.
burgdorferi became possible (Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006).
Recent studies showed that this initial requirement for OspC can be overridden by either
increasing expression of another Osp (Xu et al., 2008), or simply adapting ospC mutants in
mammalian hosts (Tilly et al., 2009) . The adaptation process apparently is to increase
expression of other Osps, which replace lost OspC functions. Apparently, increasing expression
of Osps, either via genetic modification or adaptation in mammalian host, can at least partially
replace OspC. This raises a question about OspC functions. These studies led us to hypothesize
that the borrelial lipoproteins may have a common function, which is to protect B. burgdorferi
against innate immunity, while the unique function of OspC is to facilitate dissemination, which
can be only partially replaced by other Osps. In the current study, we successfully separated
protective function and dissemination-facilitating function. We successfully generated a
truncated OspC, which can effectively protect B. burgdorferi against innate elimination but fails
to make spirochetes able to disseminate as efficiently as the wild-type control.
Our previous study showed that increasing production of one of four randomly chosen
but well-investigated surface lipoproteins can effectively replace OspC to protect B. burgdorferi
against innate immunity, clearly suggesting that any surface lipoprotein apparently can
substitute OspC for this function. What strikes us is that not all truncated OspC mutants are able
to protect B. burgdorferi against innate immunity while any other wild-type surface lipoprotein
can replace OspC for this specific function. Although the 5-AA deletion retains the full
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Table 3.5. N-terminal 5-AA deletion of OspC impairs the ability of B. burgdorferi to disseminate to remote tissues in
immunodeficient mice. a
Clone

ΔospC/ospC
ΔospC/ΔNt5

No. of specimens positive/total specimens examined at post-inoculation weeks
1 wk
2 wks
3 wks
I.S. R.S. Ear Heart Joint

I.S. R.S. Ear Heart Joint

I.S. R.S. Ear Heart Joint

5/5 5/5
5/5 0/5

5/5 5/5
5/5 4/5

NDb ND ND ND
5/5 5/5 5/5 5/5

0/5 5/5
0/5 0/5

5/5
0/5

a.

5/5 5/5
1/5 4/5

5/5
5/5

ND
5/5

Groups of 10 to 15 C3HS SCID mice each received a single intradermal/subcutaneous injection of 103 organisms of the clone
ΔospC/ospC or ΔospC/ΔNt5. Five animals from each group were euthanized at 1, 2, or 3 wk post-inoculation; inoculation site (I.S.)
and remote site (R.S.) skin, ear, heart, and joint specimens were harvested for spirochete isolation. The I.S. site was at the chest;
therefore the R.S. site was at the back of mice. b. ND, not determined.
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Table 3.6. N-terminal 5-AA deletion of OspC severely impairs the ability of B. burgdorferi to disseminate to remote tissues in
immunocompetent BALB/c mice. a
Clone
1 wk
I.S. R.S. Ear Heart Joint
ΔospC/ospC
ΔospC/ΔNt5

6/6 6/6 0/6 6/6
6/6 0/6 ND 0/6

6/6
1/6

No. of specimens positive/Total specimens examined at post-inoculation weeks
2 wks
3 wks
4 wks
I.S. R.S. Ear Heart Joint
I.S. R.S. Ear Heart Joint I.S. R.S. Ear Heart Joint
6/6 6/6
1/6 0/6

6/6
0/6

6/6
0/6

6/6
0/6

a.

6/6 6/6
2/6 0/6

6/6 6/6
0/6 0/6

6/6
6/6

6/6 6/6 6/6 6/6 6/6
6/6 0/6 0/6 0/6 6/6

Groups of 24 BALB/c mice each received a single intradermal/subcutaneous injection of 105 organisms of the clone ΔospC/ospC or
ΔospC/ΔNt5. Six animals from each group were euthanized at 1, 2, 3 or 4 wk post-inoculation; inoculation site (I.S.) and remote site
(R.S.) skin, ear, heart, and joint specimens were harvested for spirochete isolation. The I.S. site was at the chest; therefore the R.S.
site was at the back of mice.
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capacity of OspC to protect B. burgdorferi against innate elimination, the 10-AA deletion
completely destroys its functions. Interestingly, a previous study showed that any of the four
Osps tested can replace OspC to protect B. burgdorferi from innate elimination. However, OspC
itself, after 10-AA deletion, failed to protect B. burgdorferi. This suggests that each Osp may
protect B. burgdorferi against innate immunity in a unique method.
After inoculated into murine skin, B. burgdorferi must first be able to evade initial innate
immune elimination and gain a foothold. This ability is best represented by the ID50 value
because this criterion measures the smallest number of organisms that is sufficient to escape
initial innate elimination. Regardless of how large the inoculum is, OspC-deficient spirochetes
are quickly cleared after inoculation into murine skin (Tilly et al., 2007, Xu et al., 2008) .
Production of OspC with 5-AA deletion conferred OspC deficient B. burgdorferi with ID50
values similar to the control, indicating that the truncated molecule has the full protective
function of OspC.
Although tissue colonization is an extremely complicated event carried out by an
extracellular bacterial pathogen during infection and can be affected by many factors, one can
predict that the ability of the pathogen to evade immune clearance should be one of the major
determinants. B. burgdorferi producing OspC with 5-AA deletion was able to generate similar
bacterial loads in both joint and skin tissues of SCID mice as the control, indicating that the
truncated OspC can effectively assist the pathogen evade innate immune clearance at least in
these tissues. Because many other determinants, such as the interactions of host cells and
extracellular matrices with the pathogen mediated with its surface antigens, may significantly
influence tissue colonization, the lower ΔospC/ΔNt5 spirochete load in the heart does not
necessarily suggest that the truncated OspC cannot effectively provide evasion from host innate
immune defenses. Alternatively, OspC may be an important factor contributing to the ability of
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B. burgdorferi to colonize the heart tissue. This explanation is also supported by previous
studies showing that treatment with OspC antibody induces the downregulation of ospC and
more effectively reduces the bacterial load in the heart more than other tissues (Liang et al.,
2004a, Liang et al., 2004b).
Both ID50 and tissue bacterial load data demonstrated that the 5-AA deletion does not
affect the innate immune evasive function of OspC, allowing us to dissect the evasive from
dissemination-facilitating functions. OspC-deficient B. burgdorferi producing OspC with 5-AA
deletion disseminated to remote tissues, especially to the heart and ear at a significantly slower
pace in immunodeficient mice. In immunocompetent mice, the defect caused by deletion was
much more severe. Four weeks after inoculation, the mutant was not able to colonize heart or
ear tissues, while the control disseminated to all tissues examined within 2 weeks. Given the
difference between immunodeficient and immunocompetent mice, infection in the latter induces
an anti-OspC humoral response, which in turn may further slow dissemination. The observation
highlights the importance of quick dissemination of B. burgdorferi during infection of
immunocompetent animals. Infection induces immune responses that slow dissemination. If B.
burgdorferi fails to colonize remote tissues and establish a systemic infection before effective
immune responses have developed, its dissemination would be dramatically slowed.
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CHAPTER 4
OUTER SURFACE PROTEIN C IS INVOLVED IN SELF-REGULATION
IN BORRELIA BURGDORFERI DURING MURINE INFECTION
INTRODUCTION
Outer surface protein C (OspC) is a critical virulence factor of the Lyme disease
spirochete Borrelia burgdorferi. Timely expression of OspC is essential for the survival of the
spirochete as it transits between a tick vector and a mammalian host (Burgdorfer et al., 1982).
The pathogen abundantly produces OspC during initial infection (Liang et al., 2002a, Liang et
al., 2002b), when the antigen is required for efficient dissemination (Xu et al., 2008b) (and, as
shown in Chapter 3), but represses its production to a baseline level after specific humoral
responses have developed and distal tissues have been colonized (Liang et al., 2004b, Xu et al.,
2006). The downregulation of OspC allows B. burgdorferi to not only effectively evade the
immune system but also preserve the integrity of the crucial gene for the subsequent enzootic
cycle, because a failure to downregulate ospC would lead to either clearance of infection or
selection of ospC mutants (Xu et al., 2006). OspC production is driven by an RpoS-dependent
promoter (Yang et al., 2005) and its repression appears to be achieved through the interaction of
the operator with an unknown repressor (Xu et al., 2007). Here we show that deletion of an Nterminal 5-amino acid sequence of OspC diminishes the ability of B. burgdorferi to repress ospC
expression during murine infection and, as a result, dramatically reduces its ability to evade the
immune system. Further investigation may lead to disclosure of how OspC can be involved in
self regulation.
Coordinated production of OspC is crucial for the pathogenic strategy of the Lyme
disease spirochete, B. burgdorferi (Burgdorfer et al., 1982). In unfed ticks, B. burgdorferi does
not express OspC (Ohnishi et al., 2003, Schwan et al., 1995); a fresh blood meal upregulates
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OspC, a process that prepares the pathogen for infection of a mammal (Grimm et al., 2004b, Pal
et al., 2004, Stewart et al., 2006). B. burgdorferi abundantly expresses OspC during early
infection when the antigen is required for efficient dissemination as shown in Chapter 3 of this
dissertation and in Liang, et al., 2004, Tilly, et al., 2006, and Xu et al., 2008 (Liang et al., 2004a,
Tilly et al., 2006, Xu et al., 2008a). However, OspC is not only a strong immunogen, but also an
effective target of protective immunity; its production ultimately induces a robust humoral
response that imposes tremendous pressure on the pathogen (Fung et al., 1994, Liang et al.,
2004a). If B. burgdorferi fails to repress ospC expression or undergo escape mutations on the
ospC gene, infection would be cleared (Xu et al., 2006). While mutation is an effective way to
evade the immune system, it may cause the functional loss of affected genes. Although the
spirochetes with lost OspC function may persist during chronic infection (Tilly et al., 2006), they
are unable to initiate an infection (Stewart et al., 2006), thus leading to a discontinuation of the
enzootic cycle. Therefore, the downregulation of OspC allows the pathogen to not only
effectively evade the specific immune response but also to preserve the integrity of the ospC
gene for subsequent need during its life cycle (Liang et al., 2004a, Liang et al., 2002a). It is also
critical for B. burgdorferi to maintain an OspC downregulation status after acquired by the tick
vector as specific antibodies in bloodmeal can efficiently kills spirochetes (Gilmore and
Piesman, 2000). Overall, when OspC is required, B. burgdorferi up-regulates it; when its
presence confers disadvantage to the bacteria, the pathogen down-regulates it.
While many gaps remain to be filled, recent advances in borrelial genetic study provide a
relatively clear picture of how ospC is regulated during the course of the enzootic cycle. ospC
expression uses a well-defined RpoS-dependent promoter (Eggers et al., 2004, Yang et al.,
2005). In response to a fresh bloodmeal, B. burgdorferi upregulates the alternative σ factor,
which in turn initiates expression of many genes important for mammalian infection, including
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ospC (Caimano et al., 2007). Because RpoS controls the expression of multiple crucial virulence
determinants, B. burgdorferi cannot afford to shut off rpoS in order to realize ospC
downregulation during mammalian infection. Instead, the pathogen is most likely to induce
expression of an unknown repressor, which specifically interacts with the ospC operator and
shuts the gene off without affecting expression of other RpoS-dependent genes in response to the
development of specific humoral responses (Xu et al., 2007). Once acquired by the tick vector,
B. burgdorferi turns rpoS off, and consequently ospC and other RpoS-dependent genes (Caimano
et al., 2007), regardless of whether the ospC operator-repressor system is involved.
Either down- or up-regulation of RpoS is initiated in the tick vector (Caimano et al.,
2007), while the ospC operator-repressor system is needed only in the response to the specific
humoral response during mammalian infection (Xu et al., 2007). A series of seminal studies by
Norgard and colleagues showed that rpoS expression is dependent on the response regulator
protein, Rrp2, which along with RpoN regulates expression of RpoS (Hubner et al., 2001, Smith
et al., 2007, Yang et al., 2003). However, nothing is known about how the environmental cues
are converted into regulatory events. In our previous study, we noticed that the ospC regulatory
element did not function well when it controlled ospA expression in an ospC knockout mutant,
leading us to hypothesize that OspC may be involved in self-regulation. The current study
focused on this issue.
Structurally, OspC is predominantly alpha-helical and forms a dimer in solution. The
lipoprotein is made up of five alpha-helices, two beta sheets, six loops and a carboxy (C-)
terminus and an amino (N)-terminus (Eicken et al., 2001, Kumaran et al., 2001). The aminoterminus anchors the lipoprotein to the outer surface of the outer membrane of Borrelia by a
lipidated cystein (Hayashi and Wu, 1990, Pugsley and Possot, 1993). Since the N-terminus is the
only portion of the crystal structure of OspC that connects the rest of the lipoprotein to the outer
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membrane, this region was chosen for a minor amino acid deletion mutation and then tested for
resulting changes in ospC regulation.
MATERIALS AND METHODS
Strains and Constructs Generated Previously and Used in This Study. The B.
burgdorferi B31 clone 13A and the ospC mutant were generated previously (Xu et al., 2007).
The shuttle vector pBBE22 was a gift from S. Norris (Purser et al., 2003). The features of the
constructs and clones used in this study are summarized in Table 4.1
Table 4.1. Constructs and clones used in the study.
Construct or clone

Description

Source

pNCO1T
homemade T/A cloning vector
(Downie, et al., 2004)
pNCO1T-ospC
pNCO1T carrying ospC gene driven by its native promoter
This study
pNCO1T-ospCnt5 pNCO1T carrying ospC gene expressing N-terminus 5-AA deletion
This study
pBBE22
pBSV2 carrying a bbe22 copy
(Purser et al., 2003)
pBBE22-ospCnt5 pBBE22 carrying ospC gene expressing N-terminus 5-AA deletion
This study
13A
B. burgdorferi B31 clone lacking plasmids lp25 and lp56
(Xu et al., 2007)
ΔospC
ospC mutant
(Xu et al., 2007)
ΔospC/FL/1
ospC mutant expressing ospC controlled by ospC regulatory elementsa (Xu et al., 2007)
ΔospC/FL/2
ospC mutant expressing ospC controlled by ospC regulatory elements (Xu et al., 2007)
ΔospC/Nt5/1
ospC mutant expressing N-terminus 5-AA deletion
This study
ΔospC/Nt5/2
ospC mutant expression N-terminus 5-AA deletion
This study
a.

The ospC regulatory elements include both operator and promoter.

Generation of B. burgdorferi Producing OspC with N-terminus 5-AA Deletion. As
illustrated in Figure 4.1A, to efficiently generate an N-terminus deletion, a 1057-bp fragment
covering the ospC region and the up- and down-stream sequences was amplified on genomic
DNA by PCR using primers P1F and P1R (Table 4.2) and cloned into the TA cloning vector
pNCO1T (Downie et al., 2004), creating an intermediate vector designated pNCO1T-ospC. One
linear and large amplicon was generated by inverse PCR using pNCO1T-ospC as a template and
primers P2F and P2R (Table 4.2). After digestion with SapI and subsequent purification, the
amplicon was circularized via ligation and then digested with BamH1 and XbaI to release
ospCnt5. This fragment, encoding an OspC variant with N-terminal 5-AA deletion, was cloned
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into the recombinant plasmid pBBE22 after the vector was digested with BamH1 and XbaI. The
resulting construct was designated pBBE22-ospCnt5. The insert and its flanking regions within
pBBE22 were sequenced to ensure the construct was as designed.
The complementation plasmid was then electroporated into an ospC mutant (∆ospC),
which was generated in our previous study (Xu et al., 2007); the seven resulting transformants
were first screened for the presence of lp28-1, a plasmid essential for persistent infection in
immunocompetent hosts (Grimm et al., 2004a, Xu et al., 2005). Two of the transformants that
contained lp28-1 were further analyzed for the content of those plasmids that tend to be
spontaneously lost during in vitro propagation, as described previously (Xu et al., 2005). The
plasmid contents for both these clones were identical with the presence of lp28-2, lp28-4 and
cp32-3. Efficient production of OspC protein by the clones was verified by immunoblots probed
with a mixture of FlaB and OspC monoclonal antibodies (MAbs) (Figure 4.1B) as previously
described (Xu et al., 2006). The clone 13A, which was generated in our previous study was
included as a control (Xu et al., 2007).
Indirect Immunofluorescene Assay (I-IFA): Indirect immunofluorescence was
performed on unfixed and fixed spirochetes. Briefly, B. burgdorferi was grown to late log phase
(108 cells/ml) in BSK-H complete medium at 33 °C. For fluorescent labeling of unfixed
spirochetes, 6x107cells were harvested from 0.6 ml of ∆ospC/FL or ∆ospC/Nt5 mutant
spirochetes by centrifugation at 8,000xg for 10 min, gently suspended in 100 μl PBS
supplemented with 3.6 μl of mouse OspC or FlaB MAb preparation, and incubated for 1 hour at
33 °C. After one wash with excess volume of PBS by centrifugation at 10,000xg for 10 min,
spirochetes were resuspended in 100 μl of PBS containing 1 μg of fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse IgG (Thermo Fisher Scientific, Rockford, IL), incubated for
1 hour, washed once with PBS by centrifugation, resuspended in 30μl PBS, applied to
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Fig. 4.1A

Fig. 4.1B

Figure 4.1. Generation of B. burgdorferi producing OspC with N-terminal 5-AA deletion.
A. Construction of pBBE22-ospCNt5 coding for OspC with N-terminal 5-AA deletion. The
five codons coding for the five amino acid residues (residues 26—30) and their adjacent codons
are presented. The amplification starting sites and directions of four primers, P1F, P1R, P2F and
P2R, used for plasmid construction are also marked. The long bar represents the 1057-bp
fragment, covering the entire ospC-coding region and down- (extending to +801 from the
transcriptional start site) and up-stream sequences (extending to -256). The detailed construction
of the vector was described in Materials and Methods section. B. Restoration of OspC
production. The parental clone 13A, ΔospC, and the clones ΔospC/FL, ΔospC/Nt5/1 and
ΔospC/Nt5/2 were verified for OspC expression by immunoblot probed with a mixture of FlaB
and OspC MAbs.
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Table 4.2 Primers used in this study:
_____________________________________________________________________________________________

Construct:
Primer name
Primer sequence (5’-3’)a
______________________________________________________________________________
FL

P1F
P1R

ΔNt5

P2F
P2R

5'-TAGTTGGCTATATTGGGATCCAA-3'
5'-TTCCTCTAGAGAAGAGCTTAAAGTTAA-3'

5'-GACTGCTCTTCAGACAATTCTGCTGATGAGTCT-3'
5'-CGTACGCTCTTCAGTCTTTCCCAGAATTATTACAAG-3’
_____________________________________________________________________________________________
a
The underlined sequences are restriction enzyme sites. P1F contains a BamHI site; P1R has an XbaI site; P2F
and P2R have a SapI site.

microscopic slides, and analyzed using Axio Imager (Carl Zeiss Microimaging, Inc., Thornwood,
NY).
For fluorescent labeling of fixed spirochetes, organisms were harvested from 0.6 ml
culture by centrifugation, suspended in 50 µl of PBS, followed by addition of 700 µl acetone
(Mallincrodt Baker, Phillipsburg, NJ), incubated at room temperature for 10 min, and then
centrifuged at 10,000xg for 10 min. After being washed once with excess volume of PBS, fixed
spirochetes were processed as described above for fluorescent labeling of unfixed bacteria.
Quantitation of ospC Gene Expression. C3H SCID mice (ages 4-6 weeks; provided by
the Division of LSU Laboratory Animal Medicine) each were intradermally/subcutaneously
inoculated with 104 spirochetes. Animals were sacrificed one month post-inoculation; heart,
joint, and skin specimens were harvested for RNA extraction. RNA was quantified for flaB and
ospC mRNA copy numbers by reverse transcription qPCR (RT-qPCR) as described below. Data
are presented as ospC transcripts per 1,000 flaB mRNA copies.
RNA Preparation. Frozen heart, joint, and skin samples were transferred in liquid
nitrogen and ground thoroughly with a mortar and pestle. RNA was isolated with the use of
Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA). Briefly, 1ml of Trizol was added to
the sample when the mortar became wet. The solution containing the powder was gently mixed
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and transferred to a microcentrifuge tube by pipetting, and the sample was incubated for 5
minutes at room temperature. 0.2 ml of chloroform:isoamyl alchohol (24:1) was added to the
tube and mixed vigorously and incubated again for 3 minutes. Samples were spun at 12400 rpm
for 15 minutes at 4 °C. The upper colorless aqueous phase was transferred to a fresh microfuge
tube. 0.5 ml of Isopropanol was added, incubated at room temperature for 10 minutes and
centrifuged for 10 minutes at 12400xg at 4 °C. The supernatant was removed by pipetting. The
RNA pellet was washed with 1 ml of fresh 75% cold Ethanol, vortexed and centrifuged at 10,000
rpm for 5 minutes at 4 °C. Ethanol was removed as much as possible. Samples were stored at -20
°C for a short period.
cDNA Preparation. The DNA-free RNA preparation was first annealed with reverse
oligonucleotide mixture of flaB (5’-ATTCCAAGCTCTTCAGCTG-3’) and ospC (5’CAGCCATCAGTAACACCTTC-3’) genes at 65, 60, 55, 50, and 45 °C each for 1 min, in the
presence of reverse transcription (RT) buffer (Invitrogen). Deoxynucleoside triphosphates and
SuperScript II RNase H- reverse transcriptase (Invitrogen) were added, RT was conducted at 42
̊ C for 1 h, and then reaction mixture was inactivated at 70 °C for 15 min.
Quantitative RT-PCR (qRT-PCR). qRT-PCR analyses were performed by using the
ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA). The Platinum
Taq DNA polymerase high fidelity kit was purchased from Invitrogen Life Technologies
(Carlsbad, CA). The sequences of primers and internal probes were: for flaB (forward: 5’GAGTTTCTGGTAA GATTAATGCTC-3’; reverse: 5’-CATTTAAATTCCCTTCTGTTG
TCTGA-3’; probe: 5’-AGAGGTTTGTCACAAGCTTCTAGAAATACTTCAAAGGC-3’) and
for ospC (forward: 5’-TACGGATTCTAATGCGGTTTTAC-3’; reverse: 5’-GTGATTATT
TTCGGTATCCA AACCA-3’; probe: 5’-TGAAGCGTTGCTGTCATCTATAGATGAAATTG
CTGCT-3’).
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Passive Immunization of SCID Mice with Anti-OspC Monoclonal Antibody. C3HS
SCID mice (ages 4-6 weeks; provided by the Division of LSU Laboratory Animal Medicine)
each were given a single intradermal/subcutaneous injection of 105 ∆ospC/FL or ∆ospC/Nt5
spirochetes. At one month post-inoculation, OspC monoclonal antibody B5 (Mbow et al., 1999)
or purified normal mouse IgG2a isotype (Sigma Aldrich) as a control was given at 100 µg. Three
days later, mice were killed and heart, joint, skin (remote), and ear specimens were collected for
bacterial culture.
Evaluation of Anti-Borrelia Specific Immune Response in Wild Type Mice. BALB/c
mice (ages 4-8 weeks; provided by the Division of LSU Laboratory Animal Medicine) each
received a single intradermal/subcutaneous injection of 105 ∆ospC/FL or ∆ospC/Nt5 spirochetes
and were euthanized at 1, 2, 3 and 4 weeks post inoculation. Tiobiotarsal joint, inoculation site
and remote site skin, ear and heart specimens were harvested for spirochete isolation as
described previously (Xu et al., 2005). Spirochetes were injected into the dermis of the chest, so
the skin from the back was harvested as remote site.
Statistical Analysis. A one-way analysis of variance (ANOVA) was used to analyze
data, followed by a two-tailed Student t test to calculate a P value for each two groups. P ≤ 0.05
was considered to be significant.
RESULTS
Generation of B. burgdorferi Producing OspC with N-terminal 5-AA Deletion.
One construct, namely pBBE22-ospCnt5, was electroporated into the ospC mutant ΔospC, which
was generated and characterized in our previous study (Xu et al., 2007). pBBE22-ospCnt5 was
constructed as illustrated in Figure 4.1A. Because ΔospC had lost lp25, the plasmid that carries
the gene bbe22 coding for a nicotinamidase essential for survival of B. burgdorferi in the
mammalian environment, the recombinant plasmid pBBE22, which harbors a copy of bbe22,
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was used as the shuttle vector (Purser et al., 2003). Thirteen transformants were obtained;
plasmid analyses led to selection of two clones, namely ΔospC/CNt5/1 and ΔospC/CNt5/2. Both
clones shared the same plasmid content as ΔospC, which had lost lp25, lp5, lp21, lp56 and cp9
(Xu et al., 2007). Expression of truncated OspC resulting from the introduced construct was
confirmed by immunoblot analysis (Figure 4.1B).
The N-terminal Truncation Does Not Affect The Surface Location of OspC. The
cellular location of borrelial lipoprotein is primarily determined by the first few residues
following the signal peptide (Schulze and Zuckert, 2006). To investigate whether removal of the
N-terminal 5 residues affects the surface location of OspC, indirect immunofluorescence was
performed using mOspC (Figure 4.2A). Since flagellin is a periplasmic protein, FlaB MAb was
used as an internal control (Figure 4.2B). Both ∆ospC/FL and ∆ospC/∆Nt5 spirochetes
fluoresced after incubation with anti-OspC antibodies (Figure 4.2A), indicating that the
truncation does not affect the cellular location of the lipoprotein. FlaB MAb could not bind its
antigen in ∆ospC/FL unfixed spirochetes but resulted in strong fluorescence on all fixed bacteria
(Figure 4.2B), indicating that our indirect immunofluoresence procedure did not expose internal
antigens of unfixed spirochetes.
Deletion of The N-terminal 5-AA Sequence Severely Affects The Ability of B.
burgdorferi to Downregulate ospC During Infection of SCID Mice. Aimed at investigating
whether deletion of N-terminal truncation affects ospC regulation, ospC mRNA accumulation
was analyzed. RNA samples were prepared from the heart, joint, and skin specimens of the 10
infected mice used for the determination of spirochetal loads, and quantified for flaB and ospC
expression by RT-qPCR. The results are shown in Figure 4.3.
There was no significant difference in the ospC mRNA accumulation between ΔospC/Nt5
and ΔospC/FL spirochetes in the heart tissue (P =0.3145). In the joint tissue, ospC mRNA levels
108

were significantly higher in the ΔospC/Nt5 spirochetes when compared to ΔospC/FL spirochetes
(P <.0001). In the skin, there was no significant difference in the levels of ospC mRNA when
ΔospC/Nt5 spirochetes were compared to ΔospC/FL spirochetes (P = 0.1064).
The results indicate that, in the joint, operator of the spirochetes expressing truncated
ospC was unable to repress ospC mRNA expression, when compared to wild type controls.
Taken together, these data indicated that deletion of the N-terminal 5-AA sequence led to
significant changes in ospC mRNA accumulation in the joints by B. burgdorferi during murine
infection.
OspC Monoclonal Antibodies Clear Borrelia Expressing N-terminus 5-AA Deleted
OspC. The ospC promoter is RpoS-dependent (Eggers et al., 2004, Yang et al., 2000, Yang et
al., 2005). Because RpoS is constitutively expressed during mammalian infection, the
downregulation of ospC is realized through the interaction of the ospC operator with its specific,
but as-yet unidentified, repressor (Xu et al., 2007). If the coding region of OspC is involved in
self-regulation, spirochetes containing a deletion of the N-terminus 5-AA sequence of OspC
would be affected adversely by anti-OspC borreliacidal antibodies.
To examine whether specific anti-OspC antibodies in the absence of T and B cells are
able to kill ∆ospC/Nt5 Borrelia for their inability to downregulate ospC, a passive immunization
study was conducted (Table 4.3). C3H SCID mice were infected with ∆ospC/FL and ∆ospC/Nt5
B. burgdorferi for one month, a time point at which Borrelia would still express OspC, and then
passively immunized either mouse IgG2a as a control or OspC monoclonal antibody B5. This
monoclonal antibody was shown to passively protect mice from a tick-transmitted challenge
infection (Mbow et al., 1999). Previous studies have shown that B. burgdorferi persistently
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Fig. 4.2A

Fig. 4.2B

Figure 4.2. The N-terminal 5-AA deletion does not affect the surface exposure of OspC. The clones ΔospC/FL and ΔospC/Nt5
were grown to late-log phase and analyzed by indirect immunofluorescence. Each pair of images (top and bottom) was taken from the
same field under differential interference contrast (DIC-top) and immunofluorescence (IFA-bottom) microscopy. (A) Unfixed
ΔospC/FL and ΔospC/Nt5 spirochetes were probed with OspC MAb. (B) Unfixed and fixed ΔospC/FL spirochetes were probed with
FlaB MAb. Images were obtained at x400 magnification.
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Figure 4.3. Deletion of N-terminus 5-AA residues leads to significant changes in ospC
mRNA accumulation in the joint tissues. RNA samples were prepared from heart, joint, and
skin specimens and quantified for flaB and ospC expression by RT-qPCR. The data are
presented as ospC transcripts per 1,000 flaB mRNA copy numbers. *, P < 0.05 between FL and
Nt5.
expresses ospC during infection of immunodeficient mice (Liang et al., 2002a, Liang et al.,
2002b). However, the pathogen downregulates ospC expression when placed under immune
selection pressure (Liang et al., 2002b).
Whereas both ∆ospC/FL and ∆ospC/Nt5 spirochetes were able to be recovered from all
sites examined upon control IgG2a treatment, ∆ospC/FL spirochetes were able to be recovered
from the skin (remote), joint, ear, and most of the heart tissues upon OspC MAb treatment.
However, ∆ospC/Nt5 spirochetes were cleared from all sites examined, except for the joint
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tissues, upon OspC MAb treatment. These results indicate that ∆ospC/Nt5 spirochetes are cleared
due to the borreliacidal nature of the anti-ospC antibodies.
Anti-Borrelia Specific Immune Responses Clear ∆ospC/Nt5 Spirochetes in
Immunocompetent Mice. B. burgdorferi abundantly expresses OspC during initial mammalian
infection, when the antigen is required. Its continued presence, however, poses a threat to the
pathogen since anti-ospC antibodies are borreliacidal (Fung et al., 1994, Liang et al., 2004b). To
evade the specific immune response B. burgdorferi reduces ospC expression through the
interaction of an as yet unidentified repressor to the ospC operator (Xu et al., 2007).
We used immunocompetent mice to investigate if the deletion of the N-terminus 5-AA of
OspC affects the regulation of ospC expression under broader immune pressure. The results are
shown in Table 4.4. Control ∆ospC/FL spirochetes were grown from the inoculation site (I.S.)
and remote site (R.S.) skin, joint, and heart specimen but from none of the ear samples at first

Table 4.3. Monoclonal antibodies clear spirochetes expressing N terminus 5-AA deleted
OspC in SCID mice. a
No. of cultures positive/no. examined
1 month
Clone
∆ospC/FL

∆ospC/Nt5

Antibody treatment

Skin

Joint

Heart Ear

All sites

mAb

5/5

5/5

3/5

5/5

18/20

IgG2a

5/5

5/5

5/5

5/5

20/20

mAb

0/6

6/6

0/6

0/6

6/24

IgG2a

6/6

6/6

6/6

6/6

24/24

a.

Groups of 5 or 6 C3H SCID mice were inoculated with either ∆ospC/FL or ∆ospC/Nt5 at
105/100 µl. At one month post inoculation, OspC monoclonal antibody or purified normal mouse
IgG2a as a control was given at 100 µg. Three days later, mice were killed and heart, joint, skin
and ear specimens were collected for bacterial culture.
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week; the ∆ospC/Nt5 bacteria were grown only from all of the skin inoculation sites and one of
six joint samples at a week post-inoculation. Whereas all sites became culture positive with
control ∆ospC/FL spirochetes by 2 weeks after initial inoculation, the ∆ospC/Nt5 bacteria were
cleared from all sites, except from one inoculation site skin. At 3 and 4 weeks post infection, the
∆ospC/Nt5 spirochetes were cleared from all sites examined except inoculation site (I.S.) and
joint tissues. These data demonstrate that ∆ospC/Nt5 spirochetes were initially (at 1 week postinoculation) unable to disseminate to remote tissues. Furthermore, upon development of specific
humoral responses at 2 weeks post-inoculation, the ∆ospC/Nt5 spirochetes began to be cleared
from all remote sites except the joint by 3 to 4 weeks, which might serve as an immuneprivileged site. This is an indirect indication that the ∆ospC/Nt5 spirochetes were unable to
downregulate ospC in response to the development of specific anti-OspC borrelicidal antibodies
in an immunocompetent environment.
DISCUSSION
B. burgdorferi upregulates the alternative sigma factor rpoS in response to a fresh blood
meal, which in turn upregulates OspC, a lipoprotein required for initial mammalian infectivity
(Caimano et al., 2007). The pathogen then selectively reduces the expression of this antibodytargeted antigen in response to immune pressure through an unknown trans-acting repressor
(Crother et al., 2003, Liang et al., 2002a, Liang et al., 2002b, Liang et al., 2004b, Xu et al.,
2007). Constitutive expression of OspC leads to clearance of infection, if not survival of
spirochetes expressing OspC escape mutants (Xu et al., 2006). Interestingly, when ospC
regulatory elements were placed upstream of OspA coding region in an ospC mutant
background, OspA was unable to be downregulated under immune pressure (data not shown).
This led us to investigate whether OspC is involved in self-regulation.
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Table 4.4. Spirochetes expressing the N-terminus 5-AA deleted OspC are unable to evade specific immune response in wild
type mice.a

Clone

No. of specimens positive/no. of specimens examined at post-inoculation week
1

2

3

4

I.S. R.S. Ear Heart Joint

I.S. R.S. Ear Heart Joint

I.S. R.S. Ear Heart Joint

I.S. R.S. Ear Heart Joint

∆ospC/FL

6/6 6/6 0/6

6/6

6/6

6/6 6/6 6/6 6/6 6/6

ND ND ND ND ND

ND ND ND ND ND

∆ospC/Nt5

6/6 0/6 ND 0/6

1/6

1/6 0/6 0/6 0/6 0/6

2/6 0/6 0/6 0/6 6/6

6/6 0/6 0/6 0/6 6/6

a.

Groups of 12 to 24 BALB/c Wt mice each received a single intradermal/subcutaneous injection of 105 organisms of the clone
∆ospC/FL and ∆ospC/Nt5. Six animals from each group were euthanized at 1, 2, 3 and 4 wk post-inoculation; inoculation site (I.S.)
and remote site (R.S) skin, ear, heart, and joint specimens were harvested for spirochete isolation. The I.S. site was at the chest;
therefore the R.S. site was at the back of the mice. b. ND, not determined.
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Structurally, OspC is a predominantly alpha-helical lipoprotein; in its dimer
conformation, the C- and N-terminus of OspC come close together and while the C-terminus of
OspC is exposed to the outer environment, the N-terminus anchors the lipoprotein to the outer
membrane of B. burgdorferi by a lipidated cystein (Eicken et al., 2001, Kumaran et al., 2001).
This study addressed the role of the N-terminus of OspC in ospC mRNA regulation when a small
5-AA region of OspC downstream of the lipidated cystein was deleted. Deletion of N-terminal 5AA did not affect the surface exposure of OspC as observed by indirect immunofluorescence
assay. Sorting of major lipoproteins in the E.coli Lol pathway is based on properties of the amino
acid following the N-terminal, acylated cystein, i.e., the so-called ‘+2’ rule (Yamaguchi et al.,
1988). Although Borrelia spirochetes have Lol homologues (Masuda et al., 2002), sorting signal
in these pathogens are different from those found in other diderm bacteria. Hence, the ‘+2’ rule
established for E.coli inner membrane (IM) and outer membrane (OM) lipoproteins does not
apply to borrelial lipoproteins. It also known that for the outer surface lipoprotein OspA, the first
five aminoacids from the N-terminus cystein are required for surface localization (Schulze and
Zuckert, 2006). In this study, the 5-AA deletion was made seven amino acids downstream of the
lipidated cystein, allowing for the translocation of the lipoprotein to the outer surface of the outer
membrane of B. burgdorferi.
The infectivity and innate immunity evasive roles of OspC were preserved in spite of the
N-terminal 5-AA deletion as reflected in the 50% infectious dose values at one month postinfection in SCID mice. Measurements of spirochete burdens showed that the deletion did not
reduce the spirochete burden in joint or skin, but did reduce in the heart, compared to control
spirochetes. A recent study has shown that OspC-deficient spirochetes over expressing
heterologous lipoproteins generated significantly lower bacterial loads when compared to
controls, indicating that OspC is required for the colonization of the heart (Xu et al., 2008b). In
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addition, OspC may serve as an adhesion molecule and was shown to colonize the heart in high
frequency (Antonara et al., 2007). Nevertheless, the deletion did not decrease spirochete burden
in the skin and, on the contrary, recorded an increase in the joint tissue when compared to FL
control spirochetes. The phenotype that resulted from these initial studies (explained in detail in
Chapter 3) allowed us to use this strain to further investigate the effect of such deletion on the
regulation of ospC.
Studies have shown that in the absence of adaptive immune pressure, the tissue
microenvironment influences the spirochetal mRNA expression. In the joint, ospC is usually
expressed at low levels (Liang et al., 2004b). Our data related to upregulation of ospC expression
in the joints in 5-AA deleted spirochetes is consistent with previous studies that also showed an
upregulation of ospC mRNA in spirochetes lacking the ospC operator region comprising the two
inverted repeats (Xu et al., 2007) indicating that both the ospC operator and the coding region of
OspC may be involved in the repression of ospC mRNA by spirochetes in this tissue and
therefore, that OspC may be involved in self-regulation.
Wild type B. burgdorferi downregulates OspC under immune pressure (Liang et al.,
2004b). In this study, the specific monoclonal OspC antibody treatment was probably unable to
downregulate OspC, hence leading to clearance of the bacteria from all the sites tested, except
joint. These results are in agreement with previous data that shows monoclonal antibody
treatment led to clearance of spirochetes expressing OspC lacking the operator region from the
sites tested, including joint tissue, whereas ear was not tested in their study (Xu et al., 2007). In
wild type mice, the data indicate that spirochetes expressing N-terminus 5-AA deleted ospC were
cleared from most sites except the inoculation site and the joint tissues. It could be that the
deletion led to an initial dissemination defect (in the first week, as also shown in Chapter 3) that
could be a confounding factor to the study of self-regulation of OspC. OspC has been shown to
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be a dissemination-facilitating factor of B. burgdorferi (Xu et al., 2008b). In addition, the fact
that the spirochetes could not be cleared from the joint tissues either under monoclonal antibody
treatment or under an anti-Borrelia immunocompetent environment denotes that the joint is an
immune-privileged site and that although ospC levels are high this tissue, it is able to harbor the
spirochetes and avoid host adaptive immune pressure. The persistent finding of spirochetes at the
site of inoculation may signify a high density of spirochetes in this particular location, and thus
the inability of OspC monoclonal antibodies to clear the spirochetes from this area. On the other
hand, it may signify a dissemination defect due to the N-terminus sequence deletion.
Researchers have shown previously that the majority of IgM and IgG OspC antibodies
produced after infection with B. burgdorferi were complement-dependent borreliacidal
antibodies that killed the spirochetes without the necessity of scavenging by phagocytic cells
(Callister et al., 1996, Jobe et al., 2003, Rousselle et al., 1998). The OspC MAb B5 is located at
the C-terminus of OspC and has a conformational-dependent epitope (Gilmore and Mbow, 1999,
Mbow et al., 1999). Therefore, since overall fold of OspC monomer brings the adjacent location
of the N- and C-terminal residues in the membrane proximal region of OspC, this explains how
the N-termini can be recognized by this B5 OspC monoclonal antibody (Eicken et al., 2001).
The current study highlighted the involvement of the coding sequence of OspC in the
regulation of the gene. The fact that a gene expressing the coding region of a heterologous
lipoprotein (OspA) was unable to be regulated by the ospC operator led us to analyze the coding
region of OspC itself for self-regulation. This study showed that there was a clear defect in the
regulation of OspC when a segment of the N-terminus of OspC was deleted. This may be a
partial defect, since some tissues still harbored the variant spirochetes. The mechanistic details of
the self-regulation of OspC are also yet to be deciphered. A long-term study may allow us to
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make stronger conclusions. Further studies with deletion of more amino acids from the Nterminus of OspC or studies of ospC expression levels in double knock-out spirochetes in which
both the ospC operator and the N-terminus 5-AA sequence are deleted can provide additional
insights into the regulation of this lipoprotein that is crucial in the enzootic life cycle of B.
burgdorferi.
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CHAPTER 5
THE C-TERMINAL 9-AA STRETCH OF OSPC IS NOT IMPORTANT
FOR VIRULENCE OF BORRELIA BURGDORFERI BUT FOR
BALANCING OSPC EXPRESSION DURING MURINE INFECTION
INTRODUCTION
The Lyme disease spirochete, Borrelia burgdorferi, is one of the most invasive bacterial
pathogens, causing persistent infection despite the development of vigorous immune responses
(Schwan et al., 1995, Seiler and Weis, 1996, Steere, 2001). Both timely up- and downregulations of the outer surface protein C (OspC) are crucial for its pathogenic strategy. In unfed
ticks, B. burgdorferi does not express OspC (Ohnishi et al., 2001, Schwan et al., 1995); a fresh
blood meal upregulates OspC and prepares the pathogen for infection of a mammal (Grimm et
al., 2004, Pal et al., 2004, Stewart et al., 2006). B. burgdorferi abundantly expresses OspC
during early infection when the antigen is required (Liang et al., 2004, Tilly et al., 2006) and its
expression ultimately induces a robust humoral response that imposes tremendous pressure on
the pathogen (Fung et al., 1994, Liang et al., 2004). If B. burgdorferi fails to repress OspC
expression or undergo escape mutations, infection is cleared (Xu et al., 2007, Xu et al., 2006).
Although mutation is an effective way to evade the immune system, it may cause the functional
loss of affected genes. B. burgdorferi with lost OspC function may eventually persist during
chronic infection (Tilly et al., 2006); however, it would lose the ability to initiate an infection
(Stewart et al., 2006), leading to discontinuation of the enzootic cycle. B. burgdorferi is able to
down-regulate OspC, thus allowing the pathogen to effectively evade specific humoral immunity
and preserve the integrity of the ospC gene for subsequent need during its life cycle (Liang et al.,
2002a, Liang et al., 2004).
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In terms of regulation, ospC is probably has been the most investigated among all
borrelial genes. Its expression is driven by an RpoS-dependent promoter (Eggers et al., 2004,
Gilbert et al., 2007, Yang et al., 2005). The alternative δ factor, RpoS, not only positively
regulates several other important borrelial genes, such as decorin-binding protein A (dbpA) and
ospF (Eggers et al., 2004, Fisher et al., 2005, Hubner et al., 2001), but may also indirectly
repress other lipoprotein genes, including ospA and lp6.6 (Caimano et al., 2005, Caimano et al.,
2007), making it unfeasible for B. burgdorferi to turn off rpoS to achieve ospC down-regulation.
To selectively repress ospC in response to specific immune pressure during mammalian
infection, B. burgdorferi may express a repressor to interact with the newly identified operator, a
large palindromic sequence consisting mainly of two 20 bp inverted repeats located immediately
upstream of the ospC promoter (Xu et al., 2007).
The ospC gene, like other microbial lipoprotein genes, encodes a leader peptide of 18-AA
residues, which is cleaved off during post-translational modification, and protein portion (Figure
5.1A). The mature OspC, a largely α-helical protein, may be a dimer with a characteristic central
four-helical bundle formed by the association of the two longest helices from each subunit
(Eicken et al., 2001, Kumaran et al., 2001). Neither the N-terminal 23-AA linker nor the Cterminal 14-AA stretch contributes to the core three-dimensional structure of OspC; instead, the
α-helices 1 and 5 bring the two terminal regions in close proximity, where the lipoprotein is
anchored to the bacterial outer membrane through lipidation of the first cystein residue of the Nterminal linker (Figure 5.1B). Compared to the N-terminal linker, the C-terminal stretch is
highly conserved among borrelial isolates (Figure 5.1C) and highly immunogenic (Mathiesen et
al., 1998).
One essential role of the N-terminal linker is to position the lipoprotein on the bacterial
outer membrane, with the essential role of the C-terminal stretch remaining elusive in its
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Figure 5.1. The tertiary structure and possible cellular location of OspC. A. Fragmentation
of the secondary structure of OspC (Eicken et al., 2001, Kumaran et al., 2001). The ospC gene
of B. burgdorferi B31 codes for a total of 210 amino acids. The first 18-AA sequence is a leader
peptide (LP) that is cleaved off before a mature OspC molecule is translocated to the spirochete
outer surface, followed by the N-terminal linker (NTL) that includes the residues 19 – 41. The
residues 42 – 73, 94 – 112, 121 – 145, 152-159, and 170 – 196 form the α-helices 1, 2, 3, 4, and
5, respectively; 78 – 82 and 85 – 89 make up the β-strands 1 and 2, respectively. The residues
197 – 210 form the C-terminal stretch (CTS). B. The tertiary structure and possible cellular
location of OspC. B. burgdorferi possesses inner and outer membranes that are separated by a
periplasmic space. As a surface lipoprotein, OspC is anchored to the outer membrane through
lipidation of the cystein residue 19. Neither the N-terminal 23-AA linker nor the C-terminal 14AA stretch contributes to the OspC core structure, which consists mainly of five α-helices. The
helices 1 and 5 bring the two terminal sequences in close proximity, where the NTL anchors the
protein to the bacterial outer membrane, thus positioning the CTS to the membrane. C. Sequence
comparison of the C-terminal 14-AA stretch among borrelial isolates. The sequences (top)
are from the three most investigated B. burgdorferi sensu stricto strains, followed by 15
sequences randomly selected from B. burgdorferi sensu stricto, Borrelia garinii, and Borrelia
afzelii isolates. The highlighted letters indicate amino acid substitutions.

contribution to the overall function of OspC. In this study, B. burgdorferi expressing OspC with
different C-terminal truncations was generated and investigated for infectivity, tissue
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colonization, pathogenicity, and gene expression in a murine model. The study allowed us to
conclude that the C-terminal stretch of OspC is not required for virulence of B. burgdorferi, but
may be involved in a yet unidentified event that either directly or indirectly regulates ospC
expression in the murine host. Interestingly, the N-terminal linker was also shown to be involved
in the regulation of ospC expression (Chapter 4).
MATERIALS AND METHODS
Generation of B. burgdorferi Expressing OspC with Different C-terminal Deletions.
As illustrated in Figure 5.2A, to efficiently generate constructs containing various versions of Cterminal deletions, a 1057-bp fragment covering the ospC-coding region and up- and downstream sequences was amplified by PCR using the primers P1F and P1R (Table 5.1) and cloned
into the TA cloning vector pNCO1T (Shi et al., 2006), creating an intermediate vector,
designated pNCO1T-ospC. Three large amplicons, namely, ct6, ct9 and ct13, were generated by
PCR using pNCO1T-ospC as a template and one common forward primer, P2F, and each of the
three reverse primers, P2R, P3R, and P4R (Table 5.1). After digestion with AflII and subsequent
purification, the amplicons were circularized via ligation and then digested with BamHI and XbaI
to release ospCct6, ospCct9, and ospCct13. These three fragments, encoding an OspC variant
with the C-terminal 6-, 9- or 13-AA deletion, were cloned into the recombinant plasmid pBBE22
(a gift from S. Norris) after the vector was digested with BamHI and XbaI. Resulting
complementation plasmids were designated pBBE22-ospCct6, pBBE22-ospCct9 and pBBE22ospCct13, respectively. The inserts and their flanking regions within pBBE22 were sequenced to
ensure the constructs were as designed.
Complementation plasmids were electroporated into an ospC mutant, namely, ospCΔ,
which was generated in our previous study (Xu et al., 2007); resulting transformants were
screened as described previously (Xu et al., 2005). Identified transformants were first surveyed
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for the presence of lp28-1, a plasmid essential for infection of immunocompetent hosts
(Labandeira-Rey et al., 2003, Purser and Norris, 2000). Only clones containing lp28-1 were
further analyzed for plasmid content as described previously (Xu et al., 2005). Restoration of
OspC expression was verified using immunoblots probed with a mixture of FlaB and OspC
monoclonal antibodies (MAbs), or of the FlaB MAb and mouse anti-OspC sera (Figure 5.2B), as
described previously (Xu et al., 2006). The clone ospCΔ/FL/1, which was generated in our
previous study (Xu et al., 2007) and expressed wild-type OspC, was included as a control.
Table 5.1. Primers used in the study
Primer
P1F
P1R
P2F
P2R
P3R
P4R

Sequences (5’ to 3’) a
TTGGGATCCAAAATCTAATACAAGT
TTCCTCTAGAGAAGAGCTTAAAGTTAA
GCGCTTAAGATCAAATTAATATTATAAGA
ATCTTAAGCCACAACAGGGC
AGCTTAAGGGCTTGTAAGCTCTTTAAC
ACATCTTAAGTTACTCTTTAACTGAATTAGCA

a

The underlined sequences are the restriction enzyme site BamHI (P1F), XbaI (P1R), or AflII
(P2F, P2R, P3R, and P4R).
Infection Study in SCID Mice. SCID mice on a C3H background, ages 4 – 8 weeks,
(provided by the Division of Laboratory Animal Medicine at Louisiana State University, Baton
Rouge, LA) were given one single intradermal/subcutaneous injection of 104 spirochetes.
Animals were examined for the development of arthritis at 2-day intervals, starting at day 7, and
sacrificed one month post-inoculation. Joint, heart, and skin specimens were collected for
spirochete isolation and histopathological examination as described previously (Xu et al., 2005).
The harvested samples were also used for DNA and RNA preparation as described below.
Determination of ID50 Values. Spirochetes were grown to late-log phase (108 cells/ml)
at 33oC and 10-fold serially diluted with Barbour-Stoenner-Kelly H (BSK-H) complete medium
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Fig.5.2A

Fig.5.2B

Figure 5.2. Generation of B. burgdorferi expressing OspC with C-terminal deletions.
A. Construction of complementation plasmids coding for OspC with C-terminal
truncations. The last 15 codons, including the stop one (marked with an asterisk), and their
encoded 14-AA sequence of OspC are presented (on top). The amplification starting sites and
directions of four primers, P2F, P2R, P3R, and P4R, used for plasmid construction are also
marked. The long bar represents the 1057-bp fragment, covering the entire ospC-coding region
and down- (extending to +801 from the transcriptional start site) and up-stream sequences
(extending to -256). B. Restoration of OspC expression. The parental clone 13A, ospCΔ, and
the ospCΔ/FL, ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2,
ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2 spirochetes were verified for OspC expression by
immunoblots probed with a mixture of FlaB and OspC MAbs (top panel), or of the FlaB MAb
and mouse antisera raised against recombinant OspC (bottom panel).

(Sigma Chemical Co., St. Louis, MO). C3H SCID mice or BALB/c mice, ages 4 to 6 weeks,
(provided by the Division of Laboratory Animal Medicine at Louisiana State University, Baton
Rouge, LA) each received one single intradermal/subcutaneous injection of 100 l of spirochetal
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suspension. SCID mice, but not wild-type, were examined for the development of arthritis as
described above. Mice were euthanized one month post-inoculation; heart, tibiotarsal joint, and
skin (not from inoculation site) specimens were harvested for bacterial culture as described
above (Xu et al., 2005). The ID50 value was calculated as described by Reed and Muench (Reed
and Muench, 1938). SCID mouse specimens were also used for DNA and RNA preparation as
described below.
Quantification of Tissue Spirochetal Load and ospC Gene Expression Level. DNA
was extracted for heart, joint, and skin specimens of infected SCID mice and quantified for the
copy numbers of flaB and murine actin genes by quantitative PCR (qPCR) as described
previously (Xu et al., 2005). The tissue spirochete burden was expressed as flaB DNA copies
per 106 host cells (2  106 actin DNA copies). RNA was prepared from heart, joint, and skin
tissues, then quantified for the mRNA copy numbers of flaB and ospC by reverse transcription
qPCR (RT-qPCR) as described previously (Xu et al., 2006). The data are presented as ospC
transcripts per 1,000 flaB mRNA copy numbers.
Statistical Analysis. A two-tailed Student t test was used to compare each two groups
and calculate P values. A P value ≤ 0.05 was considered to be significant.
RESULTS
Generation of B. burgdorferi Expressing OspC with Different C-terminal
Truncations. Three trans-complementation plasmids, pBBE22-ospCct6, pBBE22-ospCct9 and
pBBE22-ospCct13, were constructed as diagrammed in Figure 5.2A. These constructs encoded
OspC with C-terminal 6-, 9- or 13-AA deletion, respectively. Because the ospC mutant, ospCΔ,
had lost lp25, the plasmid that carries the gene bbe22 coding for a nicotinamidase essential for
survival of B. burgdorferi in the mammalian environment, all the complementation plasmids
were derived from the recombinant plasmid pBBE22, which harbors a copy of bbe22 (Purser et
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al., 2003). Between six and fourteen transformants were obtained from transformation of the
mutant ospCΔ with each construct. Plasmid analyses identified two clones receiving each
complementation plasmid, namely, ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1,
ospCΔ/ospCct9/2, ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2. These clones shared the same
plasmid content as the mutant ospCΔ (Xu et al., 2007): they all lost cp9, lp5, lp21, lp25 and lp56.
Restoration of OspC expression was confirmed by immunoblot analysis (Figure 5.2B), in
which the clone ospCΔ/FL/1 was included as a control. This clone was generated from
transformation of the mutant ospCΔ with a complementation plasmid, pBBE22-FL, which was
constructed by cloning a 1057-bp fragment covering the ospC-coding region and up- and downstream sequences into pBBE22, as described in our previous study (Xu et al., 2007). Similar to
the parental clone 13A, the ospCΔ/FL/1 spirochetes expressed full-length OspC (Figure 5.2B).
In contrast, the ospCΔ/ospCct6/1, ospCΔ/ospCct6/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2,
ospCΔ/ospCct13/1, and ospCΔ/ospCct13/2 bacteria expressed shorter versions of OspC
respective to their C-terminal deletions. The truncated OspC expressed by the clones
ospCΔ/ospCct13/1 and ospCΔ/ospCct13/2 was no longer recognized by OspC MAb (Figure
5.2B, top panel) but reacted well with antisera raised against recombinant OspC (Figure 5.2B,
bottom panel).
Deletion of the C-terminal 6- but Not 9-AA Sequence Abrogates Arthritis Virulence
in SCID Mice. Groups of three C3H SCID mice were inoculated with the clone
ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1,
or ospCΔ/ospCct6/2. Additionally, six animals received the clone ospCΔ/FL/1 as a control,
which had been extensively examined for infectivity and ospC expression in our previous study
(Xu et al., 2007). In these six mice, joint swelling evolved 10 to12 days post-inoculation and
developed into severe arthritis within a week (Figure 5.3A). In the six mice that received either
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clone ospCΔ/ospCct9/1 or ospCΔ/ospCct9/2, joint swelling developed following the same course
as described above, indicating that deletion of the C-terminal 9-AA stretch does not reduce
infectivity and arthritis virulence in immunodeficient mice. However, none of the 12 animals
inoculated with the ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct6/1, or
ospCΔ/ospCct6/2 bacteria showed joint swelling during the course of 1 month, indicating that
truncation of either the C-terminal 6- or 13-AA sequence completely diminished arthritis
virulence, and probably infectivity as well. Histopathological examination confirmed that
intensive inflammatory responses appeared in and around the joint space of mice receiving the
ospCΔ/FL/1, ospCΔ/ospCct9/1 or ospCΔ/ospCct9/2 spirochetes but not in those inoculated with
the clone ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct6/1, or ospCΔ/ospCct6/2 (Figure
5.3B).
To rule out the possibility that the loss of infectivity disabled the four clones from
inducing arthritis, the heart, joint, and skin samples were cultured for spirochetes. Similar to the
clones ospCΔ/FL/1, ospCΔ/ospCct9/1, and ospCΔ/ospCct9/2, ospCΔ/ospCct6/1 and
ospCΔ/ospCct6/2 bacteria were recovered from each specimen of all 12 inoculated mice (Table
5.2), indicating that deletion of the C-terminal 6-AA stretch does not abrogate infectivity.
Neither ospCΔ/ospCct13/1 nor ospCΔ/ospCct13/2 spirochetes could be grown from any of the
six inoculated mice, indicating that deletion of the C-terminal 13-AA sequence abrogates the
infectivity of B. burgdorferi. The loss of infectivity in this clone occurs as early as 24h postinoculation as shown in Chapter 2.
Deletion of the C-terminal 6- or 9-AA Sequence Does Not Lead to an Increase in
The ID50 Values in SCID or Immunocompetent Mice. Groups of two or three C3H SCID
mice each received one single inoculation of 101 to 104 spirochetes of the clone ospCΔ/FL/1,
ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1, or ospCΔ/ospCct6/2. Animals were
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Figure 5.3. Deletion of the C-terminal 6- but not 9-AA sequence diminishes arthritis
virulence in SCID mice. A. SCID mice were inoculated with the ospCΔ/FL/1,
ospCΔ/ospCct13/1, ospCΔ/ospCct9/1 or ospCΔ/ospCct6/1 spirochetes, and sacrificed one
month later. Severe joint swelling was noted only in mice challenged with ospCΔ/FL or
ospCΔ/ospCct9/1, but not with ospCΔ/ospCct13/1or ospCΔ/ospCct6/1. B. Intensive
inflammatory responses (pointed with black arrows) were noted in and around the joint
space of mice inoculated with ospCΔ/FL or ospCΔ/ospCct9/1, but not with
ospCΔ/ospCct13/1or ospCΔ/ospCct6/1. Tissue sections were stained with hematoxylin and
eosin. js: joint space; sm: synovial membrane; tb: tibial bone; tr: tarsal bone.
euthanized one month later; heart, joint and skin specimens were cultured for spirochetes for
ID50 determination. The ID50 values were 18 and 32 organisms for the clone ospCΔ/FL/1 (in two
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Table 5.2. Deletion of the C-terminal 13- but not 6- or 9-AA sequence abrogates infectivity
in SCID micea
No. of cultures positive/total
No. of mice infected/total no.
no of specimens examined
of mice inoculated
Inoculum
Heart Joint Skin All sites
ospCΔ/FL/1

6/6

6/6

6/6

18/18

6/6

ospCΔ/ospCct13/1
ospCΔ/ospCct13/2

0/3
0/3

0/3
0/3

0/3
0/3

0/9
0/9

0/3
0/3

ospCΔ/ospCct9/1
ospCΔ/ospCct9/2

3/3
3/3

3/3
3/3

3/3
3/3

9/9
9/9

3/3
3/3

ospCΔ/ospCct6/1
ospCΔ/ospCct6/2

3/3
3/3

3/3
3/3

3/3
3/3

9/9
9/9

3/3
3/3

a

Groups of three or six C3H SCID mice were inoculated with the clone ospCΔ/FL/1,
ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1,
or ospCΔ/ospCct6/2, and sacrificed one month later. Heart, tibiotarsal joint, and skin specimens
were harvested and cultured for spirochetes in BSK-H complete medium.

separate experiments), 56 and 178 for the clones ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2, and 32
and 32 for the clones ospCΔ/ospCct9/1 and ospCΔ/ospCct9/2, respectively (Table 5.3).
The ID50 values were also determined in immunocompetent mice. The values were 32
and 32 organisms for the clone ospCΔ/FL/1 (in two separate experiments), 32 and 56 for the
clones ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2, and 316 and 56 for the clones ospCΔ/ospCct9/1
and ospCΔ/ospCct9/2, respectively (Table 5.4). Taken together, the study indicated that either
C-terminal deletion leads to a decrease in infectivity in both immunodeficient and
immunocompetent mice.
Deletion of The C-terminal 9-AA Sequence Does Not Affect Tissue Colonization in
Heart or Joint Tissue but Increases Colonization in The Skin of SCID Mice. The spirochetal
burden was analyzed to further assess whether truncations affected tissue colonization. Heart,
joint and skin specimens were harvested from SCID mice that were infected with ospCΔ/FL/1,
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Table 5.3. Deletion of neither C-terminal 6- nor 9-AA sequence significantly affects the ID50
value in SCID micea
No. of cultures positive/total
No. of mice infected/total
ID50
Inoculum &
no. of specimens examined
no. of mice inoculated
(No. of
dose
Heart Joint Skin All sites
organisms)
ospCΔ/FL/1
18
4
10
2/2
2/2
2/2
6/6
2/2
103
2/2
2/2
2/2
6/6
2/2
2
10
3/3
3/3
3/3
9/9
3/3
101
1/3
1/3
1/3
3/9
1/3
ospCΔ/FL/2
32
104
2/2
2/2
2/2
6/6
2/2
103
2/2
2/2
2/2
6/6
2/2
102
3/3
3/3
3/3
9/9
3/3
1
10
0/3
0/3
0/3
0/9
0/3
ospCΔ/ospCct6/1
104
103
102
101
ospCΔ/ospCct6/2
104
103
102
101
ospCΔ/ospCct9/1
104
103
102
101
ospCΔ/ospCct9/2
104
103
102
101

56
2/2
2/2
2/3
0/3

2/2
2/2
1/3
0/3

2/2
2/2
2/3
0/3

6/6
6/6
5/9
0/9

2/2
2/2
2/3
0/3

2/2
2/2
1/3
0/3

2/2
2/2
0/3
0/3

2/2
2/2
1/3
0/3

6/6
6/6
2/9
0/9

2/2
2/2
1/3
0/3

178

32
2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

6/6
6/6
9/9
0/9

2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

6/6
6/6
9/9
0/9

2/2
2/2
3/3
0/3

32

a

The ospCΔ/FL/1, ospCΔ/ospCct6/1, ospCΔ/ospCct6/2, ospCΔ/ospCct9/1 and ospCΔ/ospCct9/2
spirochetes were grown to late-log phase (108 cells/ml) and 10-fold serially diluted with BSK-H
medium. Approximately 100 µl of bacterial suspension with cell densities at 102 – 105 ml-1 was
intradermally/subcutaneously inoculated into each C3H SCID mouse. Animals were sacrificed
one month later; heart, tibiotarsal joint, and skin specimens were harvested for bacterial isolation.
The ID50 values were calculated by the method of Reed and Muench.
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Table 5.4. Deletion of neither C-terminal 6- nor 9-AA sequence significantly affects the ID50
value in immunocompetent micea
No. of cultures positive/total
No. of mice infected/total
ID50
Inoculum &
no. of specimens examined
no. of mice inoculated
(No. of
dose
Heart Joint Skin All sites
organisms)
ospCΔ/FL/1
32
4
10
2/2
2/2
2/2
6/6
2/2
103
2/2
2/2
2/2
6/6
2/2
2
10
3/3
3/3
3/3
9/9
3/3
101
0/3
0/3
0/3
0/9
0/3
ospCΔ/FL/2
32
104
2/2
2/2
2/2
6/6
2/2
103
2/2
2/2
2/2
6/6
2/2
102
3/3
3/3
3/3
9/9
3/3
101
0/3
0/3
0/3
0/9
0/3
ospCΔ/ospCct6/1
104
103
102
101
ospCΔ/ospCct6/2
104
103
102
101
ospCΔ/ospCct9/1
104
103
102
101
ospCΔ/ospCct9/2
104
103
102
101

32
2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

2/2
2/2
3/3
0/3

6/6
6/6
9/9
0/9

2/2
2/2
3/3
0/3

2/2
2/2
2/3
0/3

2/2
2/2
2/3
0/3

2/2
2/2
2/3
0/3

6/6
6/6
6/9
0/9

2/2
2/2
2/3
0/3

56

316
2/2
2/2
0/3
0/3

2/2
2/2
0/3
0/3

2/2
2/2
0/3
0/3

6/6
6/6
0/9
0/9

2/2
2/2
0/3
0/3

2/2
2/2
1/3
0/3

2/2
2/2
2/3
0/3

2/2
2/2
2/3
0/3

6/6
6/6
5/9
0/9

2/2
2/2
2/3
0/3

56

a

The ospCΔ/FL/1, ospCΔ/ospCct6/1, ospCΔ/ospCct6/2, ospCΔ/ospCct9/1 and ospCΔ/ospCct9/2
spirochetes were grown to late-log phase (108 cells/ml) and 10-fold serially diluted with BSK-H
medium. Approximately 100 µl of bacterial suspension with cell densities at 102 - 105 ml-1 was
intradermally/subcutaneously inoculated into each BALB/c mouse. Animals were sacrificed one
month later; heart, tibiotarsal joint, and skin specimens were harvested for bacterial isolation.
The ID50 values were calculated by the method of Reed and Muench.
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ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1, or ospCΔ/ospCct6/2. A total of 30 mice,
which had been used for Table 5.2 or 5.3, were used, including 10 mice infected with the
ospCΔ/FL/1, 10 mice with either clone ospCΔ/ospCct6/1 (n = 5) or ospCΔ/ospCct6/2 (n = 5),
and 10 mice with clone ospCΔ/ospCct9/1 (n =5) or ospCΔ/ospCct9/2 (n = 5). DNA samples
were extracted and quantified for tissue spirochete loads. The ospCΔ/FL/1 and ospCΔ/ospCct9
spirochetes generated similar bacterial loads in the heart (P = 0.26) and joint tissues (P = 0.57)
(Figure 5.4A). In contrast, the ospCΔ/ospCct6 load was 3.6-, and 1.8-fold lower than that of the
ospCΔ/FL/1 spirochetes in the heart (P = 1.8 × 10-7) and joint tissues (P = 4.8 × 10-4),
respectively, but both bacteria generated similar burdens in skin (P = 0.14). The ospCΔ/ospCct6
load was also 3.0-, and 2.1-fold lower than that of the ospCΔ/ospCct9 bacteria in the heart (P =
6.0 × 10-4) and joint tissues (P < 0.03), respectively, but they registered similar burdens in skin
(P = 0.17). Interestingly, deletion of the C-terminal 9-AA sequence led to a two-fold increase in
the bacterial load in the skin over the control (P < 0.05). Taken together, deletion of the Cterminal 9-AA stretch did not affect tissue colonization in either heart or joint but led to a
significant increase in the bacterial load in the skin of SCID mice.
Deletion of the C-terminal 9-AA Sequence Leads to Significant Changes in ospC
mRNA Accumulation in All Tissues of SCID Mice. Aimed at explaining how truncations
affected tissue colonization, ospC mRNA accumulation was analyzed. Heart, joint, and skin
specimens were randomly selected from 15 mice that were infected with the ospCΔ/FL/1 (n = 5),
ospCΔ/ospCct6/1 (n = 4), ospCΔ/ospCct6/2 (n = 1), ospCΔ/ospCct9/1 (n = 1), or
ospCΔ/ospCct9/2 (n = 4) spirochetes. These 15 mice had been used either for Table 5.3 or 5.4.
RNA samples were prepared and quantified for flaB and ospC expression by RT-qPCR. No
significant differences in ospC mRNA accumulation were noted between the ospCΔ/FL and
ospCΔ/ospCct6 bacteria in either heart (P = 0.25) or skin tissue (P = 0.81), but deletion of the 6136

AA sequence led to a seven-fold decrease in ospC mRNA density in the joint (P = 0.0002)
(Figure 5.4B). The ospCΔ/ospCct9 spirochetes accumulated ospC transcripts 61% and 84%
more than the clone ospCΔ/FL/1 in the heart (P = 0.001) and skin tissues (P = 0.002),
respectively, but 3.4-fold less in the joint (P = 0.0007). B. burgdorferi expressing OspC with the
9-AA deletion accumulated ospC mRNA 37%, 109%, and 92% more than the ospCΔ/ospCct6
spirochetes in the heart (P = 0.03), joint (P = 0.04), and skin tissues (P = 0.0003), respectively.
Taken together, these data indicated that deletion of the C-terminal residues led to significant
changes in ospC mRNA accumulation by B. burgdorferi during murine infection.
DISCUSSION
OspC is a well-defined virulence factor of B. burgdorferi in mammalian hosts (Grimm et
al., 2004, Stewart et al., 2006, Tilly et al., 2006). In immunocompetent mice, OspC is
abundantly expressed only during early infection when it is required (Liang et al., 2004, Tilly et
al., 2006), and its expression ultimately induces a robust, protective humoral response (Fung et
al., 1994, Liang et al., 2004). To evade the specific immune response, B. burgdorferi must
repress OspC expression (Liang et al., 2002a, Liang et al., 2002b, Liang et al., 2004, Xu et al.,
2006). To investigate how the C-terminal sequence contributes to the overall function of OspC,
B. burgdorferi expressing OspC with different deletions were generated. The study showed that
deletion of the C-terminal 13- but not the 6- or 9-AA sequence completely abolishes infectivity
as tested at one month post-inoculation. This loss in protection occurs as early as 24h postinoculation (as shown in Chapter 2). Although truncation of the 6-AA region did not
significantly increase the ID50 values in SCID or immunocompetent mice, B. burgdorferi
expressing OspC lacking the six residues generated lower bacterial loads in both heart and joint
tissues and was unable to induce arthritis in SCID mice. However, removal of the C-terminal 9AA sequence did not increase the ID50 value in SCID or immunocompetent mice, or reduce the
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Fig. 5.4A

Fig. 5.4B

Figure 5.4. Influence of deletion of the C-terminal 6- and 9-AA sequences on the tissue
bacterial burden and ospC expression. A. Deletion of the C-terminal 6- but not 9-AA
sequence reduces bacterial burdens in both heart and joint tissues but not skin. Heart, joint
and skin specimens were harvested from 10 mice infected with the clone ospCΔ/FL/1, 10 mice
with either clone ospCΔ/ospCct6/1 (n = 5) or ospCΔ/ospCct6/2 (n = 5), and 10 mice with clone
ospCΔ/ospCct9/1 (n = 5) or ospCΔ/ospCct9/2 (n = 5); the three groups are labeled as FL, ct6 and
ct9, respectively. These 30 mice had been used in Tables 5.2 and 5.3. B. Deletion of the
C-terminal residues leads to significant changes in ospC mRNA accumulation. RNA
samples were prepared from heart, joint, and skin specimens and quantified for flaB and ospC
expression by RT-qPCR. The data are presented as ospC transcripts per 1,000 flaB mRNA copy
numbers. Because of a smaller variation in ospC expression compared with the tissue bacterial
load, the size of five samples was large enough to generate sufficient statistical power to show a
significant difference. *, P < 0.05 (Ct6 or Ct9 compared with FL controls) *, P < 0.05 (Ct6
compared with Ct9).
tissue bacterial load either in heart or joint tissue, but did significantly increase the burden in skin
while retaining arthritis virulence in immunodeficient mice. Deletion of the 6-AA region led to a
decrease in ospC mRNA accumulation only in the joint. Likewise, the removal of additional
three residues significantly reduced mRNA accumulation in the joints, as it increased in both
heart and skin tissues of SCID mice.
As a lipoprotein, OspC repeatedly has been shown to be essential for initial mammalian
infection (Grimm et al., 2004, Stewart et al., 2006, Tilly et al., 2006). It likely contributes to the
virulence of B. burgdorferi by interacting with host components and protecting the pathogen
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against hostile mammalian environments. Portions of some of its five helices are exposed to the
environment (Buckles et al., 2006, Eicken et al., 2001, Kumaran et al., 2001), so they potentially
may play such a protective role. In contrast, neither the N-terminal 23-AA linker nor the Cterminal 14-AA stretch composes the core structure of OspC; instead, these terminal sequences
are brought together by the α-helices 1 and 5, therefore allowing the terminal regions to directly
interact with the components of the spirochetal outer membrane. Although the last 14-AA
sequence of the C-terminus does not contribute to the core structure, some of the residues,
especially those that are close to the fifth helix, may play a critical role in stabilizing the core
structure. The removal of the last 13 residues indeed abolished the reactivity with the MAb. It is
unknown whether deletion of these residues causes a collapse of the core structure and, as a
result, abolishes infectivity. Alternatively, the residues, especially those that are close to the
helix, may mediate crucial interactions of OspC with the bacterial outer membrane, essential for
the function of OspC during mammalian infection.
Deletion of the C-terminal 6-AA region did not significantly reduce infectivity, in terms
of ID50, in either immunodeficient or immunocompetent mice, but impaired the ability of B.
burgdorferi to colonize both heart and joint tissues and diminished arthritis virulence in SCID
mice. In the heart tissue, the C-terminal truncation did not affect ospC expression, but
significantly reduced the bacterial load, providing evidence that the integrity of OspC is crucial
for its full function and that the lipoprotein is important for maintaining a high bacterial load in
this specific tissue. In joints, removal of the six residues significantly reduced ospC mRNA
accumulation and the bacterial load, while diminishing arthritis virulence. The reduced ospC
expression level could be the primary reason for this chain of defects, as the OspC density on the
spirochetal surface may be crucial for maintaining the bacterial load, which, in turn, may be
important for the induction of arthritis. Alternatively, the OspC expression level may be less
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important than the integrity of OspC for these capacities. In skin, the lack of the 6-AA sequence
affected neither ospC mRNA accumulation nor tissue colonization, indicating that the integrity
of OspC is not important for its full function; or alternatively, the lipoprotein has no significant
contribution to borrelial virulence in this tissue. In addition, these data indicate that the effect
resulting from the deletion of the C-terminal 6-AA sequence is tissue-dependent, in both ospC
mRNA accumulation and bacterial load.
No significant defects were noted, in terms of ID50, tissue colonization and arthritis
virulence, due to deletion of the C-terminal 9-AA sequence; instead, the truncation elevated the
tissue bacterial load in skin. An analysis of ospC expression revealed that the deletion
significantly increased ospC mRNA accumulation in both heart and skin tissues. As discussed
above, the integrity of OspC may be critical for OspC function in the heart tissue. The increased
OspC expression resulting from the removal of the 9-AA sequence apparently compensated for
the structural defects caused by the truncation, therefore allowing the mutant to maintain a
bacterial burden at the control level. In the joint, the lack of the 9-AA sequence led to a decrease
in ospC expression but maintained the bacterial load and retained arthritis virulence, indicating
that neither OspC expression level nor structural integrity is crucial for the virulence of B.
burgdorferi in this tissue. However, a threshold level of OspC expression may be required for
these two capacities, as the removal of the 6-AA sequence led to a reduced ospC mRNA
accumulation, a lower bacterial load, and diminished arthritis virulence. In skin, the integrity of
OspC may not be important for tissue colonization as evidenced by the dramatically elevated
tissue bacterial load resulting from the 9-AA deletion. It also provides evidence that OspC is an
important virulence factor in colonization of the skin tissue, although its integrity is not critical in
this specific tissue. Again, the study highlights tissue-dependent effects resulting from deletion
of the C-terminal sequence.
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Rosa and colleagues repeatedly showed that OspC is not required for the enzootic cycle
of B. burgdorferi in the tick vector (Grimm et al., 2004, Stewart et al., 2006); in contrast, neither
Pal et al. nor Fingerle et al. could make OspC mutants cross the salivary gland barrier to a
murine host (Fingerle et al., 2007, Pal et al., 2004). The first group used fully competent ospC
mutants in their studies, while the ospC mutants generated by the latter two groups could not be
restored to infectivity. Remaining reasons for the disparity could be techniques used by different
groups. A fresh blood meal leads to the upregulation of OspC and other antigens, a process that
prepares B. burgdorferi for mammalian infection. The requirement for OspC is temporal; once
B. burgdorferi has adapted to the mammalian environment, the lipoprotein becomes unessential
(Tilly et al., 2006). If OspC plays a role in the tick, it remains to be addressed whether the Cterminal stretch is negligible for B. burgdorferi during the life cycle in the vector.
The presence of the C-terminal stretch influences ospC mRNA accumulation, which is
determined by both transcriptional initiation and RNA turnover. Deletion of the 6-codons
affected ospC mRNA accumulation only in the joint, while removal of three more influenced all
tissues. The 6-codon deletion unlikely affected mRNA turnover; nevertheless, removal of an
additional three codons increased ospC mRNA accumulation in both heart and skin tissues,
arguing against faster mRNA turnover. For these reasons, the reduced mRNA accumulation
originated most likely from lowered transcriptional initiation. The ospC expression is driven by
an RpoS-dependent promoter (Eggers et al., 2004, Yang et al., 2005) and repressed through the
interaction of the newly identified operator with a unknown repressor (Xu et al., 2007).
Reducing RpoS expression and/or inducing the repressor would lead to the down-regulation of
OspC, unless other unidentified regulatory layers exist. It is well known that B. burgdorferi
adapts to diverse environments, in part, by selective gene expression. How environmental cues,
such as temperature (Brooks et al., 2003, Ojaimi et al., 2003, Ramamoorthy and Scholl-Meeker,
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2001, Stevenson et al., 1995), pH (Carroll et al., 1999, Yang et al., 2000), nutrients or chemicals
(Yang et al., 2001), and mammalian environments and specific immune responses (Caimano et
al., 2007, Liang et al., 2002a, Liang et al., 2004), are decoded to specific signals, which
ultimately influence gene expression in B. burgdorferi, remains unknown. The C-terminal 9-AA
stretch does not contribute to the core structure of OspC (Eicken et al., 2001, Kumaran et al.,
2001) and is not required for virulence of B. burgdorferi; given its special membranous location,
future research should address how the C-terminal deletion affects ospC expression during
murine infection. It is interesting to find that while deletion of N-terminus 5-AA of OspC led to
an upregulation of ospC (Chapter 4), deletion of C-terminus of up to 9-AA of OspC led to a
down-regulation of ospC, further suggesting a role for the termini of OspC in self-regulation of
this enigmatic lipoprotein of B. burgdorferi.
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CHAPTER 6
GENERAL CONCLUSIONS
Lyme disease is included in the current list of emerging and re-emerging infectious
diseases posted online by the National Institute of Allergy and Infectious disease (NIAID)
(http://www3.niaid.nih.gov/topics/emerging). The disease is caused by at least three species of
bacteria belonging to the genus Borrelia (Johnson et al., 1984). Borrelia burgdorferi sensu lato
is the major cause of Lyme disease in the United States (Baranton et al., 1992). Borrelia is
transmitted to humans by the bite of an infected tick of the genus Ixodes (the so-called hard
ticks) (Cooley and Kohls, 1945). The pathogen accomplishes some remarkable feats during its
enzootic life cycle. Not only does it adjust physiologically to two markedly different host
environments, the arthropod vector and the mammalian reservoir, but on a molecular level the
pathogen changes its surface lipoprotein expression in order to maintain its enzootic life cycle.
The outer surface protein C (OspC) is a major lipoprotein of B.burgdorferi that is induced
within the tick during blood-feeding and is maintained in mammals only during the early stages
of infection (Grimm et al., 2004). Using improved genetic and molecular methodologies,
investigators have begun to slowly decipher the various functions of OspC. Some of these
functions are specific while others are non-specific to OspC. Table 6.1 summarizes these
functions of OspC within the tick and the mammalian host (with their respective references),
some of which are already well characterized, while others remain controversial.
Within the tick vector, OspC was shown not to be required for either tick colonization or
transmission from the tick vector to a mammal at least in B. burgdorferi (Grimm et al., 2004,
Tilly et al., 2006) . However, OspC was shown to be crucial for the dissemination of the
European species B. afzelii, transmitted by the European vector Ixodes ricinus (Fingerle et al.,

147

2007). OspC also serves as a ligand for tick salivary gland protein Salp15, and thus facilitates the
survival of the spirochete after inoculation into the mammal (Ramamoorthi et al., 2005).
Table 6.1: Functions of OspC within the tick vector and the mammalian host.

Tick vector

References:

Crucial for dissemination of B.afzelii in I. ricinus
Not required for migration to salivary glands or
transmission to the mammal of B. burgdorferi in I. scapularis

Interacts with Salp15 tick salivary gland protein

(Fingerle et al., 2007)

(Grimm et al., 2004)
(Tilly et al., 2006)
(Ramamoorthi et al., 2005)

Mammalian host
Protection against host innate defenses (non-specific)

(Tilly et al., 2006)
(Xu et al., 2008)

Dissemination-facilitating factor of B. burgdorferi (specific)

(Xu et al., 2008)
This research project

Not required for dissemination of host-adapted B.burgdorferi

(Tilly et al., 2009)

Adhesion for heart colonization

(Antonara et al., 2007)

Plasminogen-binding protein

(Lagal et al., 2006)

Self-regulation

This research project

______________________________________________________________________________
Within the mammalian host, OspC is absolutely required in the early stages of infections
initiated by tick bite or needle inoculation. OspC deletion mutants were shown to be cleared
within 48h. Eight days are required for the wild type spirochetes to disseminate. OspC then
becomes dispensable as infection proceeds (Tilly et al., 2007), because a product produced
during persistent infection can perform the early essential function normally performed by OspC
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(Tilly et al., 2009). The requirement for OspC ends by 28 days post-inoculation (Tilly et al.,
2006). The essential function of OspC in evasion from host innate defences can be replaced by
other lipoproteins, if properly regulated (Xu et al., 2008).
One function that is uniquely attributed to OspC is that of facilitating the dissemination of
B. burgdorferi. OspC-deficient spirochetes over-expressing heterologous lipoproteins were
shown not to be as efficient in disseminating to distal tissues as those over-expressing OspC
itself (Xu et al., 2008). Although OspC as a whole was shown to be involved in assisting the
dissemination of B. burgdorferi to remote tissues, this research work was the first of its kind
being able to delineate this particular function of OspC to at least 5-AA of the N-terminus of
OspC. This was also the first study to dissect the dissemination-facilitating function from the
protection-promoting role of OspC. A study by the Tilly, K. et al., however, reports
contradictory findings (Tilly et al., 2009). Their study suggests that OspC plays no role in
dissemination since spirochetes lacking OspC could disseminate and efficiently colonize distal
tissues within 3 weeks of infection. However, the spirochetes used in their study were hostadapted, and thus, it is not possible to discriminate between the role that OspC performs from the
role that a presumptive OspC surrogate (produced by the transferred host-adapted bacteria)
performs in facilitating dissemination of B. burgdorferi. Further experiments directed towards
solving this controversy are required.
Yet another function for OspC in the mammalian host is that of an adhesion to
endothelial cells for the colonization of the heart (Antonara et al., 2007). ospC transcripts were
shown to be more abundant in the heart than in any other tissues (Hodzic et al., 2003). Finally,
the role of OspC as a plasminogen receptor was confirmed by using ELISA and surface plasmon
resonance (Lagal et al., 2006). The results of this study suggest that the correlation between
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OspC polymorphism and Borrelia invasiveness is attributed in part to differences in OspC
affinity for plasminogen.
In spite of recent advances in borrelial genetics that led to the development of selectable
markers and shuttle vectors ((Bono et al., 2000, Eggers et al., 2002, Elias et al., 2003, Stewart et
al., 2001), targeted gene inactivation (Rosa et al., 2005), and identification of virulence factors
such as OspC, OspA/B and PncA (Grimm et al., 2004, Purser et al., 2003, Yang et al., 2004), the
use of these methodologies alone cannot help investigators elucidate the functions of these
virulence factors. The analysis of secondary structures and three-dimensional crystal structures
of solved proteins may lead to a more thorough understanding of the functions of these virulence
factors. However, the resolution of OspC in 2001 did not help much in elucidating the function
of this lipoprotein. Although a similarity between OspC and the aspartate receptor of Salmonella
was found (Kumaran et al., 2001), it did not have further implications. One reason for this gap in
knowledge being that research groups have so far been focusing on the OspC structure as it
relates to epitopes for the purposes of vaccine production and characterization of monoclonal
antibodies (Earnhart et al., 2007, Earnhart and Marconi, 2007, Yang et al., 2006).
The overall goal of this research project was to investigate how the secondary structure of
OspC relates to its functions and/or regulation of the ospC mRNA expression. This goal was
accomplished by deleting certain amino acid sequences of OspC and studying their effects on
infectivity, dissemination, spirochete burden, pathogenicity and ospC mRNA expression. A
summary of how the diverse amino acid sequences affect the function of the OspC protein, its
regulation of the ospC transcript, and other parameters are shown in Table 6.2.
The studies in this dissertation have shown that deletion of AA sequences within the core
structure of OspC led to complete loss of infectivity of B. burgdorferi, whereas deletions towards
the N-terminus or the C-terminus of the lipoprotein had different effects: from loss of infectivity,
150

depending on the number of amino acids deleted, to inefficient dissemination of the spirochetes
to distal tissues, or changes in pathogenicity, to changes in ospC mRNA accumulation. Thus, our
hypothesis that phenotypic changes related to the function(s) of OspC in B. burgdorferi can be
attributed to certain structures of OspC was proven to be true.
It is interesting that the roles that OspC plays in innate immune evasion and in
dissemination of B.burgdorferi have significance in the light of its regulation. While OspC aids
B. burgdorferi to evade early innate host defences at the site of the tick bite, its role in facilitating
dissemination aids the spirochetes to spread to distal tissues within two weeks, at which crucial
period anti-OspC borreliacidal antibodies have been developed. However, since the pathogen has
already disseminated to and colonized the remote tissues, it can then afford to downregulate
ospC expression. Although other lipoproteins can substitute the role of OspC in dissemination to
various extents, they are not as efficient and as fast in facilitating the dissemination as OspC (Xu
et al., 2008). One study has shown that OspC is not needed for persistence in the mammalian
host. It is hypothesized that other lipoproteins may to be able to substitute for the role of OspC
after a certain period (Tilly et al., 2009). VlsE, a lipoprotein that is required for persistence of B.
burgdorferi, may take over the function of OspC, which only remains a possibility.
It is interesting that the roles that OspC plays in innate protection and in dissemination of
B.burgdorferi have significance in the light of its regulation. While OspC assists B. burgdorferi
in evasion of host innate defences at the site of the tick bite, its role in facilitating dissemination
aids the spirochete to spread to distal tissues within two weeks, at which crucial period antiOspC borreliacidal antibodies have been developed. However, since the pathogen has already
disseminated to and colonized the remote tissues, it can then afford to downregulate ospC
expression. Although other lipoproteins can substitute the role of OspC in dissemination to
various extents, they are not as efficient and as fast in facilitating the dissemination as OspC
151

Table 6.2. The effect of OspC amino-acid sequence deletions on OspC function, regulation
of ospC transcript, and other parameters.a

OspC AA-sequence deleted

Function related to OspC

αH4
βs1
βs2
Nt10
Ct13

Loss of protection against host innate defenses

Nt5

No loss of protection against host innate defenses
Inefficient dissemination of spirochetes

Regulation of ospC transcript (SCID mice)
Heart

Joint

Skin

Nt5
Ct6
Ct9

Spirochete burden (SCID mice)
Heart Joint

Skin

Nt5
Ct6
Ct9

Arthritis virulence (SCID mice)
Nt5 and Ct6
Ct9
a.

Symbols:

: no change

Loss
Preserved

: Significantly increased

: Significantly decreased

(Xu et al., 2008). One study has shown that OspC is not needed for persistence in the
mammalian host. It is hypothesized that other lipoproteins may to be able to substitute for the
role of OspC after a certain period (Tilly et al., 2009). VlsE, a lipoprotein that is required for
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persistence of B. burgdorferi, may take over the function of OspC, which only remains a
possibility.
OspC is among the major lipoproteins regulated by the RpoN-RpoS pathway (Hubner et
al., 2001). The two-component response regulator Rrp2, along with RpoN, plays a role in
activating the transcription of rpoS (Yang et al., 2003). An operator region containing two
inverted repeats has been identified upstream of the RpoS-dependent promoter of ospC (Xu et
al., 2007). This operator is critical for the immune evasion of B. burgdorferi. A repressor for
ospC has not yet been identified. A recent study has shown that spirochetes lacking lp281 exhibit
a sustained and higher production of OspC, suggesting that ospC gene expression is
downregulated during murine infection by a repressor encoded on lp28-1 and that the absence of
the repressor in spirochetes lacking lp28-1 plasmid led to constitutive OspC production (Embers
et al., 2008).
OspC protein, on the other hand, is involved in self-regulation. This hypothesis was
confirmed by the results of this research project have shown that there was an either down- or
up-regulation of ospC mRNA transcripts in spirochetes expressing truncated OspC. When the Cterminus 6-AA and 9-AA sequence of OspC was deleted, there was a down-regulation of ospC
transcript, whereas when the N-terminus 5-AA sequence of OspC was deleted, there was an upregulation of ospC transcript compared to the transcripts of control spirochetes. However, we
cannot exclude the possibility that another molecule could be binding to these C-terminus or Nterminus sites and thus causing the effect in regulation of ospC transcript.
In conclusion, OspC is a virulence factor of B.burgdorferi that has multiple functions. In
deciphering the functions of this lipoprotein one can appreciate the pathogenicity of Borrelia
within the mammalian host. This research project was able to relate the structure of OspC to its
function and transcript regulation among other phenotypic changes. Since in biological solutions,
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OspC forms dimers, further studies of mutagenesis and crystal structure of truncated versions of
OspC will be helpful. Further studies are also needed to better understand the regulation of ospC.
Since OspC is involved in facilitating the dissemination of Borrelia in the mammalian host,
prevention of disease progression from an early stage to a disseminated stage can be possible. In
terms of regulation, molecular control over ospC regulation while the spirochetes remain in the
mammalian host could mean a discontinuation of the enzootic life cycle of the Lyme disease
spirochete, B. burgdorferi.
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APPENDIX A
CALCULATION OF ID50 VALUE BASED ON REED AND MUENCH MATHEMATICAL TECHNIQUE
Doses No. of infected No. of uninfected

Accumulated Number

105

10

0

Percentage of infected
Infected (A) Not infected (B) Total No. of tested(A+B)
31
0
31
31/31=100%

4

10

0

21

0

21

21/21=100%

10

3

8

2

11

2

13

11/13=85%

102

3

7

3

9

12

3/12=25%

1

0

10

0

19

19

0/19=0%

10

10

Calculation of the index
(% infected at dilution immediately above 50%) – 50%
Index = _______________________________________________________________________________
(% infected immediately above 50%) – (% infected immediately below 50%)

This is the application for calculating ID50, please prepare your data as shown above, then fill out the form below
Please input your number of dilution factor (it is 10 in the table above)
Please input the series of dilution from low to high (e.g. 1, 2, 3, 4, 5 in the table above)
Please input numbers of positive treatments (infected in the above table) in the series of dilution from low to high (0, 3, 8, 10, 10 in the
table above)
Please input numbers of negative treatments (uninfected in the above table) in the series of dilution from low to high (10, 7, 2, 0, 0 in
the table above)
Submit query
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APPENDIX B
COMPARISION OF ARTHRITIS VIRULENCE BETWEEN MICE
INOCULATED WITH CONTROL SPIROCHETES AND MICE
INOCULATED WITH SPIROCHETES EXPRESSING THE N-TERMINUS
5-AA DELETED OSPC
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